
<html lang="en"     class="pb-page"  data-request-id="48db8d5c-2cc2-47b9-bb40-31ea5cb141d0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-1;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b01360;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles" /></meta><meta name="dc.Creator" content="Shome S.  Bhunia" /></meta><meta name="dc.Creator" content="Ankita  Misra" /></meta><meta name="dc.Creator" content="Imran A.  Khan" /></meta><meta name="dc.Creator" content="Stuti  Gaur" /></meta><meta name="dc.Creator" content="Manish  Jain" /></meta><meta name="dc.Creator" content="Surendra  Singh" /></meta><meta name="dc.Creator" content="Aaruni  Saxena" /></meta><meta name="dc.Creator" content="Thomas  Hohlfield" /></meta><meta name="dc.Creator" content="Madhu  Dikshit" /></meta><meta name="dc.Creator" content="Anil K.  Saxena" /></meta><meta name="dc.Description" content="The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo an..." /></meta><meta name="Description" content="The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo an..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01360" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01360" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01360" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01360" /></link>
        
    
    

<title>Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01360" /></meta><meta property="og:title" content="Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0005.jpeg" /></meta><meta property="og:description" content="The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo antithrombotic activity, the most active compound 6b (ED50 = 28.36 μmol/kg po in mice) showed improved inhibition for collagen (IC50 = 6.7 μM), CRP-XL (IC50 = 53.5 μM), and convulxin (CVX) (IC50 = 5.7 μM) mediated platelet aggregation as compared to losartan (LOS) (collagen, IC50 = 10.4 μM; CRP-XL, IC50 = 158 μM; CVX, IC50 = 11 μM) than any of its enantiomers S (6c) (collagen, IC50 = 25.3 μM; CRP-XL, IC50 = 181.4 μM; CVX, IC50 = 9 μM) and R (6d) (collagen, IC50 = 126.3 μM; CRP-XL, IC50 &gt; 500 μM; CVX, IC50 = 86.8 μM). Compound 6b also inhibited platelet P-selectin expression and thus may diminish atherosclerosis. The molecular interactions of both enantiomers 6c and 6d at the GPVI receptor have been explained through docking studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01360"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01360">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01360&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01360&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01360&amp;href=/doi/10.1021/acs.jmedchem.6b01360" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 322-337</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01284" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01393" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-<i>b</i>)indoles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shome+S.++Bhunia">Shome S. Bhunia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ankita++Misra">Ankita Misra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Imran+A.++Khan">Imran A. Khan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuti++Gaur">Stuti Gaur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manish++Jain">Manish Jain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Surendra++Singh">Surendra Singh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaruni++Saxena">Aaruni Saxena</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Hohlfield">Thomas Hohlfield</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Madhu++Dikshit">Madhu Dikshit</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anil+K.++Saxena">Anil K. Saxena</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0212-7246" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Division of Medicinal and Process Chemistry, and <sup>‡</sup>Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">Academy of Scientific and Innovative Research, New Delhi 110 025, India</span></div><div class="corresp-info"><strong>*</strong>M.D.: phone, +91 522 2771940; e-mail, <a href="/cdn-cgi/l/email-protection#046965606c715b606d6f776c6d70446760766d2a7661772a6d6a"><span class="__cf_email__" data-cfemail="472a26232f3218232e2c342f2e33072423352e69352234692e29">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>A.K.S.: phone, +91-9839012951; e-mail, <a href="/cdn-cgi/l/email-protection#aecfc0c7c2ddcfc5eec9c3cfc7c280cdc1c3"><span class="__cf_email__" data-cfemail="49282720253a2822092e24282025672a2624">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01360&amp;href=/doi/10.1021%2Facs.jmedchem.6b01360" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 322–337</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 7, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 September 2016</li><li><span class="item_label"><b>Published</b> online</span>20 December 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01360" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01360</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D322%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShome%2BS.%2BBhunia%252C%2BAnkita%2BMisra%252C%2BImran%2BA.%2BKhan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D1%26contentID%3Dacs.jmedchem.6b01360%26title%3DNovel%2BGlycoprotein%2BVI%2BAntagonists%2Bas%2BAntithrombotics%253A%2BSynthesis%252C%2BBiological%2BEvaluation%252C%2Band%2BMolecular%2BModeling%2BStudies%2Bon%2B2%252C3-Disubstituted%2BTetrahydropyrido%25283%252C4-b%2529indoles%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D337%26publicationDate%3DJanuary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01360"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1207</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01360" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shome&quot;,&quot;last_name&quot;:&quot;S. Bhunia&quot;},{&quot;first_name&quot;:&quot;Ankita&quot;,&quot;last_name&quot;:&quot;Misra&quot;},{&quot;first_name&quot;:&quot;Imran&quot;,&quot;last_name&quot;:&quot;A. Khan&quot;},{&quot;first_name&quot;:&quot;Stuti&quot;,&quot;last_name&quot;:&quot;Gaur&quot;},{&quot;first_name&quot;:&quot;Manish&quot;,&quot;last_name&quot;:&quot;Jain&quot;},{&quot;first_name&quot;:&quot;Surendra&quot;,&quot;last_name&quot;:&quot;Singh&quot;},{&quot;first_name&quot;:&quot;Aaruni&quot;,&quot;last_name&quot;:&quot;Saxena&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Hohlfield&quot;},{&quot;first_name&quot;:&quot;Madhu&quot;,&quot;last_name&quot;:&quot;Dikshit&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;K. Saxena&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;322-337&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01360&quot;},&quot;abstract&quot;:&quot;The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo antithrombotic activity, the most active compound 6b (ED50 = 28.36 μmol/kg po in mice) showed improved inhibition for collagen (IC50 = 6.7 μM), CRP-XL (IC50 = 53.5 μM), and convulxin (CVX) (IC50 = 5.7 μM) mediated platelet aggregation as compared to losartan (LOS) (collagen, IC50 = 10.4 μM; CRP-XL, IC50 = 158 μM; CVX, IC50 = 11 μM) than any of its enantiomers S (6c) (collagen, IC50 = 25.3 μM; CRP-XL, IC50 = 181.4 μM; CVX, IC50 = 9 μM) and R (6d) (collagen, IC50 = 126.3 μM; CRP-XL, IC50 &gt; 500 μM; CVX, IC50 = 86.8 μM). Compound 6b also inhibited platelet P-selectin expression and thus may diminish atherosclerosis. The molecular interactions of both enantiomers 6c and 6d at the GPVI receptor have been explained through docking studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01360&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01360" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01360&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01360" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01360&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01360" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01360&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01360&amp;href=/doi/10.1021/acs.jmedchem.6b01360" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01360" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01360" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01360%26sid%3Dliteratum%253Aachs%26pmid%3D27996269%26genre%3Darticle%26aulast%3DBhunia%26date%3D2017%26atitle%3DNovel%2BGlycoprotein%2BVI%2BAntagonists%2Bas%2BAntithrombotics%253A%2BSynthesis%252C%2BBiological%2BEvaluation%252C%2Band%2BMolecular%2BModeling%2BStudies%2Bon%2B2%252C3-Disubstituted%2BTetrahydropyrido%25283%252C4-b%2529indoles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D1%26spage%3D322%26epage%3D337%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/jmcmar.2017.60.issue-1/20170112/jmcmar.2017.60.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo antithrombotic activity, the most active compound <b>6b</b> (ED<sub>50</sub> = 28.36 μmol/kg po in mice) showed improved inhibition for collagen (IC<sub>50</sub> = 6.7 μM), CRP-XL (IC<sub>50</sub> = 53.5 μM), and convulxin (CVX) (IC<sub>50</sub> = 5.7 μM) mediated platelet aggregation as compared to losartan (LOS) (collagen, IC<sub>50</sub> = 10.4 μM; CRP-XL, IC<sub>50</sub> = 158 μM; CVX, IC<sub>50</sub> = 11 μM) than any of its enantiomers <i>S</i> (<b>6c</b>) (collagen, IC<sub>50</sub> = 25.3 μM; CRP-XL, IC<sub>50</sub> = 181.4 μM; CVX, IC<sub>50</sub> = 9 μM) and <i>R</i> (<b>6d</b>) (collagen, IC<sub>50</sub> = 126.3 μM; CRP-XL, IC<sub>50</sub> > 500 μM; CVX, IC<sub>50</sub> = 86.8 μM). Compound <b>6b</b> also inhibited platelet P-selectin expression and thus may diminish atherosclerosis. The molecular interactions of both enantiomers <b>6c</b> and <b>6d</b> at the GPVI receptor have been explained through docking studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The sequential activation of platelets on interaction with extracellular matrix proteins in artery wall is the key determinant leading to atherothrombotic complications culminating in coronary and cerebrovascular diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> GPVI, a type I transmembrane glycoprotein of the immunoreceptor family at platelet surface, has a decisive role in thrombus formation due to its participation in collagen mediated platelet activation and adhesion.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The clinical and experimental studies have established significant role of GPVI in the hemostasis. Regulation of its expression level has direct link in the prognosis of acute cardiovascular diseases, as enhanced expression of GPVI on circulating platelets is an early marker of myocardial infarction and ischemic stroke.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The distinguishing role of GPVI in arterial thrombosis has invoked the development of competitive inhibitors targeting collagen–GPVI interaction having the potential to block GPVI-dependent thrombotic events to prevent cardiovascular complications. The current antiplatelet agents in the management of pathological thrombosis such as aspirin (cyclooxygenase inhibitor), clopidogrel and prasugrel (ADP receptor antagonists), cilostazol (phosphodiesterase inhibitor), and abciximab (fibrinogen receptor blocking antibodies) are associated with undesirable side effects like gastrointestinal bleeding, cerebral hemorrhage, and neutropenia.</div><div class="NLM_p">The extracellular domain of GPVI involved in binding of fibrous collagen is defined by two immunoglobin like domains D1 (N-terminal) and D2 (C-terminal) that share high level of sequence conservation with other leukocyte Ig-like receptor complex (LRC) such as FcαRI and the leukocyte Ig-like (LILR or LIR) and killer-cell Ig-like (KIR) receptor families.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Interestingly, triggering of platelet activation and downstream signaling through GPVI is not only restricted to physiological collagen but is extended up to the recognition of diverse ligands such as synthetic triple-helical collagen related peptides (CRP) that have a repeated GPO motif (glycine–proline–hydroxyproline) and CVX (CVX), a multimeric, C type lectin-like toxin from the venom of a rattlesnake having higher affinity toward GPVI as compared to collagen and CRP.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> Monoclonal antibody binding assays have led to the determination of distinct sites with sharing of some common residues at the functional domain of GPVI for binding with collagen, CRP, and CVX.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">A number of contemporary studies have strengthened the concept of blocking GPVI–collagen interactions as an attractive strategy for the treatment of thromboischemic diseases. The beneficial role of GPVI fusion (GPVI-Fc) proteins has been shown in the reduction of atheroprogression<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> and infarct size with improvement in arterial remodeling<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and regaining of myocardial function<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in murine models. The GPVI receptor as a pharmacological target has a superlative aspect of minimal bleeding time that indicates that antiplatelet strategies targeting GPVI/collagen could be an attractive alternative for preventing pathological thrombosis without hemostatic negotiation.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> Hence the development of small GPVI antagonists may have high therapeutic value.</div><div class="NLM_p">Losartan (I) (LOS) and its metabolite (EXP3179) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) (concentration of both at 500 μM/L has significant effect on collagen (2 μg/mL) mediated platelet aggregation) were the first small molecules identified as GPVI inhibitors independent of angiotensin 1 (AT1) receptor antagonism.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In this study Grothusen et al. have reported that LOS prevents collagen I mediated platelet aggregation when stimulated by selective GPVI-receptor activating antibody 4C9 in human PRP (platelet-rich plasma), thus indicating that LOS prevents collagen mediated platelet aggregation. The first evidence about the direct interaction of LOS with GPVI protein was reported by Ono et al. where LOS has <i>K</i><sub>D</sub> = 1.7 × 10<sup>–4</sup> M for human GPVI receptor.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, in a recent study it has been reported that LOS does not compete with collagen for binding to GPVI; instead it inhibits the collagen induced clustering of GPVI on platelets.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> LOS is followed by other small molecule antagonists such as cinanserin (III) (IC<sub>50</sub> = 35 μM and 40 μM for CRP (1 μg/mL) and collagen (2 μg/mL) mediated platelet aggregation, respectively; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> discovered through structure based repurposing, S14161 (IV) (IC<sub>50</sub> = 3.79 ± 1.17 μM for collagen (2 μg/mL) mediated platelet aggregation) a Pan-PI3K inhibitor<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and other small molecules such as CompA(VI) (<i>K</i><sub>D</sub> = (5.2 ± 0.4) × 10<sup>–5</sup> M), CompB (VII) (no chemical shift perturbation in NMR based study), and CompC (VIII) (<i>K</i><sub>D</sub> = (8.5 ± 0.5) × 10<sup>–4</sup> M) derived through combination of losartan substructure and an active peptide molecule pep10L(YSDTDWLYFSTS) (<i>K</i><sub>D</sub> = 5.7 × 10<sup>–5</sup> M) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The binding site of LOS has been interpreted at the hydrophobic pocket of the GPVI receptor through NMR and docking based interaction studies.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This binding site has been also postulated to be the binding site for the peptide ligands (pep10L).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Although these compounds prevent GPVI mediated platelet activation, still there is a need for specific inhibitors that selectively block GPVI mediated platelet activation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the compounds that prevent collagen mediated platelet aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We report here the development of a selective, racemic small-molecule antagonist with β-carboline core, initially screened from a series of potential antithrombotic candidates (based on in vivo activity). The design of these molecules was based on the observed antiaggregatory effect of 3<i>S</i>-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid moiety present in plant <i>A. chinense</i> G. Don.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> There are ample evidence about β-carboline alkaloids preventing collagen-induced platelet aggregation.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Further the synthesized molecules reported by us have a tryptophan substructure in the β-carboline core that is reported to be essential for the binding of the peptide antagonist pep10L at the GPVI active site.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p last">The binding interactions for the most active compound in the series at the GPVI receptor were further determined with the help of docking studies. The insights gained in this study may provide opportunities for the development of small molecular therapeutics targeting GPVI.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Tryptophan was used as a precursor to synthesize the target 2,3-disubstituted pyridoindoles. Unlike our earlier reported<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and successively used method<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> where the first step was the Pictet–Spengler cyclization of tryptophan with formaldehyde followed by the esterification of the 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole carboxylic acid thus obtained, the procedure was changed where in the first step the methyl ester of tryptophan was synthesized using dry methanol and thionyl chloride (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). It was then followed by Pictet–Spengler cyclization reaction of this ester to give the hydrochloride of the methyl 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole carboxylate hydrochloride salt which on treatment with sodium bicarbonate (NaHCO<sub>3</sub>) yielded the free base (<b>3</b>). The free base (<b>3</b>) thus obtained was converted to respective sulfonamides (<b>4a</b>–<b>l</b>) by treatment with individual sulfonyl chlorides using a combination of DMF as solvent with triethylamine (TEA) at room temperature.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reagents and conditions: (a) SOCl<sub>2</sub>, dry methanol, −10 to 30 °C; (b) HCHO, MeOH, H<sub>2</sub>O; (c) NaHCO<sub>3</sub> saturated solution; (d) R-SO<sub>2</sub>-Cl, dry acetone, TEA; (e) MeOH,NH<sub>3</sub>; (f) 2 N NaOH, H<sub>2</sub>O, 1,4-dioxane; (g) COCl<sub>2</sub>, dry THF; (h) TEA, R-NH<sub>2</sub>, dry THF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole carboxamide (<b>5</b>) was synthesized by dissolving the ester (<b>3</b>) in methanolic ammonia under sealed conditions and kept overnight. The reaction of the 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole carboxamide (<b>5</b>) with different sulfonyl chlorides yielded the corresponding sulfonamides (<b>6a</b>–<b>i</b>) under similar reaction conditions as described above for the conversion of esters to their sulfonamides. The amine substitutions at position 3 of the tetrahydropyridoindole were further explored by synthesizing compounds <b>9a</b>–<b>d</b>. Compounds <b>9a</b>–<b>d</b> were synthesized by de-esterification of the starting compounds <b>7a</b> and <b>7b</b> to yield their corresponding acids (<b>8a</b>, <b>8b</b>) followed by the conversion of the acids to acid chlorides using oxalyl chloride. The reaction mixture containing the acid chlorides was concentrated under high vacuum conditions and without further isolation was treated with individual amines in the presence of dry THF and TEA to yield <b>9a</b>–<b>d</b>.</div></div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structure–Activity Relationship</h3><div class="NLM_p">In order to investigate the structural requirements involving the pyridoindole core, we have synthesized 25 derivatives with a substitution of diverse functionalities to rationalize the antithrombotic activity of these compounds in terms of structural modifications. The antithrombotic activity was examined in the mouse antithrombotic model employed primarily for the screening of antiplatelet agents. Through this screening method we have identified some promising antiplatelet agents (ED<sub>50</sub> = 28–91 μmol/kg). Among these synthesized compounds the compound substituted by a methylsulfonyl and methyl carboxylate at 2 and 3 positions of 1,2,3,4-tetrahydropyridoindole (<b>4a</b>) showed good activity (ED<sub>50</sub> = 54.09 μmol/kg). Since it has a asymmetric center at 3-position, its two enantiomers <i>S</i> (<b>4b</b>) and <i>R</i> (<b>4c</b>) were evaluated where the racemic <b>4a</b> (50% protection; ED<sub>50</sub> = 54.09 μmol/kg) showed better activity than the corresponding <b>4b</b> (20% protection) and <b>4c</b> (20% protection) enantiomers. However, the compounds having aryl/heteroaryl sulfonyl substituent at 2-position showed improved activity; viz., the compound with a quinonylsulfonyl, <b>4d</b> (ED<sub>50</sub> = 41.94 μmol/kg), and with a 2,5-dichlorophenylsulfonyl substitution <b>4g</b> (ED<sub>50</sub> = 36.1 μmol/kg). Thus, aromatic hydrophobic substituents at this position showed positive contribution toward activity. Similar to compound <b>4a</b>, the enantiomers of the compounds <b>4d</b> (<b>4e</b> and <b>4f</b>) and <b>4g</b> (<b>4h</b> and <b>4i</b>) also exhibited lower activity than their corresponding racemates. The compound <b>4j</b> with 5-dimethylaminonaphthylsulfonyl substitution showed promising antithrombotic activity, while <b>4k</b> with 2,4,6-trimethylphenylsulfonyl substitution showed lower activity than <b>4j</b>. The compound <b>4l</b> with the 2-trifluoromethylphenylsulfonyl substitution showed improvement in activity. To explore further, compound <b>4g</b> having a methyl ester at the 3-position of the 1,2,3,4- tetrahydropyridoindole moiety was modified to an amide functionality that resulted in compound <b>6a</b> (ED<sub>50</sub> = 68.34 μmol/kg). The other amide analogs such as compound <b>6b</b> with a 4-methoxyphenylsulfonyl (ED<sub>50</sub> = 28.36 μmol/kg), <b>6e</b> (ED<sub>50</sub> = 40.79 μmol/kg) with a 4-fluorophenylsulfonyl, and <b>6f</b> with a 2-naphthylsulfonyl moiety showed better antithrombotic activity compared to <b>6a</b>. Compound <b>6g</b> with a 3-nitrophenylsulfonyl substitution at the N2 atom showed a moderate decrease in antiplatelet activity (ED<sub>50</sub> = 80.68 μmol/kg). No significant loss in activity was observed for the amide <b>6h</b> as compared to ester compound <b>4d</b>, while improvement in activity was observed on amidation of the compound <b>4k</b> to <b>6i</b>. As the compound <b>6f</b> with a naphthylsulfonyl and carboxamido groups at 2 and 3 positions, respectively, showed better activity, further modifications were performed at the 3-position where the carboxamide group was modified with propylamide (<b>9a</b>) and isopropylamide groups (<b>9b</b>). However, both these compounds <b>9a</b> (ED<sub>50</sub> = 66.54 μmol/kg) and <b>9b</b> (ED<sub>50</sub> = 91.19 μmol/kg) showed a decrease in activity; hence the 2-naphthylsulfonyl moiety was replaced with a 2-phenylsulfonyl group that resulted in improved activity. Compound <b>9c</b> (ED<sub>50</sub> = 42.64 μmol/kg) substituted by 3-propylamido group displayed better activity than compound <b>9d</b> (ED<sub>50</sub> = 63.62 μmol/kg) having a isopropylamido group.</div><div class="NLM_p last">As <b>6b</b> turned to be the most potent compound in the series, further investigations on its isomers <b>6c</b> and <b>6d</b> were performed, but none of them were found to be equipotent compared to <b>6b</b>.</div></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biology. Collagen–Epinephrine Induced Pulmonary Thromboembolism in Mice</h3><div class="NLM_p">The compounds were screened for their antithrombotic efficacy in a mice model of collagen–epinephrine induced pulmonary thromboembolism. Compounds <b>4g</b> and <b>6b</b> exhibited remarkable antithrombotic potential, with <b>6b</b> displaying the lowest ED<sub>50</sub> (28.36 μmol/kg) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and hence was preferred over <b>4g</b> (ED<sub>50</sub> = 36.1 μmol/kg) for a more detailed investigation for its probable mode of action and specific target.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vivo Antithrombotic Activity of the Pyridoindole Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Sl.no</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">antithrombotic activity (% protection at 30 μmol/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (μmol/kg)</th><th class="colsep0 rowsep0" align="center">Sl.no</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">antithrombotic activity (% protection at 30 μmol/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (μmol/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">54.09</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">28.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">41.94</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">40.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">80.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">36.10</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">66.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">91.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">42.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">55.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">63.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">68.34</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">aspirin</td><td class="colsep0 rowsep0" align="left">38 ± 3</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">The antithrombotic efficacy of compound <b>6b</b> was further evaluated against collagen–epinephrine induced thrombosis in mice in a dose and time dependent study (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). Compound <b>6b</b> (30 μmol/kg) displayed a significant protection against thrombotic challenge (60 ± 1%; 1 h, po dosing) which was sustained for up to 24 h (30%) and thus highlights its excellent bioavailability (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). The standard antiplatelet drugs aspirin (170 μmol/kg) and clopidogrel (70 μmol/kg) were effective only up to 5 h after which their effect perishes and that too at a very high dose sufficient enough to cause bleeding complications. The bleeding time for compound <b>6b</b> was found to be similar to aspirin for 4 h and clopidogrel for 6 h after which it was reduced (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c) gradually. However, the mice treated with losartan exhibited low bleeding time when compared to mice treated with <b>6b</b>. Compound <b>6b</b> also depicted better protection in ferric chloride induced arterial thrombosis in mice (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_001.pdf" class="ext-link">Supporting Information Figure S1</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>6b</b> on collagen–epinephrine induced pulmonary thromboembolism in mice in (a) time dependent study and (b) dose dependent study. Results are expressed as the mean ± SEM (<i>n</i> = 5, 10 animals/group/experiment). (c) Effect of compound <b>6b</b> on bleeding time (aspirin, 170 μmol/kg; clopidogel, 70 μmol/kg; losartan, 100 μmol/kg; <b>6b</b>, 30 μmol/kg). Effect of compound <b>6b</b> on coagulation cascade in human plasma (in vitro) at various concentrations: (d) thrombin time, (e) prothrombin time, (f) activated partial thromboplastin time (<i>n</i> = 3). Results are expressed as the mean ± SEM. (g) Effect of compound <b>6b</b> on human platelet adhesion (in vitro) on collagen coated surface in presence and absence of Mg<sup>2+</sup> (<i>n</i> = 3). Data are shown as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs control. (h) Effect of compound <b>6b</b> on aggregation of human platelets (in vitro) induced by TRAP (thrombin receptor activating peptide), ristocetin, arachidonic acid, and ADP (<i>n</i> = 3). Results are expressed as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs vehicle. Effect of compounds <b>6b</b>, <b>6d</b>, and <b>6c</b> on aggregation of human platelet rich plasma (in vitro) induced by (i) collagen, (j) convulxin, and (k) CRP-XL. (l) Effect of compound <b>6b</b> on collagen, CRP-XL, and convulxin induced aggregation in human platelet rich plasma (in vitro).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibition of Platelet Aggregation by Compound <b>6b</b> and Its Isomers</h3><div class="NLM_p">The effects of the active compound <b>6b</b> and its isomers <b>6c</b> (<i>S</i> isomer) and <b>6d</b> (<i>R</i> isomer) were further assessed for their inhibitory potential against platelet aggregation as well as coagulation cascade, in order to identify their probable mechanism of antithrombotic action. The compounds did not display any alteration in the coagulation cascade, as evident from the assessment of thrombin time (TT) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d), prothrombin time (PT) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>e), and activated partial thromboplastin time (aPTT) in human plasma (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>f). Thus, the antithrombotic mechanism of compound <b>6b</b> and its isomers may be platelet specific and thus was further evaluated for the identification of its target receptor over platelet surface.</div><div class="NLM_p">Compound <b>6b</b> and its isomers <b>6c</b> and <b>6d</b> did not inhibit ADP, TRAP, and arachidonic acid induced platelet aggregation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>h). However, compound <b>6b</b> and its isomer <b>6c</b> significantly inhibited collagen-induced aggregation in a concentration-dependent manner, in contrast to the other isomer <b>6d</b>, which showed no promise at lower concentrations but only at 300 μM (IC<sub>50</sub> = 126.3 μM). Among the two active compounds, the racemic mixture <b>6b</b> exhibited a relatively better platelet inhibitory profile (IC<sub>50</sub> = 6.7 μM) than its enantiomer <b>6c</b> (IC<sub>50</sub> = 25.3 μM) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>i) and hence was further pursued for the identification of its target receptor (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Collagen, CRP-XL, and CVX Mediated Platelet Aggregation by <b>6b</b>, <b>6c</b>, and <b>6d</b> Compared with LOS and LOS-met</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">collagen</th><th class="colsep0 rowsep0" align="center">CRP-XL</th><th class="colsep0 rowsep0" align="center">CVX</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">53.5</td><td class="colsep0 rowsep0" align="left">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">25.3</td><td class="colsep0 rowsep0" align="left">181.4</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">126.3</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">86.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LOS</td><td class="colsep0 rowsep0" align="left">10.4</td><td class="colsep0 rowsep0" align="left">158</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LOS-met</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">50</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Identification of the Target Receptor: Platelet Adhesion</h3><div class="NLM_p last">To further address whether compound <b>6b</b> interferes with platelet adhesion by selectively binding to GPVI, it was further examined on human platelet adhesion to fibrillar collagen in the presence of Mg<sup>2+</sup> (integrin mediated) and in the absence of Mg<sup>2+</sup> (GPVI mediated). Compound <b>6b</b> significantly inhibited GPVI mediated platelet adhesion over fibrillar collagen in a concentration dependent manner. On the contrary, the integrins mediated platelet adhesion to collagen in the presence of Mg<sup>2+</sup> remained unaltered even at a concentration of 100 μM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>g). Thus, <b>6b</b> effectively inhibited GPVI mediated platelet adhesion under static conditions.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Identification of the Target Receptor: Platelet Aggregation</h3><div class="NLM_p">In a platelet suspension ristocetin promotes vWF-GPIb-IX-V interaction and aggregates platelets. Compound <b>6b</b> did not reduced ristocetin-induced platelet aggregation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>h), indicating that GPIb-IX-V is not a target for <b>6b</b>.</div><div class="NLM_p last">Two specific agonists were used to examine the probable interaction between <b>6b</b> and GPVI: the synthetic, triple-helical, collagen-related peptide (CRP) based on a repeated GPO (glycine–proline–hydroxyproline) motif,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and convulxin (CVX), a multimeric C-type lectin-like toxin from the venom of a rattlesnake.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Both molecules activate platelets selectively via GPVI. Compound <b>6b</b> attenuated both CRP-XL (IC<sub>50</sub> = 53.5 μM) and CVX (IC<sub>50</sub> = 16.3 μM) induced platelet aggregation in a concentration-dependent manner (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>l); however, the platelet inhibition was more pronounced against CVX and was almost similar to that observed against collagen induced platelet aggregation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>l). Compound <b>6c</b> (<i>S</i>), however, better attenuated CRP-XL mediated platelet aggregation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>k) when compared to collagen (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>i) and CVX (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>j). The other isomer <b>6d</b> (<i>R</i>) showed promising activity at higher concentrations. It should be noticed that the racemic mixture <b>6b</b> showed better antithrombotic profile than compound <b>6c</b> in collagen induced platelet aggregation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>i).</div></div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Effect of Compound <b>6b</b> on Collagen Induced P-Selectin Expression</h3><div class="NLM_p">Collagen (30 μg/mL) stimulated P-selectin expression in platelets more than 10-fold in comparison to control. Compound <b>6b</b> did not change basal platelet P-selectin expression. However, compound <b>6b</b> exerted a concentration-dependent inhibition of collagen-stimulated platelet P-selectin expression, which was statistically significant at a concentration of 300 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Effect of compounds <b>6b</b>, <b>6d</b>, and <b>6c</b> on platelet P-selectin expression in human platelet rich plasma (in vitro) induced by collagen. <i>n</i> = 4. Results are expressed as the mean ± SEM: control = unstimulated platelets; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle. (b) Effect of compound <b>6b</b> at different concentrations on collagen induced P-selectin expression of human platelets. <i>n</i> = 3. Data are shown as the mean ± SEM: control = unstimulated platelets; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle. Effect of compound <b>6b</b> at different concentrations on (c) collagen induced ATP release from human platelets, (d) collagen induced thromboxane A<sub>2</sub> release from human platelets. <i>n</i> = 3. Data are shown as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs control. (e, f) Effect of <b>6b</b> at different concentrations on collagen induced intraplatelet calcium mobilization in Fura-2AM loaded human platelets. Effect of compound <b>6b</b> at different concentrations on collagen induced (g) global tyrosine phosphorylation of platelet proteins, (h) tyrosine phoshorylation of PLC-γ2. Washed platelets preincubated at 37 °C with vehicle or various concentrations of <b>6b</b> for 5 min were further stimulated with collagen (2 μg/mL). Blots are representative of three separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of Compound <b>6b</b> on Collagen Induced ATP Release</h3><div class="NLM_p last">The results presented in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>c depicts that compound <b>6b</b> prevented ATP release from collagen stimulated platelets in a concentration dependent manner. The concentrations of <b>6b</b> required to inhibit dense granule secretion were comparable to those required to inhibit platelet aggregation.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effect of Compound <b>6b</b> on Collagen Induced Thromboxane A2 Generation</h3><div class="NLM_p last">Upon collagen stimulation, platelets released thromboxane A<sub>2</sub> which was significantly inhibited by compound <b>6b</b> in a concentration dependent manner (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>d). Moreover, the COX inhibitor aspirin exhibited a significant inhibition in collagen stimulated platelets, thus confirming the importance of secondary mediators in collagen signaling.</div></div><div id="sec2_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effect of Compound <b>6b</b> on Collagen Induced [Ca<sup>2+</sup>]i Mobilization</h3><div class="NLM_p last">The effect of compound <b>6b</b> on [Ca<sup>2+</sup>]i mobilization was observed after 5 min of incubation with platelet before adding the collagen. Collagen induced a slow but stable increase of [Ca<sup>2+</sup>]i, which reached the peak level of 300 nM after 3 min. Pretreatment of platelet suspension with <b>6b</b> attenuated the elevation of the [Ca<sup>2+</sup>]i in response to collagen in a concentration dependent manner (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>e and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>f).</div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effect of Compound <b>6b</b> on Collagen Induced Tyrosine Phosphorylation</h3><div class="NLM_p last">The activation of platelets by collagen involving GPVI interaction causes tyrosine phosphorylation of various proteins in platelets, which peaked at about 1–1.5 min after activation and gradually declines after 5 min. Hence, platelets incubated with <b>6b</b> were stimulated with collagen for 1 min and then subjected to Western blotting with an anti-phosphotyrosine antibody. It revealed that the phosphorylated level of few proteins was decreased at 3 and 10 μM, which was further reduced to its entirety at concentrations ranging from 30 to 100 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>g) compared to the vehicle control. It also attenuated the phosphorylation of PLC-γ2 at tyrosine residue, thereby implicating that the compound disrupts platelet function via modulation of collagen induced signaling cascade (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>h).</div></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Docking Studies</h3><div class="NLM_p">The docking studies for compounds <b>6c</b> and <b>6d</b> were performed using the induced fit docking (IFD) protocol to ascertain their binding priority for each of the racemates at the LOS binding site. The binding area for S1 was defined by the residues E40 to R60 which had been reported to be the binding site for LOS based on NMR study. We considered the results for the 10 best docked conformations for each of the enantiomers <b>6c</b> and <b>6d</b> giving priority for conformations showing the best induced fit XP docking score and having the tryptophan moiety at the base of the binding groove. Among the two enantiomers, the best docked conformation of <b>6c</b> showed a better docking score (Glide XP score = −5.2) than the compound <b>6d</b> (Glide XP score = −4.28) at this site. The mean docking score for all 10 conformers of compound <b>6c</b> at the site (Glide XP score = −4.73) is also higher than the mean docking score of <b>6d</b> (Glide XP score = −4.03), indicating the preference of <i>S</i> enantiomer <b>6c</b>. The 10 best conformations of <b>6c</b> (<i>S</i>-isomer) were found to harbor the β-carboline fragment in the D1 domain of GPVI in a similar fashion with slight differences in conformational orientation. The phenyl ring of the indole moiety resided in the hydrophobic pocket formed by the residues L53 and I55 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). The nitrogen atom of the indole fragment showed H-bond interaction with the hydroxyl group of Y66 at the base of the hydrophobic pocket. The sulfonyl moiety in <b>6c</b> had hydrogen bond interactions with S44 and K41, and the attached 4-methoxyphenyl group, besides maintaining hydrophobic contacts with L62, formed H-bond contacts with S61 and K59 through the oxygen atom of the methoxy group. The nitrogen atom of the carboxamide fragment attached to the C3 carbon formed hydrogen bond contact with backbone carbonyl of R46. Unlike <b>6c</b> the 10 best poses of <b>6d</b> were not similar regarding the binding location of the β-carboline moiety at the site, as we got three different binding preferences for the β-carboline moiety. The best binding conformation of <b>6d</b> has the phenyl methoxy moiety in the hydrophobic groove formed by the residues L39 and L53 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b). The β-carboline fragment in the <b>6d</b> remained planar with the indole nitrogen facing toward the hydrophobic groove formed by L53, I55, and L62. The carboxamide fragment in <b>6d</b> maintained hydrogen bond contact with the side chain of S44 and backbone carbonyl of S61, respectively. The other H-bond contacts for this molecule included contact of the oxygen atom in the 4-methoxyphenyl moiety with the side chain of K59. These docking studies do explain the observed higher activity of <b>6c</b> (<i>S</i>) enantiomer than the corresponding <b>6d</b> (<i>R</i>) isomer. However, the higher activity of the racemic compound <b>6b</b> than any of these enantiomers may be due to a second binding site that may exist at the interdomain region.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Best conformation of compound <b>6c</b> at the primary binding site of GPVI (site 1). (b) Best conformation of <b>6d</b> at the primary binding site of GPVI (site 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Collagen is the most reactive component of the extracellular matrix, and its interactions with the platelets play a pivotal role in the initiation of hemostasis and thrombosis in vivo. The GPVI has a central role in platelet activation by collagen and thus is considered as a potential pharmacological target for the treatment of ischemic cardiovascular diseases and stroke.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, there is considerable interest in developing novel agents against collagen mediated platelet activation, such as peptide based receptor antagonists,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> snake venom metalloproteinase (Kistomin),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> human GPVI-specific monoclonal antibody (acts via cAMP-dependent endocytosis of the GPVI),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> or GPVI-Fc fusion protein revacept<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> that directly blocks vascular collagen at atherosclerotic plaques or ruptured endothelium. With these approaches still under investigation, we took an initiative to develop a clinically useful synthetic molecule targeting platelet–collagen interaction at the sites of arterial injury or plaques. This compound <b>6b</b> (CDRI-S002-333) is undergoing pharmacokinetic<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40">(35-40)</a> and toxicological studies. From the pharmacokinetic studies it was observed that the isomer <b>6c</b> or <b>6d</b> does not interconvert in vivo.</div><div class="NLM_p">The present study, therefore, describes a novel synthetic platelet GPVI antagonist, <b>6b</b>, that blocks platelet adhesion to collagen and subsequent platelet aggregation and signaling. Compound <b>6b</b> thus might prevent a very early step in acute vascular thrombosis and might hold promise for a reduced risk of associated complications due to the exclusive presence of GPVI receptor on platelets and megakaryocytes.</div><div class="NLM_p">The mice treated with <b>6b</b> were protected from the collagen–epinephrine induced pulmonary thromboembolism. Its antithrombotic efficacy was much better as compared to the standard antiplatelet drug aspirin, while it was almost similar to that of P2Y12 antagonist clopidogrel, when studied in the same model. Moreover, <b>6b</b> exhibited its antithrombotic potential for almost 24 h and thus displayed an excellent bioavailability, in contrast to the standard antiplatelet drugs, aspirin and clopidogrel, which remained active for merely 4–6 h in the same study. Furthermore, our results are in agreement with the previous report by Nieswandt et al. which stated that mice depleted of GPVI were completely protected from lethal collagen-induced pulmonary thromboembolism.</div><div class="NLM_p">The current view of collagen-induced platelet activation is that collagen initially interacts with GPVI and integrin α2β1, and platelet activation signals are then conveyed by GPVI. Therefore, we confirmed the possibility of direct interactions between <b>6b</b> and platelet GPVI by the following pieces of evidence: (1) the two GPVI receptor agonists CRP and CVX competed with <b>6b</b> for platelet aggregation, while the other agonists (ADP, TRAP, arachidonic acid, and ristocetin) mediated platelet aggregation remained unaffected; (2) the platelets treated with <b>6b</b> were prevented from GPVI dependent adhesion over fibrillar collagen, while the other adhesion mechanism via integrins remained unaltered. The compound did not modify the coagulation cascade and hence might be platelet specific pertaining to its mode of antithrombotic action</div><div class="NLM_p">Although compound <b>6b</b> exhibited a profound platelet inhibition via GP VI antagonism, it displayed a disparity in the inhibitory profiles against the three GPVI agonists (IC<sub>50</sub>: CVX > collagen ≫ CRP-XL). Platelet GPVI belongs to the immunoglobulin superfamily of receptors with two Ig-like loops in their extracellular domain and hence binds to their ligands using either the first or the second loop or the hinge interdomain region. Studies involving GPVI chimeric proteins, anti-GPVI monoclonal antibodies, and mutant recombinant soluble GPVI proteins have postulated that although collagen, CVX, and CRP binding sites share various overlapping features, at the same time they also recognize some distinct residues required for the specific interaction of these ligands. Both collagen and CVX are complex multimeric proteins requiring the participation of both the GPVI extracellular loops, and thus their binding site appears to be widespread covering a larger surface on GPVI. CRP, in contrast, requires only the first Ig loop for binding, and the presence of other loop is indispensable for its binding to GPVI. These structural discrepancies regarding GPVI and ligand interaction might be responsible for the different pattern (IC<sub>50</sub>) of platelet inhibition by <b>6b</b> following stimulation with different GPVI specific agonists.</div><div class="NLM_p">Compound <b>6b</b> effectively blunted the release of ATP from dense granules as well as the cycloxygenase mediated thromboxane A2 production following collagen stimulation. These observations indicated that <b>6b</b> blocked the GPVI receptor, thereby preventing platelet activation and interfered with intracellular signaling that further prevented the release of platelet granule components as well as COX activity. The inhibitory action of compound <b>6b</b> on collagen mediated platelet signaling was further studied on various platelet nonreceptor tyrosine kinases. The compound reduced the phosphorylation phospholipase γ-2 and arrested the assembly of platelet signaling complex following collagen stimulation. Intraplatelet calcium mobilizations induced by collagen were severely attenuated in the presence of <b>6b</b>, which was manifested not only as a reduction in maxima but also as a delay in its onset.</div><div class="NLM_p">These results clearly indicated that compound <b>6b</b> inhibited platelet collagen interaction by blocking GPVI and thus interfered at the preliminary step of thrombus initiation. In addition to their pivotal role in thrombosis and wound repair, the growing literature regarding the proinflammatory capacity of platelets suggests that the potential drug targets directed at inhibiting platelet function may also provide alternative and powerful treatments for inflammatory diseases in the future. Boilard  et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> used both genetic and pharmacologic approaches to identify the collagen receptor GPVI as a key trigger for platelet microparticle generation in arthritis pathophysiology, and hence antagonism of this receptor represents a novel therapeutic approach. Therefore, besides its role as an antithrombotic agent, <b>6b</b> might be an attractive compound to study the functional consequences of blocking platelet GPVI during chronic inflammatory diseases like rheumatoid arthritis and atherosclerosis. However, the present study warrants further studies to emphasize the therapeutic promise of the <b>6b</b> initially characterized here.</div><div class="NLM_p">The effects of <b>6b</b> were also studied on P-selectin expression. P-selectin, a transmembrane protein, is involved in inflammatory responses by regulating the leucocytes adherence onto the endothelium. Other strong function of P-selectin is seen in atherosclerosis because in the case of P-selectin deficiency a delay in formation of atherosclerotic lesion formation has been observed.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> P-selectin is mainly present in blood platelets and mediates platelet leukocyte interaction.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> A decrease of P-selectin expression in blood platelets has been experimentally attributed to antiatherosclerotic activity of the compound. Compound <b>6b</b> showed a decrease in P-selectin expression subsequently at increasing concentrations from 30 μM to 300 μM. Thereby, reducing the capability of platelets to interact with leukocytes by inhibition of P-selectin expression suggests that <b>6b</b> may have anti-inflammatory activity.</div><div class="NLM_p last">The pan assay interference compound (PAINS) filter identified the 3-alkylindoles substructure in the active compounds that may be problematic. However, in the publication on PAINS it is mentioned that this substructure is not well refined and requires further evaluation as PAINS.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Additionally the comprehensive antithrombotic assays performed for compound <b>6b</b> as antithrombotic agent exclude it from being PAINS. The molecular modeling studies were used to investigate the binding pattern of the enantiomers <b>6c</b> and <b>6d</b> at the GPVI surface. The putative ligand binding pocket at the GPVI extracellular surface is situated at the D1 domain that is reported to bind LOS. Further this binding pocket also binds the tryptophan residue of pep10L; hence the synthesized compounds having a tryptophan substructure have high probability to bind at this site.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The development of highly specific GPVI inhibitors has the potential to result in effective antithrombotic agents with minimal bleeding tendency. In this study we report a new class of 2,3-disubstituted tetrahydropyridoindoles that prevent collagen mediated platelet aggregation. The most active compound <b>6b</b> showed better activity than either of its enantiomers in collagen mediated platelet aggregation. It also displayed better activity than LOS in collagen, CRP-XL, and CVX mediated platelet aggregation. Compound <b>6b</b> also inhibited platelet P-selectin expression, suggesting its antiatherosclerotic potential. The binding interactions for the enantiomers have been provided by docking the compounds at the LOS binding site at the GPVI surface that may provide additional insights to design better GPVI antagonists.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p last">All chemicals used were of reagent grade unless stated otherwise. Melting points were determined in open capillaries on an electrically heated melting point apparatus and are otherwise uncorrected. Reactions were monitored by thin layer chromatography on self-made plates of silica gel G (Merck, India) or 0.25 mm ready-made plates of silica gel 60F<sub>254</sub> (E. Merck, Darmstadt, Germany), and the detection was done by iodine vapors/spraying with Dragondorf spray reagent or by UV radiation. Compounds were purified by column chromatography performed with silica gel (Merck, 60–120 mesh) or Chromatotron. Melting points (mps) were determined on an electrical heated mp apparatus/using silicon oil bath. Characterization of the synthesized compounds was accomplished in the Sophisticated Analytical Instrument Facility (SAIF) Department of CDRI, Lucknow. IR spectroscopy was carried out using PerkinElmer 881 spectrophotometer, and the values are expressed as ν<sub>max</sub>, cm<sup>–1</sup>. Mass spectra (MS) were recorded on a Jeol (Japan) SX 102/DA-6000 mass spectrometer. <sup>1</sup>H NMR spectra were recorded on Bruker Spectrospin spectrometer at 300 MHz. The chemical shifts are reported in δ scale (ppm) and are relative to tetramethyl silane (TMS) as internal standard. The coupling constants <i>J</i> are given hertz, and spin multiplicities are expressed as s (singlet), d (doublet), t (triplet), dd (double doublet), quint (quintet), and m (multiplet). Elemental analyses were performed on a Carlo Erba model EA-1108 elemental analyzer, and data of C, H, and N are within 0.4% of calculated values. All reported title compounds were assessed to be 95% pure by analytical HPLC method unless stated otherwise. Optical rotations were determined on Autopol III automatic polarimeter using the sodium D-line (<i>c</i> in g/100 mL).</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure A: Sulfonation Reaction with Methyl 1,2,3,4-Tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole-3-carboxylate</h3><div class="NLM_p last">To a stirred solution of racemic methyl 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole-3-carboxylate (1 g, 1 equiv) in dry DMF (20 mL), dry triethylamine (1.5 equiv) was added followed by respective addition of sulfonyl chlorides (1.2 equiv) at 0 °C. The reaction mixture was stirred for 6–10 h at room temperature, and the completion of the reaction was monitored by TLC. Upon completion, the reaction mixture was concentrated under vacuum and the residue was triturated with water to get the products.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure B: Sulfonation Reaction with 2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide</h3><div class="NLM_p last">The racemic 2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (1 g, 1 equiv) in dry DMF was stirred followed by addition of dry triethylamine (1.5 equiv) and respective sulfonyl chlorides (1.2 equiv) at 0 °C. The reaction mixture was stirred for 6–10 h at room temperature, and the completion of the reaction was monitored by TLC. Upon completion the reaction mixture was concentrated under vacuum and the residue was triturated with water to get the product.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure C: Amide Formation</h3><div class="NLM_p last">To a solution of acid (1 equiv) in dry THF, oxalyl chloride (1.2 equiv) was added dropwise and stirred for 4–6 h. The completion of the reaction was followed by TLC. The reaction mixture was evaporated under reduced pressure to obtain the acid chloride. The acid chloride was dissolved in dry THF followed by addition of dry TEA at 0 °C. The corresponding amines (1.5 equiv) were added at 0 °C and stirred for 6–8 h. Upon completion the reaction mixture was evaporated and dissolved in EtOAc. The EtOAc layer was washed with brine solution, and the organic layer was separated and dried over anhydrous sodium sulfate. Upon evaporation under reduced pressure the title compounds were obtained that were further purified by crystallization in methanol.</div></div><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3<i>SR</i>-Methyl 2-Amino-3-(1<i>H</i>-indol-3-yl)propanoate Hydrochloride (<b>2a</b>)</h3><div class="NLM_p">To a stirred suspension of <span class="smallcaps smallerCapital">dl</span>-tryptophan (<b>1</b>) (10 g, 0.245 mol) in dry methanol (45 mL) at −10 °C, thionyl chloride (7 mL, 0.295 mol) was added dropwise after which stirring was continued for 6 h during which temperature was gradually raised from −10 °C to room temperature (37 °C). After 6 h cream colored product was observed to be formed. The reaction mixture was filtered under suction and the cream colored product (<b>2a</b>) washed with ether (10 mL) and dried. Yield (92%); mp 214–217 °C. FTIR (KBr cm<sup>–1</sup>) 3267, 1747, 1441, 1225, 1107, 1074, 731; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub> + DMSO-<i>d</i><sub>6</sub>) δ 8.47 (s, 1H), 7.60 (dd, <i>J</i> = 6.8, 1.9 Hz, 1H), 7.32 (dd, <i>J</i> = 5.8, 2.8 Hz, 1H), 7.13 (dt, <i>J</i> = 4.6, 3.8 Hz, 2H), 7.00 (s, 1H), 3.86 (m, 1H), 3.69 (s, 3H), 3.36–3.23 (m, 1H), 3.10–2.98 (m, 1H), 2.52 (s, 2H); <sup>13</sup>C NMR (50 MHz, CDCl<sub>3</sub> + DMSO-<i>d</i><sub>6</sub>) δ 174.08, 136.40, 127.40, 122.55, 121.59, 119.09, 118.51, 111.49, 109.90, 51.93, 50.75, 32.20. MS (FAB): <i>m</i>/<i>z</i> 218 (M<sup>+</sup>). Anal. Calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 66.04; H 6.47; N 12.84%. Found: C 66.01; H 6.43; N 12.81%.</div><div class="NLM_p last">Compounds <b>2b</b> and <b>2c</b> were prepared from <span class="smallcaps smallerCapital">l</span>-tryptophan and <span class="smallcaps smallerCapital">d</span>-tryptophan, respectively, following the same procedure as mentioned for compound <b>2a</b>.</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3<i>S</i>-Methyl 2-Amino-3-(1<i>H</i>-indol-3-yl)propanoate Hydrochloride (<b>2b</b>)</h3><div class="NLM_p last">Yield (88%); mp 220–223 °C; [α]<sub>D</sub><sup>20</sup> −17.5°. FTIR (KBr cm<sup>–1</sup>) 3267, 1747, 1441, 1225, 1107, 1074, 731; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 2.52 (s, 2H), 3.09–3.16 (dd, <i>J</i> = 14.4, 6.5, 1H), 3.40–3.45 (d, <i>J</i> = 14.4, 1H), 3.65 (s, 3H), 4.54–4.56 (d, <i>J</i> = 6.4, 1H), 6.93–7.07 (m, 3H), 7.33–7.42 (m, 2H), 10.65 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.7, 135.2, 128.2, 126.9, 121.3, 120.3, 119.3, 112.6, 109.4, 57.2, 52.7, 27.3. MS (FAB): <i>m</i>/<i>z</i> 218 (M<sup>+</sup>). Anal. Calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 66.04; H 6.47; N 12.84%. Found: C 66.08; H 6.45; N 12.82%.</div></div><div id="sec5_1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3<i>R</i>-Methyl 2-Amino-3-(1<i>H</i>-indol-3-yl)propanoate Hydrochloride (<b>2c</b>)</h3><div class="NLM_p last">Yield (93%); mp 219–222 °C; [α]<sub>D</sub><sup>20</sup> +17.4°. FTIR (KBr cm<sup>–1</sup>) 3267, 1747, 1441, 1225, 1107, 1074, 731; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 2.52 (s, 2H), 3.08–3.15 (dd, <i>J</i> = 14.4, 6.5, 1H), 3.40–3.45 (d, <i>J</i> = 14.4, 1H), 3.66 (s, 3H), 4.53–4.55 (d, <i>J</i> = 6.4, 1H), 6.93–7.07 (m, 3H), 7.34–7.43 (m, 2H), 10.65 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.7, 135.3, 128.3, 126.9, 121.3, 120.3, 119.3, 112.6, 109.4, 57.3, 52.7, 27.2. MS (FAB): <i>m</i>/<i>z</i> 218 (M<sup>+</sup>). Anal. Calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 66.04; H 6.47; N 12.84%. Found: C 66.07; H 6.42; N 12.81%.</div></div><div id="sec5_1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3<i>SR</i>-Methyl 2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>3a</b>)</h3><div class="NLM_p">To a solution of <span class="smallcaps smallerCapital">dl</span>-tryptophan methyl ester hydrochloride <b>2a</b> (22g, 0.86 mol) in methanol and water (154 mL; methanol/water = 10:1), formaldehyde (37–41% w/v solution in water, 11 mL) was added dropwise. The reaction mixture was stirred for 12 h at room temperature, concentrated, and cooled to give (<i>SR</i>)-methyl 1,2,3,4-tetrahydro-9<i>H</i>-pyrido(3,4-<i>b</i>)indole-3-carboxylate hydrochloride (<b>3a</b>). Yield (57%); mp 162 °C. FTIR (KBr cm<sup>–1</sup>) 738, 820, 866, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 2.78 (s, 1H), 2.86–2.89 (d, <i>J</i> = 6.5, 1H), 3.08–3.15 (dd, <i>J</i> = 15.8, 6.5, 1H), 3.42–3.48 (d, <i>J</i> = 15.8, 1H), 3.67 (s, 3H), 4.11–4.16 (d, <i>J</i> = 17.0, 1H), 4.21–4.26 (d, <i>J</i> = 17.0, 1H), 6.92–7.04 (m, 1H), 7.02–7.14 (m, 1H), 7.37–7.53 (m, 2H), 10.27 (s, 1H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.1, 136.8, 131.6, 129.2, 121.2, 118.4, 117.4, 110.8, 105.8, 55.9, 53.8, 40.7, 20.7. MS (FAB): <i>m</i>/<i>z</i> 230 (M<sup>+</sup>). Anal. Calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 67.81; H 6.13; N 12.17%. Found: C 67.86; H 6.15; N 12.19%.</div><div class="NLM_p last">Compounds <b>3b</b> and <b>3c</b> were prepared from <b>2b</b> and <b>2c</b> following the same procedure as mentioned for compound <b>3a</b>.</div></div><div id="sec5_1_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3<i>R</i>-Methyl 2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>3b</b>)</h3><div class="NLM_p last">Yield (64%); mp 168 °C; [α]<sub>D</sub><sup>20</sup> +71.4°; FTIR (KBr cm<sup>–1</sup>) 738, 820, 868, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 2.78 (s, 1H), 2.86–2.89 (d, <i>J</i> = 6.5, 1H), 3.08–3.15 (dd, <i>J</i> = 15.8, 6.5, 1H), 3.42–3.48 (d, <i>J</i> = 15.8, 1H), 3.67 (s, 3H), 4.11–4.16 (d, <i>J</i> = 17.0, 1H), 4.21–4.26 (d, <i>J</i> = 17.0, 1H), 6.92–7.04 (m, 1H), 7.02–7.14 (m, 1H), 7.37–7.53 (m, 2H), 10.27 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.1, 136.8, 131.6, 129.2, 121.2, 118.4, 117.4, 110.8, 105.8, 55.9, 53.8, 40.7, 20.7. MS (FAB): <i>m</i>/<i>z</i> 230 (M<sup>+</sup>). Anal. Calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 67.81; H 6.13; N 12.17%. Found: C 67.85; H 6.12; N 12.19%.</div></div><div id="sec5_1_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3<i>S</i>-Methyl 2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>3c</b>)</h3><div class="NLM_p">Yield (54%); mp 167 °C; [α]<sub>D</sub><sup>20</sup> −71.5°; FTIR (KBr cm<sup>–1</sup>) 738, 820, 866, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 2.78 (s, 1H), 2.86–2.89 (d, <i>J</i> = 6.5, 1H), 3.08–3.15 (dd, <i>J</i> = 15.8, 6.5, 1H), 3.42–3.48 (d, <i>J</i> = 15.8, 1H), 3.67 (s, 3H), 4.11–4.16 (d, <i>J</i> = 17.0, 1H), 4.21–4.26 (d, <i>J</i> = 17.0, 1H), 6.92–7.04 (m, 1H), 7.02–7.14 (m, 1H), 7.37–7.53 (m, 2H), 10.27 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.1, 136.8, 131.6, 129.2, 121.2, 118.4, 117.4, 110.8, 105.8, 55.9, 53.8, 40.7, 20.7. MS (FAB): <i>m</i>/<i>z</i> 230 (M<sup>+</sup>). Anal. Calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: C 67.81; H 6.13; N 12.17%. Found: C 67.86; H 6.14; N 12.19%.</div><div class="NLM_p last">Compounds <b>4a</b>–<b>l</b> were prepared using general procedure A. The racemic <i>SR</i> compounds were prepared from <b>3a</b>, while the <i>S</i> and <i>R</i> isomers for these compounds were synthesized following the same procedure using <b>3b</b> and <b>3c</b> as the starting material, respectively.</div></div><div id="sec5_1_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3<i>SR</i>-Methyl 2-(Methylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4a</b>)</h3><div class="NLM_p last">Yield (77.9%); mp 198 °C; IR (KBr cm<sup>–1</sup>) 746, 1016, 1152, 1234, 1278, 1632, 1736, 3026, 3384; HPLC (isocratic (H<sub>2</sub>O/MeOH/1% proline 68:31:1), 0.6 mL/min), <i>t</i><sub>R</sub> = 16 and 21 min; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.52 (dd, <i>J</i> = 4.2, 3.8 Hz, 1H), 7.38 (dd, <i>J</i> = 7.8, 0.5 Hz, 1H), 7.12 (t, <i>J</i> = 7.4 Hz, 1H), 7.00 (dd, <i>J</i> = 11.3, 3.9 Hz, 1H), 4.64–4.38 (m, 3H), 3.70 (s, 3H), 3.51 (dd, <i>J</i> = 16.5, 7.4 Hz, 1H), 2.96 (s, 3H), 2.77 (ddd, <i>J</i> = 16.5, 5.6, 1.4 Hz, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 168.23, 135.84, 134.76, 125.13, 119.57, 119.27, 118.13, 110.88, 108.43, 53.29, 51.65, 41.05, 36.34, 22.72; mass (FAB) <i>m</i>/<i>z</i> 309 (M + 1); molecular formula, C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S; calculated C, 54.53; H, 5.23; N, 9.08. Found C, 54.54; H, 5.27; N, 9.04.</div></div><div id="sec5_1_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3<i>S</i>-Methyl 2-(Methylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4b</b>)</h3><div class="NLM_p last">Yield (75%); mp 203 °C; [α]<sub>D</sub><sup>20</sup> −54.5°; IR (KBr) cm<sup>–1</sup> 767, 965, 1020, 1062, 1154, 1218, 1277, 1332, 1451, 1627, 1738, 2367, 2857, 2955, 3024, and 3395; HPLC using reverse phase CHIRADEX column (isocratic (H<sub>2</sub>O/MeOH/1% proline 68:31:1), 0.6 mL/min), <i>t</i><sub>R</sub> = 16 min; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.52 (dd, <i>J</i> = 4.2, 3.8 Hz, 1H), 7.38 (dd, <i>J</i> = 7.8, 0.5 Hz, 1H), 7.12 (t, <i>J</i> = 7.4 Hz, 1H), 7.06–6.87 (m, 1H), 4.75–4.39 (m, 3H), 3.77 (s, 3H), 3.51 (dd, <i>J</i> = 16.5, 7.4 Hz, 1H), 2.96 (s, 3H), 2.78 (ddd, <i>J</i> = 16.5, 8.6, 4.3 Hz, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 168.6, 135.8, 134.9, 125.5, 119.5, 119.2, 118.5, 110.9, 105.9, 53.6, 51.8, 40.8, 36.9, 22.2. MSFAB = 309 M + 1; molecular formula, C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S; calculated, C, 54.53; H, 5.23; N, 9.08. Found: C, 54.55; H, 5.26; N, 9.03.</div></div><div id="sec5_1_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3<i>R</i>-Methyl 2-(Methylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4c</b>)</h3><div class="NLM_p last">Yield (71%); mp 202 °C; [α]<sub>D</sub><sup>20</sup> +54.4°; IR (KBr) cm<sup>–1</sup> 767, 965, 1020, 1062, 1154, 1218, 1277, 1332, 1451, 1627, 1738, 2367, 2857, 2955, 3024, and 3395; HPLC using reverse phase CHIRADEX column (isocratic (H<sub>2</sub>O/MeOH/1%proline 68:31:1), 0.6 mL/min), <i>t</i><sub>R</sub> = 21 min; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.52 (dd, <i>J</i> = 4.2, 3.8 Hz, 1H), 7.38 (dd, <i>J</i> = 7.8, 0.5 Hz, 1H), 7.12 (t, <i>J</i> = 7.4 Hz, 1H), 7.06–6.87 (m, 1H), 4.75–4.39 (m, 3H), 3.77 (s, 3H), 3.51 (dd, <i>J</i> = 16.5, 7.4 Hz, 1H), 2.96 (s, 3H), 2.78 (ddd, <i>J</i> = 16.5, 8.6, 4.3 Hz, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 168.6, 135.8, 134.9, 125.5, 119.5, 119.2, 118.5, 110.9, 105.9, 53.6, 51.8, 40.8, 36.9, 22.2. MSFAB = 309 M + 1; molecular formula, C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated: C, 54.53; H, 5.23; N, 9.08. Found: C, 54.54; H, 5.24; N, 9.03.</div></div><div id="sec5_1_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3<i>SR</i>-Methyl 2-(Quinolin-8-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4d</b>)</h3><div class="NLM_p last">Yield (73.6%); mp 235 °C; IR (KBr cm<sup>–1</sup>) 743, 1161, 1213, 1327, 1446, 1564, 1621, 1733, 3400; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.97 (d, <i>J</i> = 3.6 Hz, 1H), 8.68–8.52 (m, 2H), 8.27 (dd, <i>J</i> = 13.4, 4.4 Hz, 2H), 7.97 (dd, <i>J</i> = 8.7, 4.3 Hz, 1H), 7.46 (t, <i>J</i> = 7.7 Hz, 1H), 7.41–7.33 (m, 1H), 7.24–7.17 (m, 1H), 7.12 (ddd, <i>J</i> = 7.8, 4.4, 3.8 Hz, 1H), 7.00 (ddd, <i>J</i> = 7.7, 4.1, 3.6 Hz, 1H), 5.21–5.03 (m, 1H), 4.87–4.62 (m, 2H), 3.60 (s, 3H), 3.26–3.07 (m, 1H), 2.50–2.30 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.9, 150.8, 149.7, 138.3, 138.2, 132.2, 130.5, 129.8, 128.5, 126.2, 124.9, 124.5, 123.5, 119.6, 119.2, 117.2, 110.0, 106.8, 52.7, 52.0, 39.6, 23.7. Mass (FAB) <i>m</i>/<i>z</i>: 422 (M + 1). Molecular Formula: C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S. Calculated C, 62.69; H, 4.54; N, 9.97. Found C, 62.72; H, 4.56; N, 9.94</div></div><div id="sec5_1_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3<i>S</i>-Methyl 2-(Quinolin-8-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4e</b>)</h3><div class="NLM_p last">Yield (80%); mp 240 °C; [α]<sub>D</sub><sup>20</sup> −48°; IR (KBr) cm<sup>–1</sup> 745, 1057, 1150, 1214, 1324, 1389, 1443, 1623, 1733, 2128, 2373, 2945, 3059, 3405; HPLC (isocratic (H<sub>2</sub>O/MeOH 68:32), 0.6 mL/min), <i>t</i><sub>R</sub> = 16 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>) δ 8.97 (d, <i>J</i> = 3.6 Hz, 1H), 8.68–8.52 (m, 2H), 8.27 (dd, <i>J</i> = 13.4, 4.4 Hz, 2H), 7.97 (dd, <i>J</i> = 8.7, 4.3 Hz, 1H), 7.46 (t, <i>J</i> = 7.7 Hz, 1H), 7.41–7.33 (m, 1H), 7.24–7.17 (m, 1H), 7.12 (ddd, <i>J</i> = 7.8, 4.4, 3.8 Hz, 1H), 7.00 (ddd, <i>J</i> = 7.7, 4.1, 3.6 Hz, 1H), 5.21–5.03 (m, 1H), 4.87–4.62 (m, 2H), 3.60 (s, 3H), 3.26–3.07 (m, 1H), 2.50–2.30 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>) δ 170.3, 150.7, 149.4, 138.3, 132.2, 130.5, 129.9, 129.8, 128.9, 126.1, 124.9, 124.4, 123.5, 119.5, 119.2, 117.6, 110.0, 104.2, 52.9, 52.0, 39.4, 23.2. MSFAB = 421 M<sup>+</sup>. Molecular formula: C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S. Calculated C, 62.69; H, 4.54; N, 9.97. Found C, 62.71; H, 4.58; N, 9.94</div></div><div id="sec5_1_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3<i>R</i>-Methyl 2-(Quinolin-8-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4f</b>)</h3><div class="NLM_p last">Yield (74%); mp 240 °C; [α]<sub>D</sub><sup>20</sup> +48°; IR (KBr) cm<sup>–1</sup> 745, 1057, 1150, 1214, 1324, 1389, 1443, 1623, 1733, 2128, 2373, 2945, 3059, 3405; HPLC (isocratic (H<sub>2</sub>O/MeOH 68:32), 0.6 mL/min), <i>t</i><sub>R</sub> = 17.5 min; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>) δ 8.97 (d, <i>J</i> = 3.6 Hz, 1H), 8.68–8.52 (m, 2H), 8.27 (dd, <i>J</i> = 13.4, 4.4 Hz, 2H), 7.97 (dd, <i>J</i> = 8.7, 4.3 Hz, 1H), 7.46 (t, <i>J</i> = 7.7 Hz, 1H), 7.41–7.33 (m, 1H), 7.24–7.17 (m, 1H), 7.12 (ddd, <i>J</i> = 7.8, 4.4, 3.8 Hz, 1H), 7.00 (ddd, <i>J</i> = 7.7, 4.1, 3.6 Hz, 1H), 5.21–5.03 (m, 1H), 4.87–4.62 (m, 2H), 3.60 (s, 3H), 3.26–3.07 (m, 1H), 2.50–2.30 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>) δ 170.3, 150.7, 149.4, 138.3, 132.2, 130.5, 129.9, 129.8, 128.9, 126.1, 124.9, 124.4, 123.5, 119.5, 119.2, 117.6, 110.0, 104.2, 52.9, 52.0, 39.4, 23.2. MSFAB = 421 M<sup>+</sup>. Molecular formula: C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S. Calculated C, 62.69; H, 4.54; N, 9.97. Found C, 62.72; H, 4.56; N, 9.96</div></div><div id="sec5_1_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3<i>SR</i>-Methyl 2-(2,5-Dichlorophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4g</b>)</h3><div class="NLM_p last">Yield = 0.650 g (74.03%); mp 205 °C; IR (KBr cm<sup>–1</sup>) 738, 1162, 1271, 1343, 1446, 1600, 1730, 3412; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.63 (dd, <i>J</i> = 5.5, 0.5 Hz, 2H), 7.53–7.44 (m, 1H), 7.38 (dd, <i>J</i> = 7.5, 0.4 Hz, 1H), 7.25–7.17 (m, 1H), 7.16–7.06 (m, 1H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 5.13 (ddd, <i>J</i> = 12.1, 4.3, 0.4 Hz, 1H), 4.69 (ddd, <i>J</i> = 14.4, 11.0, 8.6 Hz, 2H), 3.60 (s, 3H), 3.32–3.06 (m, 1H), 2.47 (dd, <i>J</i> = 16.4, 7.3 Hz, 1H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.13, 137.74, 136.74, 133.63, 133.57, 131.73, 130.46, 130.39, 129.55, 128.01, 120.87, 117.49, 117.45, 110.06, 105.87, 53.25, 52.55, 39.15, 20.93. Mass (FAB) <i>m</i>/<i>z</i>: 440 (M + 1). Molecular formula: C<sub>19</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 51.95; H, 3.67; N, 6.38. Found C, 51.93; H, 3.66; N, 6.41.</div></div><div id="sec5_1_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3<i>S</i>-Methyl 2-(2,5-Dichlorophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4h</b>)</h3><div class="NLM_p last">Yield (84%); mp 212–215 °C; [α]<sub>D</sub><sup>20</sup> −27.5°; HPLC on CHIRADEX column (gradient (H<sub>2</sub>O/MeOH 68:32), 0.7 mL/min), <i>t</i><sub>R</sub> = 23.8 min; IR (KBr) cm<sup>–1</sup> 740, 018, 1060, 1157, 1233, 1331, 1381, 1449, 1618, 12, 2952, 3107, 3292, 3587; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.73–7.57 (m, 2H), 7.49 (dd, <i>J</i> = 5.7, 3.1 Hz, 1H), 7.38 (dd, <i>J</i> = 7.5, 0.4 Hz, 1H), 7.25 (dd, <i>J</i> = 3.5, 2.7 Hz, 1H), 7.11 (td, <i>J</i> = 6.9, 3.5 Hz, 1H), 6.99 (t, <i>J</i> = 7.4 Hz, 1H), 5.30–5.02 (m, 1H), 4.83–4.52 (m, 2H), 3.67 (s, 3H), 3.30–3.09 (m, 1H), 2.62–2.36 (m, 1H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.13, 137.83, 136.74, 133.84, 133.63, 131.73, 130.50, 130.39, 128.96, 128.10, 120.87, 119.10, 117.68, 110.08, 104.19, 53.25, 52.55, 39.22, 20.93. Mass (FAB): 439 M<sup>+</sup>; molecular formula, C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>SCl<sub>2</sub>. Calculated C, 51.95; H, 3.67; N, 6.38. Found C, 51.98; H, 3.69; N, 6.34</div></div><div id="sec5_1_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3<i>R</i>-Methyl 2-(2,5-Dichlorophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4i</b>)</h3><div class="NLM_p last">Yield (70%), mp 212–215 °C; [α]<sub>D</sub><sup>20</sup> +27.5°; HPLC on CHIRADEX column (gradient (H<sub>2</sub>O/MeOH 68:32), 0.7 mL/min), <i>t</i><sub>R</sub> = 23.3 min; IR (KBr) cm<sup>–1</sup> 740, 1158, 1732, 3292, 3587; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.64 (s, 2H), 7.54–7.44 (m, 1H), 7.38 (dd, <i>J</i> = 6.8, 0.5 Hz, 1H), 7.25 (dd, <i>J</i> = 3.5, 2.7 Hz, 1H), 7.12 (dd, <i>J</i> = 10.2, 3.8 Hz, 1H), 6.99 (t, <i>J</i> = 6.8 Hz, 1H), 5.29–4.94 (m, 1H), 4.95–4.42 (m, 2H), 3.64 (s, 3H), 3.29–2.95 (m, 1H), 2.60–2.34 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.13, 137.83, 136.74, 133.84, 133.63, 131.73, 130.50, 130.39, 128.96, 128.10, 120.87, 119.10, 117.68, 110.08, 104.19, 53.25, 52.55, 39.22, 20.93. Mass (FAB), 439 M<sup>+1</sup>; molecular formula, C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>SCl<sub>2</sub>; molecular formula, C<sub>19</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>SCl<sub>2</sub>. Calculated C, 51.95; H, 3.67; N, 6.38. Found C, 51.98; H, 3.69; N, 6.34.</div></div><div id="sec5_1_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3<i>SR</i>-Methyl 2-(5-(Dimethylamino)naphthalen-1-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4j</b>)</h3><div class="NLM_p last">Yield (44.9%); mp 195 °C; IR (KBr cm<sup>–1</sup>) 744, 1151, 1201, 1345, 1451, 1595, 1741, 3407; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.49–7.32 (m, 4H), 7.33–7.28 (m, 1H), 7.23 (dd, <i>J</i> = 7.9, 0.5 Hz, 1H), 7.17–7.07 (m, 1H), 7.06–6.93 (m, 2H), 5.14–4.95 (m, 1H), 4.76–4.51 (m, 2H), 3.60 (s, 3H), 3.29–3.10 (m, 1H), 3.01 (s, 6H), 2.55–2.35 (m, 1H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.9, 151.2, 138.2, 138.1, 133.1, 131.8, 130.9, 130.4, 129.0, 128.3, 127.9, 119.6, 119.3, 119.2, 117.9, 117.2, 109.9, 109.7, 104.4, 53.9, 51.9, 40.8, 39.7, 23.9. Mass (FAB) <i>m</i>/<i>z</i>: 464 (M + 1). Molecular formula: C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>S. Calculated C, 64.78; H, 5.44; N, 9.06. Found C, 64.75; H, 5.43; N, 9.04</div></div><div id="sec5_1_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3<i>SR</i>-Methyl 2-(2,4,6-Trimethylphenyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4k</b>)</h3><div class="NLM_p last">Yield (63.21%); mp 160 °C; IR (KBr cm<sup>–1</sup>) 738, 1153, 1237, 1330, 1452, 1599, 1734, 2938, 3400; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.43–7.32 (m, 2H), 7.25–7.18 (m, 1H), 7.16–7.06 (m, 1H), 7.04–6.95 (m, 1H), 6.91 (d, <i>J</i> = 0.5 Hz, 1H), 5.13–4.92 (m, 1H), 4.75–4.49 (m, 2H), 3.60 (s, 3H), 3.27–3.06 (m, 1H), 2.71 (s, 6H), 2.50–2.34 (m, 1H), 2.28 (s, 3H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.45, 142.20, 142.11, 137.74, 132.36, 132.02, 129.96, 129.55, 120.87, 117.49, 117.45, 110.06, 105.87, 52.82, 52.55, 38.72, 23.54, 20.93, 20.89. Mass (FAB): <i>m</i>/<i>z</i> 413 (M + 1). Molecular formula: C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>S.Calculated C, 64.06; H, 5.86; N, 6.79. Found C, 64.08; H, 5.88; N, 6.75.</div></div><div id="sec5_1_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3<i>SR</i>-Methyl 2-(2-(Trifluoromethyl)phenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>4l</b>)</h3><div class="NLM_p last">Yield (59.8%); mp 176 °C; <i>R<sub>f</sub></i> (hexane/EtOAc = 10:1.5) 0.68; IR (KBr cm<sup>–1</sup>) 771, 1169, 1218, 1272, 1308, 1347, 1449, 1563, 1741, 3400; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.84–7.64 (m, 2H), 7.58–7.43 (m, 3H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.12 (dd, <i>J</i> = 10.8, 3.9 Hz, 1H), 6.99 (t, <i>J</i> = 7.2 Hz, 1H), 4.76–4.45 (m, 3H), 3.70 (s, 3H), 3.51 (dd, <i>J</i> = 16.4, 7.4 Hz, 1H), 2.77 (dd, <i>J</i> = 16.4, 7.3 Hz, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.65, 137.15, 134.34, 131.6, 130.1, 129.2, 128.80, 126.13, 120.93, 120.87, 118.36, 117.49, 113.05, 110.94, 107.27, 105.19, 55.9, 53.8, 40.5, 20.6. Mass (FAB) <i>m</i>/<i>z</i>: 439 (M + 1). Molecular formula: C<sub>20</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 54.79; H, 3.91; N, 6.39. Found C, 54.82; H, 3.95; N, 6.36</div></div><div id="sec5_1_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3<i>SR</i>-2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>5a</b>)</h3><div class="NLM_p">The dried hydrochloride salt <b>3a</b> (3.0 g, 11 mmol) was taken in dried 100 mL sealed tube, and to it was added freshly prepared MeOH–NH<sub>3</sub> (∼7 N solution, 60 mL, 200 equiv), and the reaction mixture was stirred for 6–7 h under 40 bar pressure at 30 °C. After completion of the reaction (as per TLC; <i>R<sub>f</sub></i> = 0.3 EtOAc/CH<sub>3</sub>OH (95:1)) solvent was distilled and the solid thus obtained was dissolved in MeOH (30 mL). The separated salt was filtered out and the clear solution was evaporated under vacuum to obtain the pure compound <b>5a</b> (2.4 g, 81.5%). Yield (81.5%); mp 149 °C; IR (KBr cm<sup>–1</sup>) 738, 820, 866, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 2.52 (s, 1H), 2.84–2.91 (dd, <i>J</i> = 15.4, 6.5, 1H), 3.13–3.18 (d, <i>J</i> = 15.4, 1H), 4.48–4.53 (d, <i>J</i> = 16.9, 1H), 4.70–4.75 (d, <i>J</i> = 16.9, 1H), 4.90–4.92 (d, <i>J</i> = 6.5, 1H), 6.98–7.05 (m, 1H), 7.08–7.13 (m, 1H), 7.24 (s, 2H), 7.33–7.36 (m, 1H), 7.52–7.55 (m, 1H), 10.11 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 27.2, 41.1, 57.1, 107.2, 112.5, 117.2, 118.9, 123.1, 127.8, 133.7, 137.1, 175.8. Mass (FAB): <i>m</i>/<i>z</i> 216 (M<sup>+</sup>). Molecular formula: C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>O. Calculated C, 66.96; H, 6.09; N, 19.52. Found C, 66.92; H, 6.07; N, 19.54.</div><div class="NLM_p last">Compounds <b>5b</b> and <b>5c</b> were prepared from <b>3b</b> and <b>3c</b>, respectively, following the same procedure as mentioned for compound <b>5a</b>.</div></div><div id="sec5_1_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3<i>S</i>-2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>5b</b>)</h3><div class="NLM_p last">Yield (84%); mp 151 °C; [α]<sub>D</sub><sup>20</sup> −62.5°; IR (KBr cm<sup>–1</sup>) 738, 820, 866, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 2.52 (s, 1H), 2.84–2.91 (dd, <i>J</i> = 15.4, 6.5, 1H), 3.13–3.18 (d, <i>J</i> = 15.4, 1H), 4.48–4.53 (d, <i>J</i> = 16.9, 1H), 4.70–4.75 (d, <i>J</i> = 16.9, 1H), 4.90–4.92 (d, <i>J</i> = 6.5, 1H), 6.98–7.05 (m, 1H), 7.08–7.13 (m, 1H), 7.24 (s, 2H), 7.33–7.36 (m, 1H), 7.52–7.55 (m, 1H), 10.11 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 27.2, 41.1, 57.1, 107.2, 112.5, 117.2, 118.9, 123.1, 127.8, 133.7, 137.1, 175.8. Mass (FAB): <i>m</i>/<i>z</i> 216 (M<sup>+</sup>). Molecular formula: C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>O. Calculated C, 66.96; H, 6.09; N, 19.52. Found C, 66.92; H, 6.07; N, 19.54</div></div><div id="sec5_1_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3<i>R</i>-2,3,4,9-Tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>5c</b>)</h3><div class="NLM_p">Yield (82%); mp 151 °C; [α]<sub>D</sub><sup>20</sup> +62.5°; IR (KBr cm<sup>–1</sup>) 738, 820, 866, 1004, 1056, 1128, 1190, 1234, 1302, 1346, 1442, 1504, 1590, 1626, 1740, 1916, 2312, 2752, 2938, 3058, 3150, 3324; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 2.52 (s, 1H), 2.84–2.91 (dd, <i>J</i> = 15.4, 6.5, 1H), 3.13–3.18 (d, <i>J</i> = 15.4, 1H), 4.48–4.53 (d, <i>J</i> = 16.9, 1H), 4.70–4.75 (d, <i>J</i> = 16.9, 1H), 4.90–4.92 (d, <i>J</i> = 6.5, 1H), 6.98–7.05 (m, 1H), 7.08–7.13 (m, 1H), 7.24 (s, 2H), 7.33–7.36 (m, 1H), 7.52–7.55 (m, 1H), 10.11 (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 27.2, 41.1, 57.1, 107.2, 112.5, 117.2, 118.9, 123.1, 127.8, 133.7, 137.1, 175.8. Mass (FAB): <i>m</i>/<i>z</i> 216 (M<sup>+</sup>). Molecular formula: C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>O. Calculated C, 66.96; H, 6.09; N, 19.52. Found C, 66.92; H, 6.07; N, 19.54</div><div class="NLM_p last">Compounds <b>6a</b>–<b>i</b> were prepared using general procedure B. The racemic <i>SR</i> compounds were prepared from <b>5a</b>, while the <i>S</i> and <i>R</i> isomers for these compounds were synthesized following the same procedure using <b>5b</b> and <b>5c</b> as the starting material, respectively.</div></div><div id="sec5_1_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3<i>SR</i>-2-(2,5-Dichlorophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6a</b>)</h3><div class="NLM_p last">Yield = 0.185gm (87.26%); mp 220 °C; IR (KBr cm<sup>–1</sup>) 752, 1160, 1337, 1450, 1602, 1693, 3332, 3456; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.76–7.57 (m, 2H), 7.51 (d, <i>J</i> = 8.0 Hz, 1H), 7.45–7.34 (m, 1H), 7.23 (d, <i>J</i> = 7.7 Hz, 1H), 7.17–7.05 (m, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 6.44 (s, 2H), 4.79–4.59 (m, 2H), 4.59–4.48 (m, 1H), 3.40–3.07 (m, 1H), 2.98–2.75 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.35, 138.74, 138.30, 133.31, 132.78, 130.46, 130.30, 129.97, 128.02, 127.49, 119.57, 119.27, 117.22, 109.97, 106.77, 57.67, 41.33, 24.23. Mass (FAB) <i>m</i>/<i>z</i>: 425 (M + 1). Molecular formula: C<sub>18</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 50.95; H, 3.56; N, 9.90. Found C, 50.99; H, 3.54; N, 9.98.</div></div><div id="sec5_1_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3<i>SR</i>-2-(4-Methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6b</b>)</h3><div class="NLM_p last">Yield (72%) mp170 °C; IR (KBr) cm<sup>–1</sup> 758, 941, 1027, 1096, 1154, 1260, 1336, 1446, 1498, 1598, 1702, 2366, 2913, 3214, 3367; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.49–7.33 (m, 1H), 7.24 (dd, <i>J</i> = 8.0, 7.6 Hz, 2H), 7.17–7.06 (m, 1H), 7.04–6.95 (m, 1H), 6.92 (d, <i>J</i> = 8.6 Hz, 2H), 6.44 (s, 2H), 4.75–4.39 (m, 3H), 3.82 (s, 3H), 3.29–3.06 (m, 1H), 2.96–2.73 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.67, 163.74, 138.74, 130.73, 130.59, 129.44, 127.49, 119.57, 119.27, 117.22, 113.97, 109.97, 106.77, 57.74, 55.62, 41.38, 24.20. Mass (FAB) <i>m</i>/<i>z</i>: 386 M + 1. Calculated C, 59.21; H, 4.97; N, 10.90. Found C, 59.18; H, 4.96; N, 10.94. Molecular formula: C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S.</div></div><div id="sec5_1_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3<i>S</i>-2-(4-Methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6c</b>)</h3><div class="NLM_p last">Yield (88%); mp 178–180 °C; [α]<sub>D</sub><sup>20</sup> −6°; IR (KBr) cm<sup>–1</sup> 757, 941, 1027, 1096, 1154, 1260, 1336, 1446, 1498, 1598, 1702, 2366, 2913, 3214, 3367. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), δ 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.50–7.34 (m, 1H), 7.24 (dd, <i>J</i> = 8.0, 7.5 Hz, 2H), 7.17–7.07 (m, 1H), 7.04–6.96 (m, 1H), 6.92 (d, <i>J</i> = 8.6 Hz, 2H), 6.42 (s, 2H), 4.72–4.51 (m, 2H), 4.50–4.41 (m, 1H), 3.82 (s, 3H), 3.29–3.10 (m, 1H), 2.98–2.75 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.63, 163.74, 138.88, 130.72, 130.59, 129.44, 127.90, 119.57, 119.25, 117.66, 113.97, 110.04, 103.96, 58.62, 55.62, 41.19, 24.23. Mass (FAB) <i>m</i>/<i>z</i>: 386 M + 1. Calculated C, 59.21; H, 4.97; N, 10.90. Found C, 59.18; H, 4.96; N, 10.94. Molecular formula: C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S.</div></div><div id="sec5_1_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3<i>R</i>-2-(4-Methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6d</b>)</h3><div class="NLM_p last">Yield (77%) mp 180–182 °C; [α]<sub>D</sub><sup>20</sup> +6°; IR (KBr) cm<sup>–1</sup> 758, 941, 1027, 1096, 1154, 1260, 1336, 1446, 1498, 1598, 1702, 2366, 2913, 3214, 3367. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), δ 7.70 (d, <i>J</i> = 8.6 Hz, 1H), 7.55–7.35 (m, 1H), 7.24 (dd, <i>J</i> = 8.0, 7.5 Hz, 2H), 7.17–7.06 (m, 1H), 6.99 (ddd, <i>J</i> = 7.8, 4.3, 0.8 Hz, 1H), 6.93 (t, <i>J</i> = 8.5 Hz, 2H), 6.42 (s, 2H), 4.70–4.51 (m, 2H), 4.51–4.38 (m, 1H), 3.82 (s, 3H), 3.33–3.10 (m, 1H), 2.95–2.73 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.63, 163.74, 138.88, 130.72, 130.59, 129.44, 127.90, 119.57, 119.25, 117.66, 113.97, 110.04, 103.96, 58.62, 55.62, 41.19, 24.23. Mass (FAB) <i>m</i>/<i>z</i>: 386 M + 1. Calculated C, 59.21; H, 4.97; N, 10.90. Found C, 59.18; H, 4.96; N, 10.94. Molecular formula: C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>S</div></div><div id="sec5_1_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3<i>SR</i>-2-(4-Fluorophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6e</b>)</h3><div class="NLM_p last">Yield (80.41%); mp 220 °C; IR (KBr cm<sup>–1</sup>) 764, 1167, 1330, 1454, 1488, 1598, 1690, 3371, 3461; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.78 (d, <i>J</i> = 8.6 Hz, 2H), 7.61 (s, 1H), 7.44–7.31 (m, 1H), 7.23 (d, <i>J</i> = 7.8 Hz, 1H), 7.19–7.07 (m, 2H), 6.99 (ddd, <i>J</i> = 7.3, 6.8, 0.5 Hz, 1H), 6.44 (s, 2H), 4.70–4.51 (m, 2H), 4.51–4.41 (m, 1H), 3.35–3.10 (m, 1H), 2.97–2.73 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.67, 166.13, 138.74, 133.70, 130.73, 129.95, 127.49, 119.57, 119.27, 117.22, 116.05, 109.97, 106.77, 57.74, 41.38, 24.20. Mass (FAB) <i>m</i>/<i>z</i>: 374 (M + 1). Molecular formula: C<sub>18</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>3</sub>S. Calculated C, 57.90; H, 4.32; N, 11.25. Found C, 57.88; H, 4.28; N, 11.29</div></div><div id="sec5_1_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3<i>SR</i>-2-(Naphthalen-2-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6f</b>)</h3><div class="NLM_p last">Yield (70%); mp 240 °C. IR (KBr cm<sup>–1</sup>) 754, 1078, 1160, 1328, 1444, 1604, 1694, 3372, 3489. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 8.28 (s, 1H), 8.17 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 8.11–8.04 (m, 1H), 8.04–7.93 (m, 2H), 7.74–7.52 (m, 2H), 7.46–7.32 (m, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.18–7.07 (m, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 6.44 (s, 2H), 4.69–4.51 (m, 2H), 4.51–4.41 (m, 1H), 3.43–3.10 (m, 1H), 2.93–2.73 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.67, 140.81, 138.74, 133.15, 132.71, 132.43, 130.73, 129.30, 127.37, 127.03, 126.54, 126.04, 119.57, 119.27, 117.22, 109.97, 106.77, 57.49, 41.15, 24.20. Mass (FAB) <i>m</i>/<i>z</i>: 406 (M<sup>+</sup>). Molecular formula: C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 65.17; H, 4.72; N, 10.36. Found C, 65.19; H, 4.76; N, 10.33;</div></div><div id="sec5_1_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3<i>SR</i>-2-(3-Nitrophenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6g</b>)</h3><div class="NLM_p last">Yield (50%); mp 252 °C; IR (KBr cm<sup>–1</sup>) 760, 1173, 1353, 1528, 1618, 1692, 3378, 3459; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.74 (s, 1H), 8.44 (d, <i>J</i> = 8.0 Hz, 2H), 8.16–7.97 (m, 1H), 7.73 (t, <i>J</i> = 7.6 Hz, 1H), 7.54–7.33 (m, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 7.18–7.06 (m, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 6.44 (s, 2H), 4.80–4.60 (m, 2H), 4.60–4.50 (m, 1H), 3.32–3.10 (m, 1H), 2.95–2.76 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.67, 148.43, 138.74, 138.49, 132.73, 130.87, 130.73, 128.27, 127.49, 122.72, 119.57, 119.27, 117.22, 109.97, 106.77, 58.11, 41.74, 24.20. Mass (FAB) <i>m</i>/<i>z</i>: 401 (M + 1). Molecular formula: C<sub>18</sub>H<sub>16</sub>N<sub>4</sub>O<sub>5</sub>S. Calculated C, 53.99; H, 4.03; N, 13.99. Found C, 53.95; H, 4.06; N, 13.96</div></div><div id="sec5_1_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3<i>SR</i>-2-(Quinolin-8-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6h</b>)</h3><div class="NLM_p last">Yield (64.04%); mp 160 °C; IR (KBr cm<sup>–1</sup>) 740, 1139, 1161, 1328, 1450, 1493, 1617, 1686, 3338, 3426; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.97 (d, <i>J</i> = 3.6 Hz, 1H), 8.76–8.55 (m, 1H), 8.55–8.39 (m, 1H), 8.32 (d, <i>J</i> = 7.4 Hz, 1H), 8.29–8.20 (m, 1H), 7.97 (dd, <i>J</i> = 8.7, 4.3 Hz, 1H), 7.48 (t, <i>J</i> = 7.7 Hz, 1H), 7.43–7.34 (m, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.17–7.05 (m, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 6.44 (s, 2H), 4.79–4.61 (m, 2H), 4.61–4.52 (m, 1H), 3.36–3.08 (m, 1H), 2.96–2.74 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.64, 150.76, 149.56, 140.47, 138.74, 131.17, 130.31, 129.65, 127.49, 126.17, 124.98, 124.45, 123.50, 119.57, 119.27, 117.22, 109.97, 106.77, 56.75, 40.41, 23.95. Mass (FAB) <i>m</i>/<i>z</i>: 407(M<sup>+</sup>). Molecular formula: C<sub>21</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>S. Calculated C, 62.05; H, 4.46; N, 13.78. Found C, 62.08; H, 4.49; N, 13.74.</div></div><div id="sec5_1_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3<i>SR</i>-2-(2,4,6-Trimethylphenyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>6i</b>)</h3><div class="NLM_p">Yield (44.08%); mp 212 °C; IR (KBr cm<sup>–1</sup>) 752, 1155, 1324, 1455, 1596, 1668, 3299, 3394; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.51–7.32 (m, 1H), 7.23 (dd, <i>J</i> = 7.8, 0.5 Hz, 1H), 7.12 (ddd, <i>J</i> = 7.4, 4.0, 0.5 Hz, 1H), 6.99 (ddd, <i>J</i> = 7.6, 4.2, 0.7 Hz, 1H), 6.93 (s, 2H), 6.44 (s, 2H), 4.74–4.51 (m, 2H), 4.51–4.39 (m, 1H), 3.29–3.12 (m, 1H), 2.97–2.75 (m, 1H), 2.54 (s, 6H), 2.29 (s, 3H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 170.67, 142.19, 142.13, 138.74, 132.18, 131.63, 130.92, 127.49, 119.57, 119.27, 117.22, 109.97, 106.77, 57.26, 40.89, 24.18, 23.42, 20.94. Mass (FAB) <i>m</i>/<i>z</i>: 398 (M<sup>+</sup>). Molecular formula: C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 63.45; H, 5.83; N, 10.57. Found C, 63.48; H, 5.85; N, 10.54.</div><div class="NLM_p last">Compounds <b>7a</b> and <b>7b</b> were prepared following the general procedure A.</div></div><div id="sec5_1_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3<i>SR</i>-Methyl 2-(Naphthalen-2-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>7a</b>)</h3><div class="NLM_p last">Yield (85%); mp 210 °C; IR (KBr cm<sup>–1</sup>) 751, 1158, 1362, 1451, 1594, 1748, 3418; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 8.25 (s, 1H), 8.18–8.11 (m, 1H), 8.10–8.03 (m, 1H), 7.98 (dd, <i>J</i> = 8.5, 1.4 Hz, 2H), 7.66–7.52 (m, 2H), 7.43–7.32 (m, 1H), 7.25–7.18 (m, 1H), 7.12 (ddd, <i>J</i> = 7.8, 4.4, 3.8 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 5.04 (t, <i>J</i> = 7.4 Hz, 1H), 4.75–4.40 (m, 2H), 3.60 (s, 3H), 3.35–3.06 (m, 1H), 2.57–2.31 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.93, 139.04, 138.19, 133.35, 132.92, 132.44, 131.77, 129.29, 128.56, 127.46, 127.36, 127.03, 126.55, 126.03, 119.57, 119.26, 117.23, 109.96, 106.72, 53.40, 51.95, 40.39, 23.97. Mass (FAB) <i>m</i>/<i>z</i>: 421 (M<sup>+</sup>). Molecular formula: C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 65.70; H, 4.79; N, 6.66. Found C, 65.69; H, 4.83; N, 6.67.</div></div><div id="sec5_1_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3<i>SR</i>-Methyl 2-(Phenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylate (<b>7b</b>)</h3><div class="NLM_p last">Yield (50%); mp 184 °C; IR (KBr cm<sup>–1</sup>) 746, 1052, 1342, 1442, 1742, 3024, 3838; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.86–7.63 (m, 2H), 7.53–7.42 (m, 3H), 7.38 (dd, <i>J</i> = 7.3, 0.6 Hz, 1H), 7.23 (dd, <i>J</i> = 7.8, 0.5 Hz, 1H), 7.12 (ddd, <i>J</i> = 7.8, 4.4, 3.8 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 5.04 (t, <i>J</i> = 7.4 Hz, 1H), 4.76–4.42 (m, 2H), 3.60 (s, 3H), 3.19 (ddd, <i>J</i> = 16.4, 6.2, 1.7 Hz, 1H), 2.58–2.31 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 169.93, 139.00, 138.19, 133.25, 131.77, 129.68, 128.56, 127.89, 119.57, 119.26, 117.23, 109.96, 106.72, 53.64, 51.95, 40.63, 23.97. Mass (FAB) <i>m</i>/<i>z</i>: 371 (M + 1). Molecular formula: C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 61.61; H, 4.90; N, 7.56. Found C, 61.65; H, 4.93; N, 7.52.</div></div><div id="sec5_1_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3<i>SR</i>-2-(Naphthalen-2-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylic Acid (<b>8a</b>)</h3><div class="NLM_p last">To a solution of <b>7a</b> (1gm, 2.37 mmol) in water and 1,4-dioxane (25 mL, water/1,4-dioxane = 1:3), 2 N sodium hydroxide solution (3 mL) was added dropwise at 0 °C. After addition the reaction mixture was stirred for 4 h and completion was confirmed followed by TLC. After completion the reaction mixture was concentrated in vacuum and water was added. It was followed by the addition of 1 N HCl solution in ice cold condition until neutralization that precipitated the title compounds. After filtration and repeated washing with water the title compound <b>8a</b> was obtained as powder. Yield (69.3%); mp 245 °C; IR (KBr cm<sup>–1</sup>) 751, 1158, 1362, 1451, 1594, 1748, 3418; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.95 (s, 1H), 8.47 (s, 1H), 8.25 (s, 1H), 8.18–8.11 (m, 1H), 8.10–8.03 (m, 1H), 7.98 (dd, <i>J</i> = 8.5, 1.4 Hz, 2H),7.66–7.52 (m,2H), 7.42 (dd, <i>J</i> = 7.8, 0.6 Hz, 1H), 7.26–7.19 (m, 1H), 7.12 (dd, <i>J</i> = 10.7, 3.9 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 5.04–4.51 (m, 3H), 3.36–3.10 (m, 1H), 2.57–2.29 (m, 1H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 171.60, 139.45, 138.26, 133.54, 133.11, 132.44, 131.27, 129.29, 128.05, 127.98, 127.46, 127.03, 126.65, 126.55, 119.57, 119.26, 117.43, 109.96, 105.25, 58.17, 41.34, 21.61. Mass (FAB) <i>m</i>/<i>z</i>: 407 (M<sup>+</sup>). Molecular formula: C<sub>22</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 65.01; H, 4.46; N, 6.89. Found C, 65.03; H, 4.43; N, 6.92.</div></div><div id="sec5_1_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3<i>SR</i>-2-(Phenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxylic Acid (<b>8b</b>)</h3><div class="NLM_p last">Compound <b>8b</b> was prepared using <b>7b</b> (1 g, 2.7 mmol) as starting material following the same procedure as mentioned for compound <b>8a</b>. Yield (74.8%); mp 174 °C; IR (KBr cm<sup>–1</sup>) 746, 1052, 1342, 1442, 1742, 3024, 3300, 3838; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ = 3.07–3.14 (dd, <i>J</i> = 15.3, 6.9, 1H), 3.35–3.40 (d, <i>J</i> = 15.3, 1H), 4.72–4.77 (d, <i>J</i> = 16.8, 1H), 4.93–4.98 (d, <i>J</i> = 16.8, 1H), 5.27–5.29 (d, <i>J</i> = 6.9, 1H), 7.15–7.28 (m, 2H), 7.39–7.49 (m, 3H), 7.60–7.72 (m, 4H), 8.47 (s, 1H), 9.56 (s, 1H). <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 171.60, 139.35, 138.26, 133.25, 131.27, 129.87, 128.51, 128.06, 119.57, 119.26, 117.43, 109.96, 105.25, 58.41, 41.58, 21.61. Mass (FAB) <i>m</i>/<i>z</i>: 357 (M<sup>+</sup>). Molecular formula: C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S. Calculated C, 60.66; H, 4.53; N, 7.86. Found C, 60.63; H, 4.57; N, 7.84.</div></div><div id="sec5_1_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3<i>SR</i>-2-(Naphthalen-2-ylsulfonyl)-<i>N</i>-propyl-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>9a</b>)</h3><div class="NLM_p last">Compound <b>9a</b> was prepared from compound <b>8a</b> (1gm, 2.43 mmol) and <i>N</i>-propylamine following general procedure C. Yield (67.6%); mp 161 °C; IR (KBr cm<sup>–1</sup>) 751, 1158, 1362, 1451, 1594, 1748, 3418; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 8.28 (s, 1H), 8.21–8.12 (m, 1H), 8.12–8.04 (m, 2H), 8.03–7.92 (m, 2H), 7.59 (qd, <i>J</i> = 9.0, 1.5 Hz, 2H), 7.50–7.35 (m, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.12 (t, <i>J</i> = 7.3 Hz, 1H), 7.04–6.90 (m, 1H), 5.02–4.73 (m, 1H), 4.73–4.41 (m, 2H), 3.83 (dt, <i>J</i> = 13.3, 6.6 Hz, 1H), 3.00–2.71 (m, 2H), 0.92 (d, <i>J</i> = 6.6 Hz, 6H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 167.53, 140.81, 139.00, 133.16, 132.73, 132.44, 130.34, 129.29, 127.53, 127.46, 127.36, 127.03, 126.55, 126.01, 119.57, 119.24, 117.59, 110.04, 103.29, 58.62, 41.18, 39.84, 24.54, 24.30, 11.24. Mass (FAB) <i>m</i>/<i>z</i>: 448 (M + 1). Molecular formula: C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 67.09; H, 5.63; N, 9.39. Found C, 67.07; H, 5.66; N, 9.41.</div></div><div id="sec5_1_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3<i>SR</i>-<i>N</i>-Isopropyl-2-(naphthalen-2-ylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>9b</b>)</h3><div class="NLM_p last">Compound <b>9b</b> was prepared from compound <b>8a</b> (1gm, 2.43 mmol) and <i>N</i>-isopropylamine following general procedure C. Yield (69.2%); mp 171 °C; IR (KBr cm<sup>–1</sup>) 751, 1158, 1362, 1451, 1594, 1748, 3418; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 8.28 (s, 1H), 8.17 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 8.12–8.04 (m, 2H), 8.04–7.94 (m, 2H), 7.67–7.52 (m, 2H), 7.47–7.38 (m, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.12 (dd, <i>J</i> = 10.7, 3.9 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 4.94–4.73 (m, 1H), 4.71–4.43 (m, 2H), 3.83 (dt, <i>J</i> = 13.3, 6.6 Hz, 1H), 3.00–2.71 (m, 2H), 0.92 (d, <i>J</i> = 6.6 Hz, 6H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 167.53, 140.64, 139.00, 133.16, 132.73, 132.44, 130.34, 129.29, 127.53, 127.46, 127.36, 127.03, 126.55, 126.01, 119.57, 119.24, 117.59, 110.04, 104.46, 58.17, 42.20, 40.56, 24.30, 22.97. Mass (FAB) <i>m</i>/<i>z</i>: 448 (M + 1). Molecular formula: C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 67.09; H, 5.63; N, 9.39. Found C, 67.11; H, 5.65; N, 9.36;</div></div><div id="sec5_1_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3<i>SR</i>-2-(Phenylsulfonyl)-<i>N</i>-propyl-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>9c</b>)</h3><div class="NLM_p last">Compound <b>9c</b> was prepared from compound <b>8b</b> (1gm, 2.8 mmol) and <i>N</i>-propylamine following general procedure C. Yield (73.4%); mp 192 °C; IR (KBr cm<sup>–1</sup>) 746, 1052, 1342, 1442, 1742, 3024, 3300, 3838; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.82–7.68 (m, 3H), 7.61–7.34 (m, 4H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.12 (dd, <i>J</i> = 10.7, 3.9 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 5.00–4.75 (m, 1H), 4.77–4.40 (m, 2H), 3.46–3.10 (m, 2H), 2.98 (ddd, <i>J</i> = 6.1, 2.9, 1.9 Hz, 2H), 1.37 (dd, <i>J</i> = 14.2, 7.1 Hz, 2H), 0.97–0.68 (m, 3H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 167.53, 139.00, 137.09, 133.25, 130.34, 129.18, 127.53, 126.84, 119.57, 119.24, 117.59, 110.04, 103.29, 58.86, 41.41, 39.84, 24.54, 24.30, 11.24. Mass (FAB) <i>m</i>/<i>z</i>: 398 (M<sup>+</sup>). Molecular formula: C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 63.45; H, 5.83; N, 10.57. Found C, 63.48; H, 5.81; N, 10.59.</div></div><div id="sec5_1_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3<i>SR</i>-<i>N</i>-Isopropyl-2-(phenylsulfonyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole-3-carboxamide (<b>9d</b>)</h3><div class="NLM_p last">Compound <b>9d</b> was prepared from compound <b>8b</b> (1gm, 2.8 mmol) and <i>N</i>-isopropylamine following general procedure C. Yield (76.7.4%); mp 175 °C; IR (KBr cm<sup>–1</sup>) 746, 1052, 1342, 1442, 1742, 3024, 3300, 3838; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 8.47 (s, 1H), 7.81–7.68 (m, 3H), 7.55–7.33 (m, 4H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.12 (dd, <i>J</i> = 10.7, 3.9 Hz, 1H), 6.99 (td, <i>J</i> = 7.2, 3.6 Hz, 1H), 4.82 (ddd, <i>J</i> = 7.5, 2.4, 1.7 Hz, 1H), 4.68–4.48 (m, 2H), 3.83 (dt, <i>J</i> = 13.3, 6.6 Hz, 1H), 2.99–2.76 (m, 2H), 0.92 (d, <i>J</i> = 6.6 Hz, 6H); <sup>13</sup>C NMR (50 MHz, DMSO-<i>d</i><sub>6</sub> + CDCl<sub>3</sub>, ppm) δ 167.53, 139.00, 136.90, 133.25, 130.34, 129.18, 127.53, 126.84, 119.57, 119.24, 117.59, 110.04, 104.46, 58.41, 42.20, 40.80, 24.30, 22.97. Mass (FAB) <i>m</i>/<i>z</i>: 398 (M<sup>+</sup>). Molecular formula: C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S. Calculated C, 63.45; H, 5.83; N, 10.57. Found C, 63.43; H, 5.82; N, 10.56.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Biology</h3><div class="NLM_p last">Fibrillar type I collagen from equine tendon, ADP, arachidonic acid, ristocetin, Chrono-lume ATP reagent (Chronolog Corp, Havertown, USA); type I collagen from rat tail, epinephrine, bovine serum albumin (BSA), apyrase, phenylmethylsulfonyl fluoride, leupeptin and aprotinin, Fura-2AM, (Sigma-Aldrich, USA). STA thrombin reagents, neoplastin CI plus, Fibri-Prest, CK Prest were purchased from Stago (France). Thrombin receptor-activating peptide (TRAP) was synthesized by peptide synthesis facility at CDRI (CSIR). Collagen-related peptide (CRP) was a kind gift from Dr. R. W. Farndale (Department of Biochemistry, University of Cambridge, U.K.). <i>p</i>-Nitrophenyl phosphate (SRL), EIA thromboxane B<sub>2</sub> enzyme immunoassay kit (Cayman Chemicals), anti phospho-tyrosine antibody 4G10 (Upstate Biotechnology, USA), anti-PLCγ-2 antibody (Santa Cruz Biotechnology, USA). Protein A/G agarose was purchased from Amersham Biosciences. Swiss albino mice (22–25 g) were obtained from the National Laboratory Animal Centre at the Council of Scientific and industrial Research Central Drug Research institute, Lucknow, India. All the animals received humane care in compliance with the Guidelines for the Care and Use of Laboratory Animals. The mice were kept in polypropylene cages at 24 ± 0.5 °C and a 12 h day–12 h night cycle, and were fed with chow pellets and water ad libitum. All the experimental protocols and procedures were approved by the Institutional Animal Ethics Committee, in accordance with the Guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and conform to the international norms of the Indian National Science Academy. Values have been reported as the mean ± SEM in control and treated groups. Comparisons between the different groups were performed by one way ANOVA, and differences were considered significant at <i>p</i> < 0.05.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Collagen–Epinephrine Induced Pulmonary Thromboembolism in Mice</h3><div class="NLM_p last">Pulmonary thromboembolism was induced by a method as described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Briefly, the compounds to be tested, standard drugs, or the vehicles were administered by oral route 60 min prior to the thrombotic challenge. A mixture of collagen (150 μg/mL) and epinephrine (50 μg/mL) was injected into the tail vein to induce hind limb paralysis or death. Results have been reported as percentage protection, which represents protection against collagen and epinephrine induced thrombosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Bleeding Time</h3><div class="NLM_p last">The tail, approximately 2 mm from tip, of mice was incised with a sharp razor blade. The time elapsed from the tip incision to the stoppage of bleeding was determined as the bleeding time. The change in bleeding time was compared with that of vehicle treated mice, and results have been depicted as percent increase from control.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Preparation and Stimulation of Human Platelets</h3><div class="NLM_p last">Blood was drawn from healthy, drug-free volunteers after prior consent in acid citrate dextrose (ACD, 120 mM sodium citrate, 110 mM glucose, 80 mM citric acid, used at 1:7 v/v). Platelet-rich plasma (PRP) was prepared by centrifugation at 200<i>g</i> for 20 min, and the remaining blood was further centrifuged at 1000<i>g</i> for 15 min to obtain platelet poor plasma (PPP). Platelets were isolated by centrifugation for 10 min at 700<i>g</i>, in the presence of apyrase (0.002 U/mL) and prostaglandin I<sub>2</sub> (400 ng/mL). The pellet was resuspended to a density of 2 × 10<sup>8</sup> platelets/mL in a Tyrode’s-HEPES buffer (145 mM NaCl, 2.9 mM KCl, 10 mM HEPES, 1 mM MgCl<sub>2</sub>, 5 mM glucose, pH 7.3).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Stimulation of platelets was performed in an aggregometer at 37 °C, with continuous stirring at 800 rpm.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Platelet Aggregation and Coagulation Parameters</h3><div class="NLM_p">A turbidimetric method was applied to measure platelet aggregation, using a dual channel aggregometer (Chronolog Corp., USA).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Platelet rich plasma (1 × 10<sup>8</sup> platelets/mL, 0.45 mL) was prewarmed to 37 °C for 2 min, then incubated with compound (3–300 μM) or an isovolumetric solvent control (0.4% DMSO) for 5 min before addition of the agonists (i.e., 2 μg/mL collagen, 5 μM ADP, 10 ng/mL convulxin, 25 μM TRAP, 1.5 mg/mL ristocetin, 0.3 μg/mL CRP). The reaction was allowed to proceed for at least 5 min, and the extent of aggregation was expressed as percentage which was calculated by using Aggrolink software.</div><div class="NLM_p last">Coagulation parameters, prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT) were measured in the plasma within 2 h of sample collection by using commercially available kits as per manufacturer’s instructions (Stago, France) and were measured by using a semiautomated coagulometer (Start4, Young Instruments, Stago, France).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Platelet Adhesion Assay</h3><div class="NLM_p last">Washed platelets were pretreated with solvent or compound for 30 min. Ninety-six-well microtiter plates were coated with fibrillar type I collagen overnight, followed by blocking with 5 mg/mL BSA at room temperature for 1 h. Washed platelets were added to the wells (10<sup>7</sup>/well) for 1 h at room temperature. After three washes in Tyrode’s buffer, the number of adherent platelets was evaluated colorimetrically (as described by Bellavite et al).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Briefly, 150 μL of 0.1 M citrate buffer (pH 5.4) containing 5 mM <i>p</i>-nitrophenyl phosphate and 0.1% TritonX-100 was added to the wells after washing. After incubation for 60 min at 25 °C in the absence of ambient light, color was developed by the addition of 100 μL of 2 N NaOH and the absorbance at 405 nm was read using a microplate reader (Powerware XS, Biotek, USA).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> P-Selectin Expression</h3><div class="NLM_p last">The inhibition of platelet P-selectin (CD62P) expression by compound <b>6b</b> was determined by flow cytometry. Platelet rich plasma containing 50 μmol/L tirofiban was preincubated with 0, 30, 100, or 300 μmol/L of compound <b>6b</b> for 10 min at 37 °C. Then, collagen (Horm, Nycomed, Linz, Austria) was added at a concentration of 30 μg/mL. Ten minutes later, 10 μL of PRP was incubated with 2 μL of anti-CD62P-PE (Beckman Coulter, Krefeld, Germany) for 10 min and analyzed on a Guava easyCyte 5 cytometer (Millipore, Schwalmbach, Germany).</div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> ATP Secretion</h3><div class="NLM_p last">ATP secretion was monitored in platelet rich plasma in parallel with platelet aggregation (Chrono log) by adding firefly luciferase and luciferin and comparing the luminescence generated by platelet ATP release with an ATP standard (Chrono-Lume), as per manufacturer’s instructions.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Thromboxane B<sub>2</sub> Measurement</h3><div class="NLM_p last">Washed platelets were pretreated with compound or vehicle and stimulated with collagen under constant stirring at 37 °C. The reaction was terminated by the addition of an ice-cold EDTA solution (10 mM) containing 10 μM indomethacin, and the samples were centrifuged at 3000<i>g</i> for 5 min at 4 °C. Thromboxane B<sub>2</sub>, the stable metabolite of TxA<sub>2</sub>, was measured using a correlate-EIA thromboxane B<sub>2</sub> enzyme immunoassay kit (Cayman Chemicals), according to the manufacturer’s instructions.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Measurement of Intracellular Calcium Concentration</h3><div class="NLM_p last">PRP was incubated with 5 μM Fura-2 AM (Sigma) for 60 min at 37 °C, followed by incubation with solvent or test compounds for 5 min and stimulation with collagen (5 μg/mL). The fluorescence was measured for 5 min at an excitation wavelength of 340/380 nm and emission wavelength of 500 nm <a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> using a spectrofluorimeter (VARIAN, Cary Eclipse).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Immunoprecipitation and Immunoblotting</h3><div class="NLM_p last">Washed platelets (2 × 10<sup>8</sup>/mL) were preincubated with solvent or compound at 37 °C for 5 min, followed by the addition of collagen for 1 min. Platelet stimulation was terminated by the addition of an equal volume of ice-cold lysis buffer (2% (v/v) Nonidet P-40, 20 mM Tris, 300 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 2 mM Na<sub>3</sub>VO<sub>4</sub>, 10 μg/mL leupeptin, 10 μg/mL aprotinin, and 1 μg/mL pepstatin A, pH 7.3). A total of 300 μg of platelet protein was incubated overnight with protein-A-Sepharose beads and 2 μg of anti PLCγ2 overnight at 4 °C. Beads were then washed before addition of 4× Laemmli sample buffer and boiled for 5 min. Proteins were resolved by electrophoresis in 8% SDS–PAGE gels and transferred to nitrocellulose membranes, blocked with 5% bovine serum albumin, and then probed with the following primary antibodies: anti-p-Tyr(4G10) (diluted 1:10,000 in TBST), β-actin (1:5000), anti PLC-γ2 (1:1000) for 2 h. Membranes were then washed before incubation with appropriate secondary antibody followed by thorough washing. Bound peroxidase activity was detected using enhanced chemiluminescence (ECL, Amersham Biosciences).</div></div><div id="sec5_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Molecular Modeling Studies. Docking of Compounds <b>6c</b> and <b>6d</b></h3><div class="NLM_p last">The docking studies were performed using <b>6c</b> and <b>6d</b> at the GPVI primary and secondary binding site. All the structures were prepared by using the Ligprep<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> module implemented in Schrodinger 9.0. The protein preparation was performed using Protein Preparation Wizard<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> in Schrodinger 9.0.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The induced fit docking protocol was used to dock the enantiomers <b>6c</b> and <b>6d</b> using the extra precision (XP) mode in GLIDE,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and the 10 best poses were analyzed. The crystal structure of GPVI (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GI7">2GI7</a>) was used for docking, and grid generation was performed by taking the amino acid residues Glu40-Arg60 for site 1.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01360">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01360" class="ext-link">10.1021/acs.jmedchem.6b01360</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Effect of compound <b>6b</b> in ferric chloride induced arterial thrombosis model and docking scores of different conformations for <b>6c</b> and <b>6d</b> in Table S1 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Structure coordinates (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Structure coordinates (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_004.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_001.pdf">jm6b01360_si_001.pdf (84.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_002.pdb">jm6b01360_si_002.pdb (223.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_003.pdb">jm6b01360_si_003.pdb (223.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_004.csv">jm6b01360_si_004.csv (1.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01360" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Madhu Dikshit</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e28f83868a97bd868b89918a8b96a28186908bcc908791cc8b8c"><span class="__cf_email__" data-cfemail="ef828e8b879ab08b86849c87869baf8c8b9d86c19d8a9cc18681">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil K. Saxena</span> - <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0212-7246" title="Orcid link">http://orcid.org/0000-0002-0212-7246</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c2d2225203f2d270c2b212d2520622f2321"><span class="__cf_email__" data-cfemail="a5c4cbccc9d6c4cee5c2c8c4ccc98bc6cac8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shome S. Bhunia</span> - <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ankita Misra</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Imran A. Khan</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuti Gaur</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manish Jain</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Surendra Singh</span> - <span class="hlFld-Affiliation affiliation">†Division
of Medicinal and Process Chemistry, and ‡Division of Pharmacology, CSIR-CDRI, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, New Delhi 110 025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaruni Saxena</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Hohlfield</span> - <span class="hlFld-Affiliation affiliation">Institut
für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.S.B. and A.M. contributed equally. A.K.S. and M.D. share senior coauthorship.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">CDRI communication number: 9393</p></div></li></ul></div><div class="ack" id="ACK-d43e5593-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The author A.K.S. is thankful to the Alexander von Humboldt Foundation, Germany, for financial support for his visits to Heinrich-Heine-Universität Düsseldorf. The authors (S.S.B., A.M., and I.A.K.) are thankful to the Council of Scientific and Industrial Research, New Delhi, for the financial assistance in the form of fellowship. The authors also acknowledge the Sophisticated Analytical Instrument Facility (SAIF) department of Central Drug Research Institute, Lucknow, for the characterization of compounds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> Abbreviations Used</h2><tr><td class="NLM_term">aPTT</td><td class="NLM_def"><p class="first last">activated partial thromboplastin time</p></td></tr><tr><td class="NLM_term">AT1</td><td class="NLM_def"><p class="first last">angiotensin 1</p></td></tr><tr><td class="NLM_term">CRP</td><td class="NLM_def"><p class="first last">collagen related peptide</p></td></tr><tr><td class="NLM_term">CVX</td><td class="NLM_def"><p class="first last">convulxin</p></td></tr><tr><td class="NLM_term">GPO</td><td class="NLM_def"><p class="first last">glycine–proline–hydroxyproline</p></td></tr><tr><td class="NLM_term">GPVI-Fc</td><td class="NLM_def"><p class="first last">GPVI fusion</p></td></tr><tr><td class="NLM_term">GPVI</td><td class="NLM_def"><p class="first last">glycoprotein VI</p></td></tr><tr><td class="NLM_term">KIR</td><td class="NLM_def"><p class="first last">killer-cell Ig-like</p></td></tr><tr><td class="NLM_term">LOS</td><td class="NLM_def"><p class="first last">losartan</p></td></tr><tr><td class="NLM_term">LRC</td><td class="NLM_def"><p class="first last">leukocyte Ig-like receptor complex</p></td></tr><tr><td class="NLM_term">PRP</td><td class="NLM_def"><p class="first last">platelet rich plasma</p></td></tr><tr><td class="NLM_term">PT</td><td class="NLM_def"><p class="first last">prothrombin time</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TT</td><td class="NLM_def"><p class="first last">thrombin time</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Geisler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdeg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2007.02812.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2007.02812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17949474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=54-61&author=T.+Geislerauthor=D.+Grassauthor=B.+Bigalkeauthor=K.+Stellosauthor=T.+Droschauthor=K.+Dietzauthor=C.+Herdegauthor=M.+Gawaz&title=The+residual+platelet+aggregation+after+deployment+of+intracoronary+stent+%28PREDICT%29+score&doi=10.1111%2Fj.1538-7836.2007.02812.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score</span></div><div class="casAuthors">Geisler, T.; Grab, D.; Bigalke, B.; Stellos, K.; Drosch, T.; Dietz, K.; Herdeg, C.; Gawaz, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Recent studies suggest a high interindividual variability of response to clopidogrel assocd. with adverse cardiovascular outcome.  Different clin. factors are considered to influence a persistent residual platelet aggregation (RPA) despite conventional antiplatelet therapy.  Objectives: To investigate clin. factors that affect RPA after 600-mg clopidogrel loading in a large unselected cohort of patients with symptomatic CAD.  Methods: The study population included a consecutive cohort of 1092 patients treated with coronary stenting for stable angina and acute coronary syndromes (ACS).  Residual platelet activity was assessed by ADP (20 μmol L-1)-induced platelet aggregation ≥ 6 h after LD.  Eleven clin. factors were included in the primary anal.  Results: In multivariate regression anal. increased RPA was significantly influenced by ACS, reduced LV-function, diabetes mellitus, renal failure (creatinine > 1.5 mg dL-1), and age > 65 years.  In a factor-weighed model the risk for high RPA increased with higher score levels (OR for patients with a score of 1-3, 1.21, 95% CI 0.7-2.1; score 4-6, OR 2.0, 95% CI 1.17-3.5; P = 0.01; score 7-9, OR 3.3, 95% CI 1.8-6.0).  During a 30-day follow-up the incidence of major adverse events was higher in patients with RPA in the upper tertile (4.8% vs. 2.5% in the 2nd and 1.5% in the 1st tertile; P < 0.05).  Conclusions: The PREDICT score provides a good tool to est. residual platelet activity after clopidogrel LD by easily available patient details.  Addnl., we demonstrate its assocn. with short-term outcome.  Thus, patients with a high score may benefit from intensified antiplatelet therapy by improved platelet inhibition and risk redn. for thromboischemic events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmBpBhQ9J97Vg90H21EOLACvtfcHk0ljK6bib43csXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOrt7s%253D&md5=bac965b5613e701c117c2074386615a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02812.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DT.%26aulast%3DGrass%26aufirst%3DD.%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DDrosch%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DK.%26aulast%3DHerdeg%26aufirst%3DC.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520residual%2520platelet%2520aggregation%2520after%2520deployment%2520of%2520intracoronary%2520stent%2520%2528PREDICT%2529%2520score%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2008%26volume%3D6%26spage%3D54%26epage%3D61%26doi%3D10.1111%2Fj.1538-7836.2007.02812.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">Platelet-collagen interaction: is GPVI the central receptor?</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1182/blood-2002-12-3882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2002-12-3882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=12649139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=449-461&author=B.+Nieswandtauthor=S.+P.+Watson&title=Platelet-collagen+interaction%3A+is+GPVI+the+central+receptor%3F&doi=10.1182%2Fblood-2002-12-3882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-collagen interaction: Is GPVI the central receptor?</span></div><div class="casAuthors">Nieswandt, Bernhard; Watson, Steve P.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-461</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  At sites of vascular injury, platelets come into contact with subendothelial collagen, which triggers their activation and the formation of a hemostatic plug.  Besides glycoprotein Ib (GPIb) and αIIbβ3 integrin, which indirectly interact with collagen via von Willebrand factor (VWF), several collagen receptors have been identified on platelets, most notably α2β1 integrin and the Ig (Ig) superfamily member GPVI.  Within the last few years, major advances have been made in understanding platelet-collagen interactions including the mol. cloning of GPVI, the generation of mouse strains lacking individual collagen receptors, and the development of collagen receptor-specific antibodies and synthetic peptides.  It is now recognized that platelet adhesion to collagen requires prior activation of integrins through "inside-out" signals generated by GPVI and reinforced by released second-wave mediators ADP (ADP) and thromboxane A2.  These developments have led to revision of the original "2-site, 2-step" model, which now places GPVI in a central position in the complex processes of platelet tethering, activation, adhesion, aggregation, degranulation, and procoagulant activity on collagen.  This review discusses these recent developments and proposes possible mechanisms for how GPVI acts in concert with other receptors and signaling pathways to initiate hemostasis and arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0gKlek4-__bVg90H21EOLACvtfcHk0ljK6bib43csXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGitrw%253D&md5=26909f5bdfe8c7c21f57497ffbc79532</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-12-3882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-12-3882%26sid%3Dliteratum%253Aachs%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DPlatelet-collagen%2520interaction%253A%2520is%2520GPVI%2520the%2520central%2520receptor%253F%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D449%26epage%3D461%26doi%3D10.1182%2Fblood-2002-12-3882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melms, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1111/j.1468-1331.2009.02754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1468-1331.2009.02754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19686349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3czitleqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=111-117&author=B.+Bigalkeauthor=K.+Stellosauthor=T.+Geislerauthor=E.+Kremmerauthor=P.+Seizerauthor=A.+E.+Mayauthor=S.+Lindemannauthor=A.+Melmsauthor=A.+Luftauthor=M.+Gawaz&title=Expression+of+platelet+glycoprotein+VI+is+associated+with+transient+ischemic+attack+and+stroke&doi=10.1111%2Fj.1468-1331.2009.02754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke</span></div><div class="casAuthors">Bigalke B; Stellos K; Geisler T; Kremmer E; Seizer P; May A E; Lindemann S; Melms A; Luft A; Gawaz M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Platelet collagen receptor glycoprotein VI (GPVI) contributes significantly to platelet adhesion and thrombus formation.  We aimed to investigate GPVI in patients presenting with symptoms of acute cerebrovascular disease and to define GPVI as biomarker for acute stroke.  METHODS:  We consecutively evaluated 205 patients, who admitted the stroke unit with symptoms for stroke.  Surface expression of the platelet activation markers (GPVI, CD62P, GPIb) was determined by two-color whole blood flow cytometry.  RESULTS:  Patients with transient ischemic attack (TIA) (n = 18; 8.8%) as well as with stroke (n = 133; 64.9%) showed a significantly enhanced GPVI expression (mean fluorescence intensity +/- SD) on admission compared to patients with non-ischemic (NI) events (n = 54; 26.3%) (TIA: 20.9 +/- 7.1 vs.  NI: 16.2 +/- 3.9; P = 0.002; stroke: 20.4 +/- 5.7 vs.  NI; P = 0.002).  Neither CD62P nor GPIb surface expression showed a significant difference.  Logistic regression analysis revealed that on admission GPVI was associated with stroke independent of conventional laboratory markers such as C-reactive protein, blood glucose, and creatine kinase.  Using a receiver operating characteristic curve on GPVI, we have determined the cut off value of 18.2 for stroke.  Thus, patients with enhanced GPVI expression levels (>or=18.2) had a 2.4-fold relative risk for stroke.  Patients with elevated platelet GPVI expression level had a poorer clinical outcome in cumulative event-free survival for stroke, myocardial infarction, and cerebro-/cardiovascular death at 3-month follow-up (log rank; P = 0.045).  CONCLUSIONS:  These findings indicate that platelet GPVI surface expression is significantly enhanced in patients with TIA and stroke compared to patients with NI events.  Determination of platelet-specific GPVI may be useful as an early biomarker for cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo1pDLexOcHny-c-E1v-fmfW6udTcc2ebsmG-tIhBRwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czitleqtA%253D%253D&md5=85228796b4b8cbd41cc9923ae9a1039e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2009.02754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2009.02754.x%26sid%3Dliteratum%253Aachs%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DGeisler%26aufirst%3DT.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DA.%2BE.%26aulast%3DLindemann%26aufirst%3DS.%26aulast%3DMelms%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DA.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DExpression%2520of%2520platelet%2520glycoprotein%2520VI%2520is%2520associated%2520with%2520transient%2520ischemic%2520attack%2520and%2520stroke%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2010%26volume%3D17%26spage%3D111%26epage%3D117%26doi%3D10.1111%2Fj.1468-1331.2009.02754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stakos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkelmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2009.03659.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2009.03659.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19874461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=205-207&author=K.+Stellosauthor=B.+Bigalkeauthor=D.+Stakosauthor=N.+Henkelmannauthor=M.+Gawaz&title=Platelet-bound+P-selectin+expression+in+patients+with+coronary+artery+disease%3A+impact+on+clinical+presentation+and+myocardial+necrosis%2C+and+effect+of+diabetes+mellitus+and+anti-platelet+medication&doi=10.1111%2Fj.1538-7836.2009.03659.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication</span></div><div class="casAuthors">Stellos, K.; Bigalke, B.; Stakos, D.; Henkelmann, N.; Gawaz, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-207</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study tried to explore the possible assocns. between platelet P-selectin and extent of myocardial injury, measured by troponin I (Tn-I) and creatine kinase-MB (CK-MB), and to investigate the relationship between P-selectin expression and clin. presentation in patients with coronary artery disease (CAD).  There was a link between platelet P-selectin and markers of myocardial necrosis (Tn-I and CK-MB) in patients with ACS.  It was also found that improved platelet activation is indicative of the degree of myocardial damage well before peak levels of CK-MB and Tn-I are reached.  In addn., results showed that in a clin. setting of enhanced platelet activity, cardiovascular risk factors such as diabetes or conventional anti-platelet drugs may not have the same effect in platelet activation/inhibition as in patients with stable CAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWvrJspf8aLVg90H21EOLACvtfcHk0lhIRoNEeLr7Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltL0%253D&md5=2532cdd625b23c17ac60a2675cabd2c5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2009.03659.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2009.03659.x%26sid%3Dliteratum%253Aachs%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStakos%26aufirst%3DD.%26aulast%3DHenkelmann%26aufirst%3DN.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DPlatelet-bound%2520P-selectin%2520expression%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%253A%2520impact%2520on%2520clinical%2520presentation%2520and%2520myocardial%2520necrosis%252C%2520and%2520effect%2520of%2520diabetes%2520mellitus%2520and%2520anti-platelet%2520medication%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2010%26volume%3D8%26spage%3D205%26epage%3D207%26doi%3D10.1111%2Fj.1538-7836.2009.03659.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Horii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, A. B.</span><span> </span><span class="NLM_article-title">Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span><span class="refDoi"> DOI: 10.1182/blood-2006-01-010215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2006-01-010215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=16861347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=936-942&author=K.+Horiiauthor=M.+L.+Kahnauthor=A.+B.+Herr&title=Structural+basis+for+platelet+collagen+responses+by+the+immune-type+receptor+glycoprotein+VI&doi=10.1182%2Fblood-2006-01-010215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI</span></div><div class="casAuthors">Horii, Katsunori; Kahn, Mark L.; Herr, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">936-942</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Activation of circulating platelets by exposed vessel wall collagen is a primary step in the pathogenesis of heart attack and stroke, and drugs to block platelet activation have successfully reduced cardiovascular morbidity and mortality.  In humans and mice, collagen activation of platelets is mediated by glycoprotein VI (GPVI), a receptor that is homologous to immune receptors but bears little sequence similarity to known matrix protein adhesion receptors.  Here the authors present the crystal structure of the collagen-binding domain of human GPVI and characterize its interaction with a collagen-related peptide.  Like related immune receptors, GPVI contains 2 Ig-like domains arranged in a perpendicular orientation.  Significantly, GPVI forms a back-to-back dimer in the crystal, an arrangement that could explain data previously obtained from cell-surface GPVI inhibition studies.  Docking algorithms identify 2 parallel grooves on the GPVI dimer surface as collagen-binding sites, and the orientation and spacing of these grooves precisely match the dimensions of an intact collagen fiber.  These findings provide a structural basis for the ability of an immune-type receptor to generate signaling responses to collagen and for the development of GPVI inhibitors as new therapies for human cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUNnaUajDU-7Vg90H21EOLACvtfcHk0lhIRoNEeLr7Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFajtLo%253D&md5=ea2e412b4f43f072c04dc2aa84009332</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-01-010215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-01-010215%26sid%3Dliteratum%253Aachs%26aulast%3DHorii%26aufirst%3DK.%26aulast%3DKahn%26aufirst%3DM.%2BL.%26aulast%3DHerr%26aufirst%3DA.%2BB.%26atitle%3DStructural%2520basis%2520for%2520platelet%2520collagen%2520responses%2520by%2520the%2520immune-type%2520receptor%2520glycoprotein%2520VI%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D936%26epage%3D942%26doi%3D10.1182%2Fblood-2006-01-010215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Andrews, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguti, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlanga, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theakston, R. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The use of snake venom toxins as tools to study platelet receptors for collagen and von Willebrand factor</span> <span class="citation_source-journal">Pathophysiol. Haemostasis Thromb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1159/000048059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1159%2F000048059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=155-172&author=R.+K.+Andrewsauthor=A.+S.+Kamigutiauthor=O.+Berlangaauthor=M.+Leducauthor=R.+D.+G.+Theakstonauthor=S.+P.+Watson&title=The+use+of+snake+venom+toxins+as+tools+to+study+platelet+receptors+for+collagen+and+von+Willebrand+factor&doi=10.1159%2F000048059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000048059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000048059%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DR.%2BK.%26aulast%3DKamiguti%26aufirst%3DA.%2BS.%26aulast%3DBerlanga%26aufirst%3DO.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DTheakston%26aufirst%3DR.%2BD.%2BG.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520use%2520of%2520snake%2520venom%2520toxins%2520as%2520tools%2520to%2520study%2520platelet%2520receptors%2520for%2520collagen%2520and%2520von%2520Willebrand%2520factor%26jtitle%3DPathophysiol.%2520Haemostasis%2520Thromb.%26date%3D2002%26volume%3D31%26spage%3D155%26epage%3D172%26doi%3D10.1159%2F000048059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, P. G.</span><span> </span><span class="NLM_article-title">The role of collagen in thrombosis and hemostasis</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2004.00665.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2004.00665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=15102010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslWntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=561-573&author=R.+W.+Farndaleauthor=J.+J.+Sixmaauthor=M.+J.+Barnesauthor=P.+G.+de+Groot&title=The+role+of+collagen+in+thrombosis+and+hemostasis&doi=10.1111%2Fj.1538-7836.2004.00665.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of collagen in thrombosis and hemostasis</span></div><div class="casAuthors">Farndale, R. W.; Sixma, J. J.; Barnes, M. J.; De Groot, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-573</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review discusses the role of collagen in the regulation of hemostasis, embracing both coagulation and platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeIjtjelL_bVg90H21EOLACvtfcHk0lhIRoNEeLr7Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslWntLs%253D&md5=fe4872a5eaa997a7dcc4ae974820cfc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2004.00665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2004.00665.x%26sid%3Dliteratum%253Aachs%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DSixma%26aufirst%3DJ.%2BJ.%26aulast%3DBarnes%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BGroot%26aufirst%3DP.%2BG.%26atitle%3DThe%2520role%2520of%2520collagen%2520in%2520thrombosis%2520and%2520hemostasis%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2004%26volume%3D2%26spage%3D561%26epage%3D573%26doi%3D10.1111%2Fj.1538-7836.2004.00665.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navdaev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, K. J.</span><span> </span><span class="NLM_article-title">Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1016/j.toxicon.2005.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.toxicon.2005.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1089-1098&author=Q.+Luauthor=A.+Navdaevauthor=J.+M.+Clemetsonauthor=K.+J.+Clemetson&title=Snake+venom+C-type+lectins+interacting+with+platelet+receptors.+Structure-function+relationships+and+effects+on+haemostasis&doi=10.1016%2Fj.toxicon.2005.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2005.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2005.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DNavdaev%26aufirst%3DA.%26aulast%3DClemetson%26aufirst%3DJ.%2BM.%26aulast%3DClemetson%26aufirst%3DK.%2BJ.%26atitle%3DSnake%2520venom%2520C-type%2520lectins%2520interacting%2520with%2520platelet%2520receptors.%2520Structure-function%2520relationships%2520and%2520effects%2520on%2520haemostasis%26jtitle%3DToxicon%26date%3D2005%26volume%3D45%26spage%3D1089%26epage%3D1098%26doi%3D10.1016%2Fj.toxicon.2005.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Niedergang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francischetti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span> </span><span class="NLM_article-title">Convulxin binding to platelet receptor GPVI: competition with collagen related peptides</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1006/bbrc.2000.2940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1006%2Fbbrc.2000.2940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10873594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1KmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2000&pages=246-250&author=F.+Niedergangauthor=A.+Alcoverauthor=C.+G.+Knightauthor=R.+W.+Farndaleauthor=M.+J.+Barnesauthor=I.+M.+Francischettiauthor=C.+Bonauthor=M.+Leduc&title=Convulxin+binding+to+platelet+receptor+GPVI%3A+competition+with+collagen+related+peptides&doi=10.1006%2Fbbrc.2000.2940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Convulxin Binding to Platelet Receptor GPVI: Competition with Collagen Related Peptides</span></div><div class="casAuthors">Niedergang, F.; Alcover, A.; Knight, C. G.; Farndale, R. W.; Barnes, M. J.; Francischetti, I. M. B.; Bon, C.; Leduc, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-250</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Convulxin (CVX), a potent platelet aggregating protein from the venom of the snake Crotalus durissus terrificus, is known to bind to the platelet collagen receptor, glycoprotein VI (GPVI).  CVX binding to human platelets was investigated by flow cytometry, using fluorescein labeled convulxin (FITC-CVX).  Scatchard anal. indicated high and low affinity binding sites with Kd values of 0.6 and 4 nM and Bmax values of 1200 and 2000 binding sites per platelet.  FITC-CVX binding was inhibited by collagen related peptides (CRPs) comprising a repeated GPO sequence, namely GCO(GPO)10GCOGNH2 and GKO(GPO)10GKOGNH2, which also bind to receptor GPVI.  These peptides (monomeric or cross-linked forms) gave a high affinity inhibition of 10-20% for concns. between 10 ng/mL and 5 μg/mL, followed by a second phase of inhibition at concns. greater than 5 μg/mL.  It was shown also that the inhibition of FITC-CVX binding by CRPs was independent on the time of preincubation of platelets with CRPs, and the same percentage of inhibition was seen with various concns. of convulxin.  Confocal microscopy of the distribution of FITC-CVX binding sites on platelets showed an homogeneous distribution of FITC-CVX bound to GPVI, although some limited clustering may exist.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-SwyDZZ7wbVg90H21EOLACvtfcHk0lhBkEe9JWQFEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1KmsLo%253D&md5=c7d56407efe174441a3395909c4df8d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2000.2940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2000.2940%26sid%3Dliteratum%253Aachs%26aulast%3DNiedergang%26aufirst%3DF.%26aulast%3DAlcover%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DBarnes%26aufirst%3DM.%2BJ.%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DLeduc%26aufirst%3DM.%26atitle%3DConvulxin%2520binding%2520to%2520platelet%2520receptor%2520GPVI%253A%2520competition%2520with%2520collagen%2520related%2520peptides%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D273%26spage%3D246%26epage%3D250%26doi%3D10.1006%2Fbbrc.2000.2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schulz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1007/s00395-008-0722-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1007%2Fs00395-008-0722-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18431526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=356-367&author=C.+Schulzauthor=S.+Penzauthor=C.+Hoffmannauthor=H.+Langerauthor=A.+Gillitzerauthor=S.+Schneiderauthor=R.+Brandlauthor=S.+Seidlauthor=S.+Massbergauthor=B.+Pichlerauthor=E.+Kremmerauthor=K.+Stellosauthor=T.+Schonbergerauthor=W.+Siessauthor=M.+Gawaz&title=Platelet+GPVI+binds+to+collagenous+structures+in+the+core+region+of+human+atheromatous+plaque+and+is+critical+for+atheroprogression+in+vivo&doi=10.1007%2Fs00395-008-0722-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo</span></div><div class="casAuthors">Schulz, Christian; Penz, Sandra; Hoffmann, Christof; Langer, Harald; Gillitzer, Angelika; Schneider, Simon; Brandl, Richard; Seidl, Stefan; Massberg, Steffen; Pichler, Bernd; Kremmer, Elisabeth; Stellos, Konstantinos; Schoenberger, Tanja; Siess, Wolfgang; Gawaz, Meinrad</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-367</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Platelet adhesion to the atherosclerotic vascular wall induces thrombosis and boosters vascular inflammation and atheroprogression.  In the present study we studied the binding of the platelet collagen receptor glycoprotein (GP) VI to human atherosclerotic plaques (AP) and the role of GPVI-mediated platelet adhesion for atheroprogression.  Sol. GPVI-Fc fusion protein bound to immobilized collagen type I, collagen type III, and predominantly to the core region of human carotid atheromatous plaques.  The pattern of GPVI-Fc binding was similar to the immunostaining pattern of collagen type III and differed from the immunostaining of collagen type I, which was more intense in the cap than in the core.  Plaque-induced platelet aggregation in stirred blood and platelet adhesion/aggregate formation under flow were inhibited by the anti-GPVI monoclonal antibody 5C4 or by pretreatment of plaques with anti-collagen type I and anti-collagen type III antibody, or GPVI-Fc.  However, there was no correlation between GPVI-Fc binding and platelet aggregating activity of individual plaques.  GPVI bound also to atherosclerotic arteries of ApoE-deficient mice in vivo as assessed by small animal positron emission tomog. (PET).  Prolonged administration of sol. GPVI attenuated atheroprogression in ApoE-deficient mice.  In humans, GPVI binding to collagenous type I and type III structures of the plaque core region mediates plaque-induced platelet adhesion and aggregation, but GPVI binding is not the sole platelet-activating determinant of plaques.  In mice, GPVI-mediated platelet adhesion to the atherosclerotic vascular wall is involved in an atheroprogression in vivo.  Taken together, our data suggests that GPVI is a relevant target to prevent atherothrombotic events and atheroprogression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-k6AdKeGgGLVg90H21EOLACvtfcHk0lhBkEe9JWQFEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVWju78%253D&md5=d1e51ec6db43cde3c0882d5bc499ebb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00395-008-0722-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-008-0722-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DPenz%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DH.%26aulast%3DGillitzer%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DBrandl%26aufirst%3DR.%26aulast%3DSeidl%26aufirst%3DS.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DPichler%26aufirst%3DB.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DSiess%26aufirst%3DW.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DPlatelet%2520GPVI%2520binds%2520to%2520collagenous%2520structures%2520in%2520the%2520core%2520region%2520of%2520human%2520atheromatous%2520plaque%2520and%2520is%2520critical%2520for%2520atheroprogression%2520in%2520vivo%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2008%26volume%3D103%26spage%3D356%26epage%3D367%26doi%3D10.1007%2Fs00395-008-0722-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bultmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2010.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.yjmcc.2010.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20430036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3cjkvFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=532-542&author=A.+Bultmannauthor=Z.+Liauthor=S.+Wagnerauthor=M.+Pelusoauthor=T.+Schonbergerauthor=C.+Weisauthor=I.+Konradauthor=K.+Stellosauthor=S.+Massbergauthor=B.+Nieswandtauthor=M.+Gawazauthor=M.+Ungererauthor=G.+Munch&title=Impact+of+glycoprotein+VI+and+platelet+adhesion+on+atherosclerosis%2D%2Da+possible+role+of+fibronectin&doi=10.1016%2Fj.yjmcc.2010.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin</span></div><div class="casAuthors">Bultmann Andreas; Li Zhongmin; Wagner Silvia; Peluso Mario; Schonberger Tanja; Weis Carla; Konrad Ildiko; Stellos Konstantinos; Massberg Steffen; Nieswandt Bernhard; Gawaz Meinrad; Ungerer Martin; Munch Gotz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular and cellular cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glycoprotein VI (GPVI) mediates binding of platelets to subendothelial collagen during acute arterial thrombosis.  GPVI interactions with the activated atherosclerotic vascular endothelium during early atherosclerosis, however, are not well understood.  In ApoE-/- mice, platelet adhesion to atherosclerotic arteries was increased, as measured by intravital microscopy.  This platelet adhesion was significantly inhibited by IV injection of GPVI-Fc (1 mg/kg body weight).  Atherosclerosis in ApoE-/- mice was attenuated both after 7 and 10 weeks of treatment with the anti-GPVI antibody JAQ1 (2 mg/kg body weight i.p. twice weekly).  Binding of GPVI-Fc (1 mg/kg IV) occurred to deeper layers, but also to the luminal site of plaques in atherosclerotic rabbits, but not to the vessel wall of healthy littermates.  Gene transfer of GPVI-Fc to the carotid vascular wall significantly attenuated athero-progression and endothelial dysfunction in atherosclerotic rabbits in vivo.  Specific binding of the soluble GPVI receptor (GPVI-Fc) to fibronectin was found in vitro to coated ELISA plates.  Platelet adhesion to fibronectin was significantly inhibited both by GPVI-Fc and by the anti-GPVI antibody 5C4 ex vivo in flow chamber experiments.  GPVI plays a role in platelet adhesion to atherosclerotic endothelium in the absence of plaque rupture.  Inhibition of GPVI both via GPVI-Fc and anti-GPVI-antibodies results in protection against atherosclerosis in both cholesterol-fed rabbits and ApoE-/- mice.  This novel mechanism of GPVI-mediated platelet adhesion-possibly via fibronectin-could relevantly contribute to platelet-triggered atheroprogression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpD8JD25GoV1VwdslNBF-tfW6udTcc2eZtYA5wwlSnDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjkvFymsg%253D%253D&md5=bf428a60f82f51274c4f1aa1c274d76d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2010.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2010.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBultmann%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DPeluso%26aufirst%3DM.%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DWeis%26aufirst%3DC.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DGawaz%26aufirst%3DM.%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DImpact%2520of%2520glycoprotein%2520VI%2520and%2520platelet%2520adhesion%2520on%2520atherosclerosis--a%2520possible%2520role%2520of%2520fibronectin%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2010%26volume%3D49%26spage%3D532%26epage%3D542%26doi%3D10.1016%2Fj.yjmcc.2010.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel-Axel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judenhofer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reischl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE–/– mice</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1093/cvr/cvn169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1093%2Fcvr%2Fcvn169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=131-137&author=T.+Schonbergerauthor=D.+Siegel-Axelauthor=R.+Busslauthor=S.+Richterauthor=M.+S.+Judenhoferauthor=R.+Haubnerauthor=G.+Reischlauthor=K.+Klingelauthor=G.+Munchauthor=P.+Seizerauthor=B.+J.+Pichlerauthor=M.+Gawaz&title=The+immunoadhesin+glycoprotein+VI-Fc+regulates+arterial+remodelling+after+mechanical+injury+in+ApoE%E2%80%93%2F%E2%80%93+mice&doi=10.1093%2Fcvr%2Fcvn169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvn169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvn169%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DSiegel-Axel%26aufirst%3DD.%26aulast%3DBussl%26aufirst%3DR.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DJudenhofer%26aufirst%3DM.%2BS.%26aulast%3DHaubner%26aufirst%3DR.%26aulast%3DReischl%26aufirst%3DG.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DMunch%26aufirst%3DG.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DPichler%26aufirst%3DB.%2BJ.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520immunoadhesin%2520glycoprotein%2520VI-Fc%2520regulates%2520arterial%2520remodelling%2520after%2520mechanical%2520injury%2520in%2520ApoE%25E2%2580%2593%252F%25E2%2580%2593%2520mice%26jtitle%3DCardiovasc.%2520Res.%26date%3D2008%26volume%3D80%26spage%3D131%26epage%3D137%26doi%3D10.1093%2Fcvr%2Fcvn169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preissner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">C757</span><span class="NLM_x">–</span> <span class="NLM_lpage">C766</span><span class="refDoi"> DOI: 10.1152/ajpcell.00060.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1152%2Fajpcell.00060.2012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=C757-C766&author=T.+Schonbergerauthor=M.+Zieglerauthor=O.+Borstauthor=I.+Konradauthor=B.+Nieswandtauthor=S.+Massbergauthor=C.+Ochmannauthor=T.+Jurgensauthor=P.+Seizerauthor=H.+Langerauthor=G.+Munchauthor=M.+Ungererauthor=K.+T.+Preissnerauthor=M.+Elversauthor=M.+Gawaz&title=The+dimeric+platelet+collagen+receptor+GPVI-Fc+reduces+platelet+adhesion+to+activated+endothelium+and+preserves+myocardial+function+after+transient+ischemia+in+mice&doi=10.1152%2Fajpcell.00060.2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00060.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00060.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DBorst%26aufirst%3DO.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DOchmann%26aufirst%3DC.%26aulast%3DJurgens%26aufirst%3DT.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DLanger%26aufirst%3DH.%26aulast%3DMunch%26aufirst%3DG.%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DElvers%26aufirst%3DM.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520dimeric%2520platelet%2520collagen%2520receptor%2520GPVI-Fc%2520reduces%2520platelet%2520adhesion%2520to%2520activated%2520endothelium%2520and%2520preserves%2520myocardial%2520function%2520after%2520transient%2520ischemia%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2012%26volume%3D303%26spage%3DC757%26epage%3DC766%26doi%3D10.1152%2Fajpcell.00060.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Moroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinmyozu, K.</span><span> </span><span class="NLM_article-title">A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span><span class="refDoi"> DOI: 10.1172/JCI114318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1172%2FJCI114318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=2808700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK3c%252FjslGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1989&pages=1440-1445&author=M.+Moroiauthor=S.+M.+Jungauthor=M.+Okumaauthor=K.+Shinmyozu&title=A+patient+with+platelets+deficient+in+glycoprotein+VI+that+lack+both+collagen-induced+aggregation+and+adhesion&doi=10.1172%2FJCI114318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion</span></div><div class="casAuthors">Moroi M; Jung S M; Okuma M; Shinmyozu K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1440-5</span>
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Molecular level studies on platelets deficient in collagen-induced aggregation provide evidence for identifying possible platelet collagen receptors.  We investigated platelets from a patient with mild bleeding time prolongation, but otherwise normal coagulation data.  Her platelets lacked collagen-induced aggregation and adhesion, but retained normal aggregation and release by other agonists.  Labeling her platelets with 125I or 3H and analysis by SDS-PAGE/autoradiography showed normal levels of glycoproteins Ia, Ib, IIa, IIb, IIIa, and IV.  However, there were significantly decreased incorporations of both radioactivities into a 61-kD membrane glycoprotein (GP), which was identified as GPVI from its mobility on unreduced-reduced, two-dimensional SDS-PAGE.  Sugiyama et al. (1987.  Blood. 69: 1712) reported that the serum from an idiopathic thrombocytopenic purpura (ITP) patient contained an antibody against a 62-kD platelet protein.  Our patient's platelets lacked the antigen for the ITP patient's antibody, demonstrating that the ITP serum contains a specific antibody against GPVI.  The patient's parents' platelets contained approximately 50% the normal amount of GPVI, but still had normal collagen-induced aggregation and adhesion.  The patient's platelets did not bind to types I and III collagen fibrils.  Our results suggest that GPVI functions as a collagen receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBfTgYLLhhajjk2McQZ6XmfW6udTcc2eYTmnJJiPp1KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c%252FjslGltA%253D%253D&md5=9c521d6fc2f6e7bc0fa5c009cfcc91c1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1172%2FJCI114318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114318%26sid%3Dliteratum%253Aachs%26aulast%3DMoroi%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DOkuma%26aufirst%3DM.%26aulast%3DShinmyozu%26aufirst%3DK.%26atitle%3DA%2520patient%2520with%2520platelets%2520deficient%2520in%2520glycoprotein%2520VI%2520that%2520lack%2520both%2520collagen-induced%2520aggregation%2520and%2520adhesion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1989%26volume%3D84%26spage%3D1440%26epage%3D1445%26doi%3D10.1172%2FJCI114318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ryo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span> </span><span class="NLM_article-title">Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation</span> <span class="citation_source-journal">Am. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1002/ajh.2830390107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fajh.2830390107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1311144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK387mtVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1992&pages=25-31&author=R.+Ryoauthor=A.+Yoshidaauthor=W.+Suganoauthor=M.+Yasunagaauthor=K.+Nakayamaauthor=K.+Saigoauthor=M.+Adachiauthor=N.+Yamaguchiauthor=M.+Okuma&title=Deficiency+of+P62%2C+a+putative+collagen+receptor%2C+in+platelets+from+a+patient+with+defective+collagen-induced+platelet+aggregation&doi=10.1002%2Fajh.2830390107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation</span></div><div class="casAuthors">Ryo R; Yoshida A; Sugano W; Yasunaga M; Nakayama K; Saigo K; Adachi M; Yamaguchi N; Okuma M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of hematology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>
        ISSN:<span class="NLM_cas:issn">0361-8609</span>.
    </div><div class="casAbstract">Recently, we described a platelet antibody against a putative collagen receptor (P62), which was found in a patient with idiopathic thrombocytopenic purpura (ITP) (Blood 69:1712).  We now report a deficiency of the P62 receptor in a young man whose platelets showed defective collagen-induced platelet aggregation.  He had a mild bleeding tendency and slight thrombocytopenia.  The results of coagulation and fibrinolysis studies were normal.  The patient's platelets were partially unresponsive to collagen, although aggregation in response to ADP, thrombin, ristocetin, and calcium ionophore (A23187) was almost normal.  Adhesion of his platelets to bovine collagen was markedly reduced.  Addition of collagen caused no synthesis of thromboxane (TX)B2 in platelet rich plasma (PRP) from this patient.  Furthermore, collagen produced no rise of cytosolic free calcium ([Ca2+]i) in fura2-loaded platelets.  In contrast, thrombin caused TXB2 formation and an increase of [Ca2+]i in his platelets.  These results suggest defective interaction between the platelets and collagen.  The IgG from the ITP-patient induced irreversible aggregation in normal PRP, but caused no aggregation of the young man's platelets.  Immunoblot studies showed that normal platelets had antigens with a molecular weight of 62 KDa under reducing conditions and of 57 KDa under nonreducing conditions.  In contrast, the young man's platelets had no P62 band, although GPIa/IIa and thrombospondin were normally present.  These results indicate that impaired collagen-induced aggregation in the patient's platelets was due to a deficiency of P62 and confirm that P62 may play a crucial role as a collagen receptor in platelet activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSBf12Xn8tbtbHMBt0mMIXfW6udTcc2eYTmnJJiPp1KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387mtVOltQ%253D%253D&md5=397b2ecba2ba7635914cc55667fb2559</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fajh.2830390107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajh.2830390107%26sid%3Dliteratum%253Aachs%26aulast%3DRyo%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DSugano%26aufirst%3DW.%26aulast%3DYasunaga%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DN.%26aulast%3DOkuma%26aufirst%3DM.%26atitle%3DDeficiency%2520of%2520P62%252C%2520a%2520putative%2520collagen%2520receptor%252C%2520in%2520platelets%2520from%2520a%2520patient%2520with%2520defective%2520collagen-induced%2520platelet%2520aggregation%26jtitle%3DAm.%2520J.%2520Hematol.%26date%3D1992%26volume%3D39%26spage%3D25%26epage%3D31%26doi%3D10.1002%2Fajh.2830390107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoue, K.</span><span> </span><span class="NLM_article-title">Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.1995.tb08900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1365-2141.1995.tb08900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=7530476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK2M7jsVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1995&pages=124-130&author=M.+Araiauthor=N.+Yamamotoauthor=M.+Moroiauthor=N.+Akamatsuauthor=K.+Fukutakeauthor=K.+Tanoue&title=Platelets+with+10%25+of+the+normal+amount+of+glycoprotein+VI+have+an+impaired+response+to+collagen+that+results+in+a+mild+bleeding+tendency&doi=10.1111%2Fj.1365-2141.1995.tb08900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency</span></div><div class="casAuthors">Arai M; Yamamoto N; Moroi M; Akamatsu N; Fukutake K; Tanoue K</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-30</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">Platelet glycoprotein VI (GPVI), a 62kD membrane protein, has been identified as one of the platelet receptors for collagen, since GPVI-deficient platelets exhibit abnormal responses to collagen and an abnormal bleeding tendency.  We report a female patient with a mild bleeding history whose platelets expressed 10% GPVI of normal platelets.  Shape change, aggregation and ATP release of the patient's platelets were completely absent in response to 1-5 micrograms/ml collagen but present normally in response to ADP and Ca2+ ionophore A23187.  Adhesion of the patient's platelets to coated collagen was mildly affected (40-60% of normal platelets) in spite of only 10% expression of GPVI.  Flow cytometrical studies revealed that the patient's platelets expressed normal amounts of the GPIa/IIa complex.  These results suggest that platelet GPVI is less involved in adhesion to collagen than shape change and aggregation induced by collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFDOy1mMTTRfKb6ELK8t0fW6udTcc2eYTmnJJiPp1KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7jsVKmsw%253D%253D&md5=36557c1a1f65ca0829c1ac2ae2b5a287</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1995.tb08900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1995.tb08900.x%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DMoroi%26aufirst%3DM.%26aulast%3DAkamatsu%26aufirst%3DN.%26aulast%3DFukutake%26aufirst%3DK.%26aulast%3DTanoue%26aufirst%3DK.%26atitle%3DPlatelets%2520with%252010%2525%2520of%2520the%2520normal%2520amount%2520of%2520glycoprotein%2520VI%2520have%2520an%2520impaired%2520response%2520to%2520collagen%2520that%2520results%2520in%2520a%2520mild%2520bleeding%2520tendency%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1995%26volume%3D89%26spage%3D124%26epage%3D130%26doi%3D10.1111%2Fj.1365-2141.1995.tb08900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Grothusen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbreen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teebken, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchtefeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.1161/ATVBAHA.106.138693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2FATVBAHA.106.138693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17347483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFagur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1184-1190&author=C.+Grothusenauthor=S.+Umbreenauthor=I.+Konradauthor=K.+Stellosauthor=C.+Schulzauthor=B.+Schmidtauthor=E.+Kremmerauthor=O.+Teebkenauthor=S.+Massbergauthor=M.+Luchtefeldauthor=B.+Schiefferauthor=M.+Gawaz&title=EXP3179+inhibits+collagen-dependent+platelet+activation+via+glycoprotein+receptor-VI+independent+of+AT1-receptor+antagonism%3A+potential+impact+on+atherothrombosis&doi=10.1161%2FATVBAHA.106.138693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">EXP3179 Inhibits Collagen-Dependent Platelet Activation via Glycoprotein Receptor-VI Independent of AT1-Receptor Antagonism</span></div><div class="casAuthors">Grothusen, Christina; Umbreen, Sumaira; Konrad, Ildiko; Stellos, Konstantinos; Schulz, Christian; Schmidt, Boris; Kremmer, Elisabeth; Teebken, Omke; Massberg, Steffen; Luchtefeld, Maren; Schieffer, Bernhard; Gawaz, Meinrad</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1184-1190</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Thrombus formation after atherosclerotic plaque rupture critically involves the platelet collagen receptor glycoprotein (GP) VI.  The authors investigated the impact of EXP3179, an active metabolite of the angiotensin II type 1 (AT1)-receptor antagonist Losartan (LOS) on GPVI-dependent platelet activation.  EXP3179 and LOS but not EXP3174-the major AT1-receptor blocking metabolite of LOS-dose-dependently inhibited collagen-I (P<0.01) and GPVI-dependent platelet aggregation (P<0.01) analyzed by optical aggregometry.  Platelet activation was further detd. by flow cytometry measuring the expression of platelet PAC-1, an epitope of the activated fibrinogen-receptor complex.  EXP3179 and LOS inhibited collagen-I (P<0.01) and GPVI-dependent PAC-1 expression (P<0.01).  EXP3179 and LOS but not EXP3174 decreased the adhesion of GPVI-receptor expressing Chinese hamster ovarian cells on collagen-I under arterial shear conditions detd. by flow chamber anal. (P<0.01 and P<0.05).  EXP3179 also reduced human atherosclerotic plaque material-induced platelet aggregation (P<0.01) in vitro and murine platelet adhesion after acute vessel injury in vivo as detd. by intravital microscopy (P<0.01).  EXP3179 acts as a specific inhibitor of the platelet collagen receptor GPVI independent of AT1-receptor antagonism.  Further investigations may clarify its individual potential as a novel pharmacol. approach to specifically inhibit atherothrombotic events by GPVI-receptor blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRZHgB-iLrrVg90H21EOLACvtfcHk0libjjIzb0qr1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFagur8%253D&md5=ca8b22fcc9d3ac66262f3c5ba772102b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.106.138693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.106.138693%26sid%3Dliteratum%253Aachs%26aulast%3DGrothusen%26aufirst%3DC.%26aulast%3DUmbreen%26aufirst%3DS.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DTeebken%26aufirst%3DO.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DLuchtefeld%26aufirst%3DM.%26aulast%3DSchieffer%26aufirst%3DB.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DEXP3179%2520inhibits%2520collagen-dependent%2520platelet%2520activation%2520via%2520glycoprotein%2520receptor-VI%2520independent%2520of%2520AT1-receptor%2520antagonism%253A%2520potential%2520impact%2520on%2520atherothrombosis%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D1184%26epage%3D1190%26doi%3D10.1161%2FATVBAHA.106.138693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span><span class="refDoi"> DOI: 10.1021/jm901534d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901534d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvF2ktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2087-2093&author=K.+Onoauthor=H.+Uedaauthor=Y.+Yoshizawaauthor=D.+Akazawaauthor=R.+Tanimuraauthor=I.+Shimadaauthor=H.+Takahashi&title=Structural+basis+for+platelet+antiaggregation+by+angiotensin+II+type+1+receptor+antagonist+losartan+%28DuP-753%29+via+glycoprotein+VI&doi=10.1021%2Fjm901534d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Platelet Antiaggregation by Angiotensin II Type 1 Receptor Antagonist Losartan (DuP-753) via Glycoprotein VI</span></div><div class="casAuthors">Ono, Katsuki; Ueda, Hiroshi; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPVI is a key receptor for collagen-induced platelet activation.  Loss or inhibition of GPVI causes only mildly prolonged bleeding times but prevents arterial thrombus formation in animal models.  Therefore, GPVI is considered to be a potent target mol. for therapy of thrombotic diseases.  Recently, it was reported that the AT1-receptor antagonist losartan (DuP-753) and EXP3179 inhibit platelet adhesion and aggregation via GPVI.  However, it is still not clear how losartan is assocd. with inhibition of binding between GPVI and collagen at the mol. level.  Here, we show by NMR that losartan directly interacts with the hydrophobic region consisting of strands C' and E in the N-terminal Ig-like domain of GPVI.  A reliable GPVI-losartan complex model is presented by using a combination of NMR data and in silico tools.  These data indicated that the Ph group with the tetrazole ring in losartan plays a crucial role in the interaction with GPVI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuEFkCuItyhrVg90H21EOLACvtfcHk0libjjIzb0qr1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvF2ktbo%253D&md5=5e8b207328c57117e78a33c174818e14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901534d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901534d%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAkazawa%26aufirst%3DD.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520platelet%2520antiaggregation%2520by%2520angiotensin%2520II%2520type%25201%2520receptor%2520antagonist%2520losartan%2520%2528DuP-753%2529%2520via%2520glycoprotein%2520VI%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2087%26epage%3D2093%26doi%3D10.1021%2Fjm901534d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchitchinadze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ropers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jondeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandrot-Perrus, M.</span><span> </span><span class="NLM_article-title">Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses: The example of losartan</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128744</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0128744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=26052700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128744&author=P.+Jiangauthor=S.+Loyauauthor=M.+Tchitchinadzeauthor=J.+Ropersauthor=G.+Jondeauauthor=M.+Jandrot-Perrus&title=Inhibition+of+glycoprotein+VI+clustering+by+collagen+as+a+mechanism+of+inhibiting+collagen-induced+platelet+responses%3A+The+example+of+losartan&doi=10.1371%2Fjournal.pone.0128744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses: the example of losartan</span></div><div class="casAuthors">Jiang, Peng; Loyau, Stephane; Tchitchinadze, Maria; Ropers, Jacques; Jondeau, Guillaume; Jandrot-Perrus, Martine</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0128744/1-e0128744/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Exposure of platelets to collagen triggers the formation of a platelet clot.  Pharmacol. agents capable of inhibiting platelet activation by collagen are thus of potential therapeutic interest.  Thrombus formation is initiated by the interaction of the GPIb-V-IX complex with collagen-bound vWF, while GPVI interaction with collagen triggers platelet activation that is reinforced by ADP and thromboxane A2.  Losartan is an angiotensin II (Ang II) type I receptor (AT1R) antagonist proposed to have an antiplatelet activity via the inhibition of both the thromboxane A2 (TXA2) receptor (TP) and the glycoprotein VI (GPVI).  Here, we characterized in vitro the effects of losartan at different doses on platelet responses: losartan inhibited platelet aggregation and secretion induced by 1 μg.mL-1 and 10 μg.mL-1 of collagen with an IC50 of ∼ 6 μM.  Losartan inhibited platelet responses induced by the GPVI specific collagen related peptide but not by the α2β1 specific peptide.  However, losartan did not inhibit the binding of recombinant GPVI to collagen, which is not in favor of a simple competition.  Indeed, the clustering of GPVI obsd. in flow cytometry and using the Duolink methodol., was inhibited by losartan.  The impact of a therapeutic dose of losartan (100 mg/day) on platelet responses was analyzed ex vivo in a double blind study.  No statistically significant differences were obsd. between losartan-treated (n = 25) and non-treated (n = 30) patients in terms of collagen and U46619-induced platelet activation.  These data indicate that in treated patients, losartan does not achieve a measurable antiplatelet effect but provide the proof of concept that inhibiting collagen-induced GPVI clustering is of pharmacol. interest to obtain an antithrombotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgPOpJVtnEbVg90H21EOLACvtfcHk0li_sNUM4uuiDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFansLc%253D&md5=0c6b5242fe698b82c22e023eebf6035f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128744%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLoyau%26aufirst%3DS.%26aulast%3DTchitchinadze%26aufirst%3DM.%26aulast%3DRopers%26aufirst%3DJ.%26aulast%3DJondeau%26aufirst%3DG.%26aulast%3DJandrot-Perrus%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520glycoprotein%2520VI%2520clustering%2520by%2520collagen%2520as%2520a%2520mechanism%2520of%2520inhibiting%2520collagen-induced%2520platelet%2520responses%253A%2520The%2520example%2520of%2520losartan%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128744%26doi%3D10.1371%2Fjournal.pone.0128744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C. H.</span><span> </span><span class="NLM_article-title">Discovery of novel GPVI receptor antagonists by structure-based repurposing</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e101209</span><span class="refDoi"> DOI: 10.1371/journal.pone.0101209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0101209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=24971515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1amtr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e101209&author=L.+Taylorauthor=S.+R.+Vasudevanauthor=C.+I.+Jonesauthor=J.+M.+Gibbinsauthor=G.+C.+Churchillauthor=R.+D.+Campbellauthor=C.+H.+Coxon&title=Discovery+of+novel+GPVI+receptor+antagonists+by+structure-based+repurposing&doi=10.1371%2Fjournal.pone.0101209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel GPVI receptor antagonists by structure-based repurposing</span></div><div class="casAuthors">Taylor, Lewis; Vasudevan, Sridhar R.; Jones, Chris I.; Gibbins, Jonathan M.; Churchill, Grant C.; Campbell, R. Duncan; Coxon, Carmen H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e101209/1-e101209/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inappropriate platelet aggregation creates a cardiovascular risk that is largely managed with thienopyridines and aspirin.  Although effective, these drugs carry risks of increased bleeding and drug 'resistance', underpinning a drive for new antiplatelet agents.  To discover such drugs, one strategy is to identify a suitable druggable target and then find small mols. that modulate it.  A good and unexploited target is the platelet collagen receptor, GPVI, which promotes thrombus formation.  To identify inhibitors of GPVI that are safe and bioavailable, we docked a FDA-approved drug library into the GPVI collagen-binding site in silico.  We now report that losartan and cinanserin inhibit GPVI-mediated platelet activation in a selective, competitive and dose-dependent manner.  This mechanism of action likely underpins the cardioprotective effects of losartan that could not be ascribed to its antihypertensive effects.  We have, therefore, identified small mol. inhibitors of GPVI-mediated platelet activation, and also demonstrated the utility of structure-based repurposing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Pe9roY0HMbVg90H21EOLACvtfcHk0lgMMQUD9F9DUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1amtr7M&md5=efa85474cb4a35a6f30a55b40342477f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0101209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0101209%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DJones%26aufirst%3DC.%2BI.%26aulast%3DGibbins%26aufirst%3DJ.%2BM.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%2BD.%26aulast%3DCoxon%26aufirst%3DC.%2BH.%26atitle%3DDiscovery%2520of%2520novel%2520GPVI%2520receptor%2520antagonists%2520by%2520structure-based%2520repurposing%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De101209%26doi%3D10.1371%2Fjournal.pone.0101209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span> </span><span class="NLM_article-title">Modulation of platelet activation and thrombus formation using a Pan-PI3K inhibitor S14161</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e102394</span><span class="refDoi"> DOI: 10.1371/journal.pone.0102394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0102394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e102394&author=W.+Yiauthor=Q.+Liauthor=J.+Shenauthor=L.+Renauthor=X.+Liuauthor=Q.+Wangauthor=S.+Heauthor=Q.+Wuauthor=H.+Huauthor=X.+Maoauthor=L.+Zhu&title=Modulation+of+platelet+activation+and+thrombus+formation+using+a+Pan-PI3K+inhibitor+S14161&doi=10.1371%2Fjournal.pone.0102394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102394%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DModulation%2520of%2520platelet%2520activation%2520and%2520thrombus%2520formation%2520using%2520a%2520Pan-PI3K%2520inhibitor%2520S14161%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De102394%26doi%3D10.1371%2Fjournal.pone.0102394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kato-Takagaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">10720</span><span class="NLM_x">–</span> <span class="NLM_lpage">10727</span><span class="refDoi"> DOI: 10.1074/jbc.M808563200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.M808563200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19228693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlGrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=10720-10727&author=K.+Kato-Takagakiauthor=Y.+Mizukoshiauthor=Y.+Yoshizawaauthor=D.+Akazawaauthor=Y.+Toriiauthor=K.+Onoauthor=R.+Tanimuraauthor=I.+Shimadaauthor=H.+Takahashi&title=Structural+and+interaction+analysis+of+glycoprotein+VI-binding+peptide+selected+from+a+phage+display+library&doi=10.1074%2Fjbc.M808563200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library</span></div><div class="casAuthors">Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Torii, Yuichi; Ono, Katsuki; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10720-10727</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glycoprotein VI (GPVI) is a major collagen receptor on the platelet surface that recognizes the glycine-proline-hydroxyproline (GPO) sequence in the collagen mol. and plays a crucial role in thrombus formation.  Inhibitors that block the interaction of GPVI with collagen have potential for use as antithrombotic drugs.  For low mol. wt. drug design for GPVI, it is essential to obtain precise structural and interaction information about GPVI-binding ligands.  However, exptl. obtained structural and interaction information of small ligands, such as peptides, in the GPVI-bound state has not been reported.  In this study, by screening a phage-displayed peptide library, we discovered a novel peptide ligand (pep-10L; YSDTDWLYFSTS) without any similarities to the sequence of collagen that inhibits GPVI-GPO binding.  Systematic Ala scanning in surface plasmon resonance expts. and a satn. transfer difference NMR expt. revealed that Trp6, Leu7, Phe9, and Ser10 residues in the pep-10L peptide interacted with GPVI.  Furthermore, the GPVI-bound conformation of the pep-10L peptide was detd. using transferred nuclear Overhauser effect anal.  The obtained structure has revealed that the central part of pep-10L (Asp5-Phe9) has a helical conformation, the side chains of Trp6, Leu7, and Phe9 form a hydrophobic side in the helix, and the Tyr8 side chain faces the opposite direction from the hydrophobic side.  Computational docking prediction has shown that the hydrophobic side of pep-10L sticks in the hydrophobic groove on the GPVI surface, which corresponds to the putative collagen-related peptide binding groove.  These data could enable the structure-guided development of a small mol. GPVI antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNeNnQfTGHArVg90H21EOLACvtfcHk0lgMMQUD9F9DUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlGrs70%253D&md5=4d73d7d531ac5958570b63b308c4ed2e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808563200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808563200%26sid%3Dliteratum%253Aachs%26aulast%3DKato-Takagaki%26aufirst%3DK.%26aulast%3DMizukoshi%26aufirst%3DY.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAkazawa%26aufirst%3DD.%26aulast%3DTorii%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DStructural%2520and%2520interaction%2520analysis%2520of%2520glycoprotein%2520VI-binding%2520peptide%2520selected%2520from%2520a%2520phage%2520display%2520library%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D10720%26epage%3D10727%26doi%3D10.1074%2Fjbc.M808563200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span> </span><span class="NLM_article-title">Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4761</span><span class="NLM_x">–</span> <span class="NLM_lpage">4774</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.bmc.2006.03.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4761-4774&author=M.+Zhaoauthor=L.+Biauthor=W.+Biauthor=C.+Wangauthor=Z.+Yangauthor=J.+Juauthor=S.+Peng&title=Synthesis+of+new+class+dipeptide+analogues+with+improved+permeability+and+antithrombotic+activity&doi=10.1016%2Fj.bmc.2006.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DL.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520class%2520dipeptide%2520analogues%2520with%2520improved%2520permeability%2520and%2520antithrombotic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4761%26epage%3D4774%26doi%3D10.1016%2Fj.bmc.2006.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Im, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, Y. P.</span><span> </span><span class="NLM_article-title">Antiplatelet activity of beta-carboline alkaloids from <i>Perganum harmala</i>: a possible mechanism through inhibiting PLCgamma2 phosphorylation</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.vph.2008.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.vph.2008.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=147-152&author=J.+H.+Imauthor=Y.+R.+Jinauthor=J.+J.+Leeauthor=J.+Y.+Yuauthor=X.+H.+Hanauthor=S.+H.+Imauthor=J.+T.+Hongauthor=H.+S.+Yooauthor=M.+Y.+Pyoauthor=Y.+P.+Yun&title=Antiplatelet+activity+of+beta-carboline+alkaloids+from+Perganum+harmala%3A+a+possible+mechanism+through+inhibiting+PLCgamma2+phosphorylation&doi=10.1016%2Fj.vph.2008.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2008.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2008.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DJ.%2BH.%26aulast%3DJin%26aufirst%3DY.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DYu%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DX.%2BH.%26aulast%3DIm%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DPyo%26aufirst%3DM.%2BY.%26aulast%3DYun%26aufirst%3DY.%2BP.%26atitle%3DAntiplatelet%2520activity%2520of%2520beta-carboline%2520alkaloids%2520from%2520Perganum%2520harmala%253A%2520a%2520possible%2520mechanism%2520through%2520inhibiting%2520PLCgamma2%2520phosphorylation%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2009%26volume%3D50%26spage%3D147%26epage%3D152%26doi%3D10.1016%2Fj.vph.2008.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tsuchiya, H.</span><span> </span><span class="NLM_article-title">Comparative effects of α-, β-, and γ-carbolines on platelet aggregation and lipid membranes</span> <span class="citation_source-journal">J. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">151596</span><span class="refDoi"> DOI: 10.1155/2011/151596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1155%2F2011%2F151596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21876689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3MjpslKnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=151596&author=H.+Tsuchiya&title=Comparative+effects+of+%CE%B1-%2C+%CE%B2-%2C+and+%CE%B3-carbolines+on+platelet+aggregation+and+lipid+membranes&doi=10.1155%2F2011%2F151596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Effects of α-, β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes</span></div><div class="casAuthors">Tsuchiya Hironori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151596</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cigarette smoking and alcohol consumption possibly affect platelet functions.  To verify the hypothesis that some α-, β-, and γ-carboline components in cigarette smoke and alcoholic beverages may change platelet aggregability, their effects on human platelets were determined by aggregometry together with investigating their membrane effects by turbidimetry.  Carbolines inhibited platelet aggregation induced by five agents with the potency being 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole > 3-amino-1-methyl-5H-pyrido[4,3-b]indole > 1-methyl-9H-pyrido[3,4-b]indole.  The most potent 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole showed 50% aggregation-inhibitory concentrations of 6-172 μM.  Both γ-carbolines interacted with phosphatidylcholine membranes to lower the lipid phase transition temperature with the potency correlating to the antiplatelet activity, suggesting that the interaction with platelet membranes to increase their fluidity underlies antiplatelet effects.  Given their possible concentration and accumulation in platelets, γ- and β-carbolines would provide cigarette smokers and alcohol drinkers with reduced platelet aggregability, and they may be responsible for the occurrence of hemorrhagic diseases associated with heavy smoking and alcoholics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1jHmAg29Abrt7lRqEFUJVfW6udTcc2eZYVKE_xyCrsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjpslKnsQ%253D%253D&md5=216de43b1163d6bfd4b3c2e9c3b2a155</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2011%2F151596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F151596%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DH.%26atitle%3DComparative%2520effects%2520of%2520%25CE%25B1-%252C%2520%25CE%25B2-%252C%2520and%2520%25CE%25B3-carbolines%2520on%2520platelet%2520aggregation%2520and%2520lipid%2520membranes%26jtitle%3DJ.%2520Toxicol.%26date%3D2011%26volume%3D2011%26spage%3D151596%26doi%3D10.1155%2F2011%2F151596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dua, P. R.</span><span> </span><span class="NLM_article-title">Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino [2′,1′:6,1]pyrido[3,4-b]indoles. New class of central nervous system depressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1021/jm00263a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00263a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=560-564&author=A.+K.+Saxenaauthor=P.+C.+Jainauthor=N.+Anandauthor=P.+R.+Dua&title=Agents+acting+on+the+central+nervous+system.+15.+2-Substituted+1%2C2%2C3%2C4%2C6%2C7%2C12%2C12a-octahydropyrazino+%5B2%E2%80%B2%2C1%E2%80%B2%3A6%2C1%5Dpyrido%5B3%2C4-b%5Dindoles.+New+class+of+central+nervous+system+depressants&doi=10.1021%2Fjm00263a036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00263a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00263a036%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DJain%26aufirst%3DP.%2BC.%26aulast%3DAnand%26aufirst%3DN.%26aulast%3DDua%26aufirst%3DP.%2BR.%26atitle%3DAgents%2520acting%2520on%2520the%2520central%2520nervous%2520system.%252015.%25202-Substituted%25201%252C2%252C3%252C4%252C6%252C7%252C12%252C12a-octahydropyrazino%2520%255B2%25E2%2580%25B2%252C1%25E2%2580%25B2%253A6%252C1%255Dpyrido%255B3%252C4-b%255Dindoles.%2520New%2520class%2520of%2520central%2520nervous%2520system%2520depressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D560%26epage%3D564%26doi%3D10.1021%2Fjm00263a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Saxena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prathipati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span> </span><span class="NLM_article-title">Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8249</span><span class="NLM_x">–</span> <span class="NLM_lpage">8258</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.bmc.2006.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17010624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8249-8258&author=M.+Saxenaauthor=S.+Gaurauthor=P.+Prathipatiauthor=A.+K.+Saxena&title=Synthesis+of+some+substituted+pyrazinopyridoindoles+and+3D+QSAR+studies+along+with+related+compounds%3A+piperazines%2C+piperidines%2C+pyrazinoisoquinolines%2C+and+diphenhydramine%2C+and+its+semi-rigid+analogs+as+antihistamines+%28H1%29&doi=10.1016%2Fj.bmc.2006.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: Piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)</span></div><div class="casAuthors">Saxena, Mridula; Gaur, Stuti; Prathipati, Philip; Saxena, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8249-8258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">3D QSAR studies on the title compds. led to the development of a model with three biophoric sites and six secondary sites viz.  H-acceptor (ACC), H-donor (DON), heteroatom (presence), hydrophobic (hydrophobicity), steric (refractivity), and a ring (presence) along with total hydrophobicity and total refractivity as global properties.  The model predicted the test set of compds. reasonably well.  Three of the five newly synthesized 2-substituted octahydropyrazinopyridoindoles have shown potent antihistaminic H1 activity with less toxicity and sedation potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowk39v6uAhWLVg90H21EOLACvtfcHk0ljWf4a3EyUTiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjt7zI&md5=ed714e960dfa30d6be42edb200dc0e5f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DM.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPrathipati%26aufirst%3DP.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520of%2520some%2520substituted%2520pyrazinopyridoindoles%2520and%25203D%2520QSAR%2520studies%2520along%2520with%2520related%2520compounds%253A%2520piperazines%252C%2520piperidines%252C%2520pyrazinoisoquinolines%252C%2520and%2520diphenhydramine%252C%2520and%2520its%2520semi-rigid%2520analogs%2520as%2520antihistamines%2520%2528H1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8249%26epage%3D8258%26doi%3D10.1016%2Fj.bmc.2006.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakebusch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari-Nejad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heemskerk, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirngibl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassler, R.</span><span> </span><span class="NLM_article-title">Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2120</span><span class="NLM_x">–</span> <span class="NLM_lpage">2130</span><span class="refDoi"> DOI: 10.1093/emboj/20.9.2120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1093%2Femboj%2F20.9.2120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=2120-2130&author=B.+Nieswandtauthor=C.+Brakebuschauthor=W.+Bergmeierauthor=V.+Schulteauthor=D.+Bouvardauthor=R.+Mokhtari-Nejadauthor=T.+Lindhoutauthor=J.+W.+Heemskerkauthor=H.+Zirngiblauthor=R.+Fassler&title=Glycoprotein+VI+but+not+alpha2beta1+integrin+is+essential+for+platelet+interaction+with+collagen&doi=10.1093%2Femboj%2F20.9.2120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.9.2120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.9.2120%26sid%3Dliteratum%253Aachs%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DBrakebusch%26aufirst%3DC.%26aulast%3DBergmeier%26aufirst%3DW.%26aulast%3DSchulte%26aufirst%3DV.%26aulast%3DBouvard%26aufirst%3DD.%26aulast%3DMokhtari-Nejad%26aufirst%3DR.%26aulast%3DLindhout%26aufirst%3DT.%26aulast%3DHeemskerk%26aufirst%3DJ.%2BW.%26aulast%3DZirngibl%26aufirst%3DH.%26aulast%3DFassler%26aufirst%3DR.%26atitle%3DGlycoprotein%2520VI%2520but%2520not%2520alpha2beta1%2520integrin%2520is%2520essential%2520for%2520platelet%2520interaction%2520with%2520collagen%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D2120%26epage%3D2130%26doi%3D10.1093%2Femboj%2F20.9.2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Francischetti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span> </span><span class="NLM_article-title">Convulxin, a potent platelet-aggregating protein from <i>Crotalus durissus terrificus</i> venom, specifically binds to platelets</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span><span class="refDoi"> DOI: 10.1016/S0041-0101(97)00021-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2FS0041-0101%2897%2900021-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1997&pages=1217-1228&author=I.+M.+Francischettiauthor=B.+Saliouauthor=M.+Leducauthor=C.+R.+Carliniauthor=M.+Hatmiauthor=J.+Randonauthor=A.+Failiauthor=C.+Bon&title=Convulxin%2C+a+potent+platelet-aggregating+protein+from+Crotalus+durissus+terrificus+venom%2C+specifically+binds+to+platelets&doi=10.1016%2FS0041-0101%2897%2900021-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0041-0101%2897%2900021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-0101%252897%252900021-4%26sid%3Dliteratum%253Aachs%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%26aulast%3DSaliou%26aufirst%3DB.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DCarlini%26aufirst%3DC.%2BR.%26aulast%3DHatmi%26aufirst%3DM.%26aulast%3DRandon%26aufirst%3DJ.%26aulast%3DFaili%26aufirst%3DA.%26aulast%3DBon%26aufirst%3DC.%26atitle%3DConvulxin%252C%2520a%2520potent%2520platelet-aggregating%2520protein%2520from%2520Crotalus%2520durissus%2520terrificus%2520venom%252C%2520specifically%2520binds%2520to%2520platelets%26jtitle%3DToxicon%26date%3D1997%26volume%3D35%26spage%3D1217%26epage%3D1228%26doi%3D10.1016%2FS0041-0101%2897%2900021-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Polgár, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrel, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnenat, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, T. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, K. J.</span><span> </span><span class="NLM_article-title">Platelet activation and signal transduction by convulxin, a C-type lectin from <i>Crotalus durissus terrificus</i> (tropical rattlesnake) venom via the p62/GPVI collagen receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">13576</span><span class="NLM_x">–</span> <span class="NLM_lpage">13583</span><span class="refDoi"> DOI: 10.1074/jbc.272.21.13576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.272.21.13576" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=13576-13583&author=J.+Polg%C3%A1rauthor=J.+M.+Clemetsonauthor=B.+E.+Kehrelauthor=M.+Wiedemannauthor=E.+M.+Magnenatauthor=T.+N.+C.+Wellsauthor=K.+J.+Clemetson&title=Platelet+activation+and+signal+transduction+by+convulxin%2C+a+C-type+lectin+from+Crotalus+durissus+terrificus+%28tropical+rattlesnake%29+venom+via+the+p62%2FGPVI+collagen+receptor&doi=10.1074%2Fjbc.272.21.13576"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.21.13576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.21.13576%26sid%3Dliteratum%253Aachs%26aulast%3DPolg%25C3%25A1r%26aufirst%3DJ.%26aulast%3DClemetson%26aufirst%3DJ.%2BM.%26aulast%3DKehrel%26aufirst%3DB.%2BE.%26aulast%3DWiedemann%26aufirst%3DM.%26aulast%3DMagnenat%26aufirst%3DE.%2BM.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26aulast%3DClemetson%26aufirst%3DK.%2BJ.%26atitle%3DPlatelet%2520activation%2520and%2520signal%2520transduction%2520by%2520convulxin%252C%2520a%2520C-type%2520lectin%2520from%2520Crotalus%2520durissus%2520terrificus%2520%2528tropical%2520rattlesnake%2529%2520venom%2520via%2520the%2520p62%252FGPVI%2520collagen%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D13576%26epage%3D13583%26doi%3D10.1074%2Fjbc.272.21.13576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Surin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span> </span><span class="NLM_article-title">Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1016/j.thromres.2007.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.thromres.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18045662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=786-803&author=W.+R.+Surinauthor=M.+K.+Barthwalauthor=M.+Dikshit&title=Platelet+collagen+receptors%2C+signaling+and+antagonism%3A+emerging+approaches+for+the+prevention+of+intravascular+thrombosis&doi=10.1016%2Fj.thromres.2007.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet collagen receptors, signaling, and antagonism: Emerging approaches for the prevention of intravascular thrombosis</span></div><div class="casAuthors">Surin, William Rasican; Barthwal, Manoj Kumar; Dikshit, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">786-803</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Collagen, one of the major proteins of sub-endothelial vasculature get exposed following endothelium denudement, is a potent stimulator of platelet adhesion and aggregation.  Adhesion of platelets following endothelial injury is the primary event usually assocd. with uncontrolled platelet activation culminating into intravascular thrombosis, thus needs to be intervened to prevent the pathol. related to various peripheral, myocardial, and cerebral ischemic episodes.  Recent advances in the understanding of collagen mediated platelet adhesion and aggregation have led to the identification of 2 prominent receptors, glycoprotein Ia/IIa (GPIa/IIa or integrin α2β1) and glycoprotein VI (GPVI) and assocd. intracellular signaling, which are undoubtedly the new emerging targets for the development of more effective antithrombotic drugs.  The optimism for collagen antagonism is based on results obtained so far by the use of monoclonal and polyclonal antibodies, peptide inhibitors, knockouts models and collagen-mimetics in various in vitro test systems and animal models.  These findings have revealed that collagen receptor inhibition is an attractive and secure strategy for the new drug development to prevent intravascular thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyost0DrcICLVg90H21EOLACvtfcHk0ljpFwp0zWtkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtb3O&md5=dbfd35e28f15f5f7b87a457e58fed830</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DSurin%26aufirst%3DW.%2BR.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26atitle%3DPlatelet%2520collagen%2520receptors%252C%2520signaling%2520and%2520antagonism%253A%2520emerging%2520approaches%2520for%2520the%2520prevention%2520of%2520intravascular%2520thrombosis%26jtitle%3DThromb.%2520Res.%26date%3D2008%26volume%3D122%26spage%3D786%26epage%3D803%26doi%3D10.1016%2Fj.thromres.2007.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hsu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. F.</span><span> </span><span class="NLM_article-title">A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1585</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2008.03071.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2008.03071.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18624975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1578-1585&author=C.+C.+Hsuauthor=W.+B.+Wuauthor=T.+F.+Huang&title=A+snake+venom+metalloproteinase%2C+kistomin%2C+cleaves+platelet+glycoprotein+VI+and+impairs+platelet+functions&doi=10.1111%2Fj.1538-7836.2008.03071.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions</span></div><div class="casAuthors">Hsu, C. C.; Wu, W. B.; Huang, T. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1578-1585</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Injuries to the vessel wall and subsequent exposure of the matrix of the subendothelial layer resulted in thrombus formation.  Platelet glycoprotein (GP) Ib and VI play a crucial role in matrix-induced activation and aggregation of platelets.  In the present study, we reported that the GPIb-cleaving snake venom metalloproteinase (SVMP), kistomin, inhibited collagen-induced platelet aggregation.  Moreover, kistomin inhibited platelet aggregation induced by convulxin (CVX, a GPVI agonist) and a GPVI-specific antibody in a concn. and time-dependent manner.  Kistomin treatment decreased platelet GPVI but not integrin α2β1 and αIIbβ3, accompanied with the formation of GPVI cleavage fragments, as detd. by flow cytometric and Western blot analyses.  In addn., intact platelet GPVI and recombinant GPVI were digested by kistomin to release 25- and 35-kDa fragments, suggesting that kistomin cleaved GPVI near the mucin-like region.  We designed four synthetic peptides ranging from Leu180 to Asn249 as the substrates for kistomin and found that kistomin cleaved these synthetic peptides at FSE205/A206TA and NKV218/F219TT, as analyzed by MALDI-TOF-MS.  In addn., GPVI-specific antibody-induced tyrosine kinase phosphorylation in platelets was reduced after kistomin pretreatment, and platelet adhesion to collagen but not to fibrinogen was attenuated by kistomin.  We provided here the first evidence that a P-I snake venom metalloproteinase, kistomin, inhibits the interaction between collagen and platelet GPVI through its proteolytic activity on GPVI, thus providing an alternative strategy for developing new anti-thrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsf1xf5kbYw7Vg90H21EOLACvtfcHk0ljpFwp0zWtkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqur3O&md5=46585511448428164ef65a1666dbb561</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2008.03071.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2008.03071.x%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DW.%2BB.%26aulast%3DHuang%26aufirst%3DT.%2BF.%26atitle%3DA%2520snake%2520venom%2520metalloproteinase%252C%2520kistomin%252C%2520cleaves%2520platelet%2520glycoprotein%2520VI%2520and%2520impairs%2520platelet%2520functions%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2008%26volume%3D6%26spage%3D1578%26epage%3D1585%26doi%3D10.1111%2Fj.1538-7836.2008.03071.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Takayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinozaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furusako, S.</span><span> </span><span class="NLM_article-title">A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1785</span><span class="NLM_x">–</span> <span class="NLM_lpage">1795</span><span class="refDoi"> DOI: 10.1172/JCI32513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1172%2FJCI32513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18382762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2ntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1785-1795&author=H.+Takayamaauthor=Y.+Hosakaauthor=K.+Nakayamaauthor=K.+Shirakawaauthor=K.+Naitohauthor=T.+Matsusueauthor=M.+Shinozakiauthor=M.+Hondaauthor=Y.+Yatagaiauthor=T.+Kawaharaauthor=J.+Hiroseauthor=T.+Yokoyamaauthor=M.+Kuriharaauthor=S.+Furusako&title=A+novel+antiplatelet+antibody+therapy+that+induces+cAMP-dependent+endocytosis+of+the+GPVI%2FFc+receptor+gamma-chain+complex&doi=10.1172%2FJCI32513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex</span></div><div class="casAuthors">Takayama, Hiroshi; Hosaka, Yoshitaka; Nakayama, Kazuyuki; Shirakawa, Kamon; Naitoh, Katsuki; Matsusue, Tomokazu; Shinozaki, Mikihiko; Honda, Motoyasu; Yatagai, Yukiko; Kawahara, Tetsushi; Hirose, Jiro; Yokoyama, Tooru; Kurihara, Michiru; Furusako, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1785-1795</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Platelet adhesion to vascular subendothelium, mediated in part by interactions between collagen and glycoprotein VI (GPVI) complexed with Fc receptor γ-chain, is crucial for thrombus formation.  Antiplatelet therapy benefits patients with various thrombotic and ischemic diseases, but the safety and efficacy of existing treatments are limited.  Recent data suggest GPVI as a promising target for a novel antiplatelet therapy, for example, GPVI-specific Abs that deplete GPVI from the surface of platelets.  Here, we characterized GPVI-specific auto-Abs (YA-Abs) from the first reported patient with ongoing platelet GPVI deficiency caused by the YA-Abs.  To obtain exptl. useful human GPVI-specific mAbs with characteristics similar to YA-Abs, we generated human GPVI-specific mouse mAbs and selected 2 representative mAbs, mF1201 and mF1232, whose binding to GPVI was inhibited by YA-Abs.  In vitro, mF1201, but not mF1232, induced human platelet activation and GPVI shedding, and mF1232 inhibited collagen-induced human platelet aggregation.  Administration of mF1201 and mF1232 to monkeys caused GPVI immunodepletion with and without both significant thrombocytopenia and GPVI shedding, resp.  When a human/mouse chimeric form of mF1232 (cF1232) was labeled with a fluorescent endocytosis probe and administered to monkeys, fluorescence increased in circulating platelets and surface GPVI was lost.  Loss of platelet surface GPVI mediated by cF1232 was successfully reproduced in vitro in the presence of a cAMP-elevating agent.  Thus, we have characterized cAMP-dependent endocytosis of GPVI mediated by a human GPVI-specific mAb as what we believe to be a novel antiplatelet therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf_nuBzYehpbVg90H21EOLACvtfcHk0ljpFwp0zWtkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2ntbw%253D&md5=afe1462e0115d9c6a2a23b76f15bc056</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI32513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI32513%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DNaitoh%26aufirst%3DK.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShinozaki%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DYatagai%26aufirst%3DY.%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DJ.%26aulast%3DYokoyama%26aufirst%3DT.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DFurusako%26aufirst%3DS.%26atitle%3DA%2520novel%2520antiplatelet%2520antibody%2520therapy%2520that%2520induces%2520cAMP-dependent%2520endocytosis%2520of%2520the%2520GPVI%252FFc%2520receptor%2520gamma-chain%2520complex%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1785%26epage%3D1795%26doi%3D10.1172%2FJCI32513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosport, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bultmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piechatzek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlieper, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Novel antiplatelet drug revacept (dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.110.980623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2FCIRCULATIONAHA.110.980623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21502572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVyntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1891-1899&author=M.+Ungererauthor=K.+Rosportauthor=A.+Bultmannauthor=R.+Piechatzekauthor=K.+Uhlandauthor=P.+Schlieperauthor=M.+Gawazauthor=G.+Munch&title=Novel+antiplatelet+drug+revacept+%28dimeric+Glycoprotein+VI-Fc%29+specifically+and+efficiently+inhibited+collagen-induced+platelet+aggregation+without+affecting+general+hemostasis+in+humans&doi=10.1161%2FCIRCULATIONAHA.110.980623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans</span></div><div class="casAuthors">Ungerer, Martin; Rosport, Kai; Bueltmann, Andreas; Piechatzek, Richard; Uhland, Kerstin; Schlieper, Peter; Gawaz, Meinrad; Muench, Goetz</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1891-1899</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Blocking of glycoprotein VI-dependent pathways by interfering in vascular collagen sites is commonly seen as an attractive target for an antiplatelet therapy of acute atherosclerotic diseases such as myocardial infarction or stroke.  Revacept (sol. dimeric glycoprotein VI-Fc fusion protein) has been shown to reduce platelet adhesion by blocking vascular collagen in plaques or erosion and to be safe in preclin. studies.  A dose-escalating clin. phase I study was performed to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of Revacept in humans.  In a first-in-humans study, 30 healthy men received a single i.v. administration of 10, 20, 40, 80, or 160 mg Revacept.  The serum concn.-time courses of each dosage of Revacept showed a narrow variation and a concn. and time dependence.  Revacept did not significantly affect the bleeding time.  Collagen-induced platelet aggregation was dose-dependently inhibited up to 48 h at lower doses and for 7 days after higher dose levels.  In contrast, ADP- or thrombin receptor activating peptide-dependent platelet aggregation remained unaltered.  There were no relevant drug-related adverse events or drug-related changes in lab. parameters (biochem., hematol., and coagulation parameters).  There were no drug-related changes in blood pressure, pulse rate, or ECG parameters (including 24-h Holter monitoring).  No anti-Revacept antibodies were detected.  This phase I study demonstrated that Revacept is a safe and well-tolerated new antiplatelet compd. with a clear dose-dependent pharmacokinetic profile with specific, dose-related inhibition of platelet aggregation despite completely unaltered general hemostasis.  Clin. TRIAL REGISTRATION-: URL: www.clinicaltrials.gov.  Unique identifier: NCT 01042964.  URL: eudract.ema.europa.eu.  Identifier: 2005-004656-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2_xaQAwFvrVg90H21EOLACvtfcHk0lg9mrFjHJ6BuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVyntrk%253D&md5=bd70cbbb2592a81c0962fc5bba38962f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.110.980623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.110.980623%26sid%3Dliteratum%253Aachs%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DRosport%26aufirst%3DK.%26aulast%3DBultmann%26aufirst%3DA.%26aulast%3DPiechatzek%26aufirst%3DR.%26aulast%3DUhland%26aufirst%3DK.%26aulast%3DSchlieper%26aufirst%3DP.%26aulast%3DGawaz%26aufirst%3DM.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DNovel%2520antiplatelet%2520drug%2520revacept%2520%2528dimeric%2520Glycoprotein%2520VI-Fc%2529%2520specifically%2520and%2520efficiently%2520inhibited%2520collagen-induced%2520platelet%2520aggregation%2520without%2520affecting%2520general%2520hemostasis%2520in%2520humans%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1891%26epage%3D1899%26doi%3D10.1161%2FCIRCULATIONAHA.110.980623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valicherla, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheruvu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhunia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.3109/00498254.2015.1034224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.3109%2F00498254.2015.1034224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1016-1023&author=A.+Saxenaauthor=G.+R.+Valicherlaauthor=P.+Joshiauthor=R.+Saxenaauthor=S.+H.+Cheruvuauthor=S.+S.+Bhuniaauthor=G.+K.+Jainauthor=H.+H.+Siddiquiauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=Pharmacokinetics%2C+dose+proportionality+and+permeability+of+S002-333+and+its+enantiomers%2C+a+potent+antithrombotic+agent%2C+in+rabbits&doi=10.3109%2F00498254.2015.1034224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F00498254.2015.1034224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2015.1034224%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DValicherla%26aufirst%3DG.%2BR.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DCheruvu%26aufirst%3DS.%2BH.%26aulast%3DBhunia%26aufirst%3DS.%2BS.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DSiddiqui%26aufirst%3DH.%2BH.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DPharmacokinetics%252C%2520dose%2520proportionality%2520and%2520permeability%2520of%2520S002-333%2520and%2520its%2520enantiomers%252C%2520a%2520potent%2520antithrombotic%2520agent%252C%2520in%2520rabbits%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D1016%26epage%3D1023%26doi%3D10.3109%2F00498254.2015.1034224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bhateria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttrevu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerrabelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span> </span><span class="NLM_article-title">Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1031</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2016.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.jchromb.2016.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=27491065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1031&publication_year=2016&pages=154-162&author=M.+Bhateriaauthor=R.+Ramakrishnaauthor=S.+K.+Puttrevuauthor=S.+Yerrabelliauthor=A.+K.+Saxenaauthor=R.+S.+Bhatta&title=Pre-clinical+investigation+of+plasma+pharmacokinetics+and+biodistribution+of+a+novel+antithrombotic+agent+S002-333+in+mice+using+LC-MS%2FMS&doi=10.1016%2Fj.jchromb.2016.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS</span></div><div class="casAuthors">Bhateria, Manisha; Ramakrishna, Rachumallu; Puttrevu, Santosh Kumar; Yerrabelli, Sahithi; Saxena, Anil K.; Bhatta, Rabi Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1031</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">154-162</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide] is a novel and potent antithrombotic agent developed by CSIR-CDRI, India.  The present study was aimed to develop a sensitive LC-MS/MS method for the quantification of S002-333 in mice plasma and tissues.  The extn. of S002-333 from relatively small amt. of mouse biomatrices (50 μL) was accomplished using protein pptn. followed by liq.-liq. extn. and the sepn. of analytes was achieved on C18 reversed phase column using acetonitrile and triple distd. water (75:25, vol./vol.) as mobile phase at a flow rate of 0.6 mL/min.  The instrument was operated in the multiple reaction monitoring (MRM) mode using electrospray ionization (ESI) in the pos. scan mode.  For all the biomatrices, linear relationship was attained over the concn. range of 0.39-200 ng/mL with correlation coeffs. ≥0.992.  The lower limit of quantification for mouse plasma and tissue homogenates was 0.39 ng/mL.  The bioanal. method was reproducible and reliable for all the matrixes with inter-day and intra-day variability in precision being less than 15% and accuracy within ±15%.  The assay was successfully applied to pharmacokinetics and tissue distribution of S002-333 in mice.  The pharmacokinetic study revealed adequate gastrointestinal absorption of S002-333 into the systemic circulation of mice with abs. oral bioavailability of 45.8%.  Tissue distribution data showed rapid and wide distribution of S002-333 in the following order: small intestine > liver > kidney ≈ lungs > heart > spleen > brain.  The present findings may provide meaningful basis for further clin. development of this new chem. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYAk61bf41BrVg90H21EOLACvtfcHk0lg9mrFjHJ6BuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgsrnO&md5=36148a0cf4dbb5501a4d707870dccec2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2016.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2016.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DBhateria%26aufirst%3DM.%26aulast%3DRamakrishna%26aufirst%3DR.%26aulast%3DPuttrevu%26aufirst%3DS.%2BK.%26aulast%3DYerrabelli%26aufirst%3DS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26atitle%3DPre-clinical%2520investigation%2520of%2520plasma%2520pharmacokinetics%2520and%2520biodistribution%2520of%2520a%2520novel%2520antithrombotic%2520agent%2520S002-333%2520in%2520mice%2520using%2520LC-MS%252FMS%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2016%26volume%3D1031%26spage%3D154%26epage%3D162%26doi%3D10.1016%2Fj.jchromb.2016.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bhateria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttrevu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span> </span><span class="NLM_article-title">Enantioselective inhibition of cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1016/j.cbi.2016.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.cbi.2016.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=27387538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2016&pages=257-265&author=M.+Bhateriaauthor=R.+Ramakrishnaauthor=S.+K.+Puttrevuauthor=A.+K.+Saxenaauthor=R.+S.+Bhatta&title=Enantioselective+inhibition+of+cytochrome+P450-mediated+drug+metabolism+by+a+novel+antithrombotic+agent%2C+S002-333%3A+Major+effect+on+CYP2B6&doi=10.1016%2Fj.cbi.2016.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6</span></div><div class="casAuthors">Bhateria, Manisha; Ramakrishna, Rachumallu; Puttrevu, Santosh Kumar; Saxena, Anil K.; Bhatta, Rabi Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-265</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A significant no. of new chem. entities (NCEs) fail in drug discovery due to inhibition of Cytochrome P 450 (CYP) enzymes.  Therefore, to avert costly drug failure at the clin. phase it becomes indispensable to evaluate the CYP inhibition profile of NCEs early in drug discovery.  In light of these concerns, we envisioned to investigate the inhibitory effects of S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide], a novel and potent antithrombotic agent, on nine major CYP enzymes (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4) of human liver microsomes (HLM).  S002-333 exists as racemic mixt. of S004-1032 (R-isomer) and S007-1558 (S-isomer), consequently, we further examd. the enantioselective differences of S002-333 in the inhibition of human CYP enzymes.  Of the CYP enzymes tested, CYP2B6-catalyzed bupropion 6-hydroxylation was inhibited by S002-333 (IC50 ∼ 9.25 ± 2.46 μM) in a stereoselective manner with (S)-isomer showing potent inhibition (IC50 ∼ 5.28 ± 1.25 μM) in contrast to (R)-isomer which showed negligible inhibition on CYP2B6 activity (IC50 > 50 μM).  S002-333 and its (S)-isomer inhibited CYP2B6 activity in a non-competitive fashion with estd. Ki values of 10.1 ± 3.4 μM and 5.09 ± 1.05 μM, resp.  No shift in the IC50 value was obsd. for S002-333 and its isomers when preincubated for 30 min in the presence of NADPH suggesting that neither S002-333 nor its enantiomers are time-dependent inhibitors.  Thus, the present findings signified that S002-333 is a potent stereoselective inhibitor of CYP2B6, whereas, inhibition for other CYPs was substantially negligible.  These in vitro findings would be useful in deciding the development of S002-333 as a single-enantiomer or as a racemic mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXLCvY6v1XLVg90H21EOLACvtfcHk0lhc20DWO8-BEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GhtLbN&md5=15737bc1b51e01af72d3e508dae3b0a7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DBhateria%26aufirst%3DM.%26aulast%3DRamakrishna%26aufirst%3DR.%26aulast%3DPuttrevu%26aufirst%3DS.%2BK.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26atitle%3DEnantioselective%2520inhibition%2520of%2520cytochrome%2520P450-mediated%2520drug%2520metabolism%2520by%2520a%2520novel%2520antithrombotic%2520agent%252C%2520S002-333%253A%2520Major%2520effect%2520on%2520CYP2B6%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D256%26spage%3D257%26epage%3D265%26doi%3D10.1016%2Fj.cbi.2016.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valicherla, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1002/bdd.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fbdd.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=26477787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Kgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=185-199&author=A.+Saxenaauthor=G.+R.+Valicherlaauthor=G.+K.+Jainauthor=R.+S.+Bhattaauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=Metabolic+profiling+of+a+novel+antithrombotic+compound%2C+S002-333+and+enantiomers%3A+metabolic+stability%2C+species+comparison+and+in+vitro-in+vivo+extrapolation&doi=10.1002%2Fbdd.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation</span></div><div class="casAuthors">Saxena, Amrita; Valicherla, Guru R.; Jain, Girish K.; Bhatta, Rabi S.; Saxena, Anil K.; Gayen, Jiaur R.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">185-199</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective : The aim of this research work was to characterize the metab. of S002-333, (2-(4'-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-pyrido (3,4-b) indole-3-carboxylic acid amide) and its enantiomers, S004-1032 (R-form) and S007-1558 (S-form) in pooled human liver microsomes (PHLM) and pooled liver microsomes (LM) of rat (RLM), rabbit (RABLM), dog (DLM) and monkey (MLM).  Another objective of this study was to identify suitable surrogate species to humans for further development of lead candidates.  Method : In vitro metabolic stability and metabolite identification of S002-333 and enantiomers were carried out in PHLM and LM of various species.  The prediction of surrogate species and in vitro in vivo extrapolation were performed based upon the calcd. in vitro intrinsic clearance (CLint).  Results/Conclusion : The in vitro CLint values for S002-333, S004-1032 and S007-1558 were 0.027 ± 0.005, 0.025 ± 0.004 and 0.036 ± 0.005 mL/min/mg, resp., in PHLM, indicating that S007-1558 was the most metabolically unstable of the three.  The LM of other species showed similar results.  A common surrogate species to humans for S002-333 and enantiomers was predicted as rabbit where the extrapolated hepatic clearance (CLH) did not show a significant difference to the in vivo CLH values.  However, none of the species closely mimic humans with respect to the proportion of major metabolites (M-1-M-4) formed in vitro.  Likewise, the CLH values were also predicted in humans for S002-333 and enantiomers using various math. models.  During anal., there was no chiral inversion evident among the individual isomers throughout in vitro and in vivo expts.  In conclusion, the in vitro results indicate a prominent role of phase I metab. in the degrdn. of S002-333 and enantiomers and predict rabbit as an alternative species to conduct further safety and efficacy studies.  Copyright © 2016 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUpd-Ck0cMbVg90H21EOLACvtfcHk0lhc20DWO8-BEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Kgtbs%253D&md5=9413e57e91ea3f7a816495007c117b9a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DValicherla%26aufirst%3DG.%2BR.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DMetabolic%2520profiling%2520of%2520a%2520novel%2520antithrombotic%2520compound%252C%2520S002-333%2520and%2520enantiomers%253A%2520metabolic%2520stability%252C%2520species%2520comparison%2520and%2520in%2520vitro-in%2520vivo%2520extrapolation%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2016%26volume%3D37%26spage%3D185%26epage%3D199%26doi%3D10.1002%2Fbdd.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhunia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">In vitro metabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.3109/00498254.2013.831958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.3109%2F00498254.2013.831958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=295-308&author=A.+Saxenaauthor=G.+K.+Jainauthor=H.+H.+Siddiquiauthor=S.+S.+Bhuniaauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=In+vitro+metabolism+of+a+novel+antithrombotic+compound%2C+S002-333%2C+and+its+enantiomers%3A+quantitative+cytochrome+P450+phenotyping%2C+metabolic+profiling+and+enzyme+kinetic+studies&doi=10.3109%2F00498254.2013.831958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.831958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.831958%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DSiddiqui%26aufirst%3DH.%2BH.%26aulast%3DBhunia%26aufirst%3DS.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520a%2520novel%2520antithrombotic%2520compound%252C%2520S002-333%252C%2520and%2520its%2520enantiomers%253A%2520quantitative%2520cytochrome%2520P450%2520phenotyping%252C%2520metabolic%2520profiling%2520and%2520enzyme%2520kinetic%2520studies%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D295%26epage%3D308%26doi%3D10.3109%2F00498254.2013.831958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhonker, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span> </span><span class="NLM_article-title">Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</span> <span class="citation_source-journal">Biomed. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1002/bmc.1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fbmc.1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20954216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1234-1239&author=R.+S.+Bhattaauthor=D.+Kumarauthor=Y.+S.+Chhonkerauthor=A.+K.+Saxenaauthor=G.+K.+Jain&title=Bioanalytical+method+development+and+validation+of+novel+antithrombotic+agent+S002-333+by+LC-MS%2FMS+and+its+application+to+pharmacokinetic+studies&doi=10.1002%2Fbmc.1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</span></div><div class="casAuthors">Bhatta, R. S.; Kumar, D.; Chhonker, Y. S.; Saxena, A. K.; Jain, G. K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Chromatography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1234-1239</span>CODEN:
                <span class="NLM_cas:coden">BICHE2</span>;
        ISSN:<span class="NLM_cas:issn">0269-3879</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A rapid, sensitive and simple liq. chromatog.-tandem mass spectrometry (LC-MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti-thrombotic agent S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-β-carboxylic acid amide] in rabbit plasma was developed and validated.  The extn. from plasma was carried out by simple protein pptn. extn. method.  The chromatog. sepn. was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 μm) with a guard column, using acetonitrile-water (75:25,vol./vol.) with flow rate of 0.6 mL/min as the mobile phase.  The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002-333 and m/z 393.4/171for the internal std. dexamethasone, using pos. ion mode.  The MS/MS response was linear over the concn. range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL.  The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concns. and showed no significant matrix effect.  The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6QkNafxqdLrVg90H21EOLACvtfcHk0lhiBHm7TNjYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqtrjI&md5=ec05deec72697d8a9363f6eae55e261e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fbmc.1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.1433%26sid%3Dliteratum%253Aachs%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DJain%26aufirst%3DG.%2BK.%26atitle%3DBioanalytical%2520method%2520development%2520and%2520validation%2520of%2520novel%2520antithrombotic%2520agent%2520S002-333%2520by%2520LC-MS%252FMS%2520and%2520its%2520application%2520to%2520pharmacokinetic%2520studies%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2010%26volume%3D24%26spage%3D1234%26epage%3D1239%26doi%3D10.1002%2Fbmc.1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Boilard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigrovic, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larabee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coblyn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarotti, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remold-O’Donnell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. M.</span><span> </span><span class="NLM_article-title">Platelets amplify inflammation in arthritis via collagen-dependent microparticle production</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1126/science.1181928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1126%2Fscience.1181928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20110505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=580-583&author=E.+Boilardauthor=P.+A.+Nigrovicauthor=K.+Larabeeauthor=G.+F.+Wattsauthor=J.+S.+Coblynauthor=M.+E.+Weinblattauthor=E.+M.+Massarottiauthor=E.+Remold-O%E2%80%99Donnellauthor=R.+W.+Farndaleauthor=J.+Wareauthor=D.+M.+Lee&title=Platelets+amplify+inflammation+in+arthritis+via+collagen-dependent+microparticle+production&doi=10.1126%2Fscience.1181928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production</span></div><div class="casAuthors">Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Remold-O'Donnell, Eileen; Farndale, Richard W.; Ware, Jerry; Lee, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5965</span>),
    <span class="NLM_cas:pages">580-583</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In addn. to their pivotal role in thrombosis and wound repair, platelets participate in inflammatory responses.  We investigated the role of platelets in the autoimmune disease rheumatoid arthritis.  We identified platelet microparticles-submicrometer vesicles elaborated by activated platelets-in joint fluid from patients with rheumatoid arthritis and other forms of inflammatory arthritis, but not in joint fluid from patients with osteoarthritis.  Platelet microparticles were proinflammatory, eliciting cytokine responses from synovial fibroblasts via interleukin-1.  Consistent with these findings, depletion of platelets attenuated murine inflammatory arthritis.  Using both pharmacol. and genetic approaches, we identified the collagen receptor glycoprotein VI as a key trigger for platelet microparticle generation in arthritis pathophysiol.  Thus, these findings demonstrate a previously unappreciated role for platelets and their activation-induced microparticles in inflammatory joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogezgHXfwd0LVg90H21EOLACvtfcHk0lhiBHm7TNjYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGmur8%253D&md5=0754291009f1bd3c999943f4262b6031</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1181928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1181928%26sid%3Dliteratum%253Aachs%26aulast%3DBoilard%26aufirst%3DE.%26aulast%3DNigrovic%26aufirst%3DP.%2BA.%26aulast%3DLarabee%26aufirst%3DK.%26aulast%3DWatts%26aufirst%3DG.%2BF.%26aulast%3DCoblyn%26aufirst%3DJ.%2BS.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DMassarotti%26aufirst%3DE.%2BM.%26aulast%3DRemold-O%25E2%2580%2599Donnell%26aufirst%3DE.%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DD.%2BM.%26atitle%3DPlatelets%2520amplify%2520inflammation%2520in%2520arthritis%2520via%2520collagen-dependent%2520microparticle%2520production%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D580%26epage%3D583%26doi%3D10.1126%2Fscience.1181928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Dong, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D. D.</span><span> </span><span class="NLM_article-title">Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2290</span><span class="NLM_x">–</span> <span class="NLM_lpage">2295</span><span class="refDoi"> DOI: 10.1161/01.CIR.101.19.2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2F01.CIR.101.19.2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10811597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFSrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=2290-2295&author=Z.+M.+Dongauthor=A.+A.+Brownauthor=D.+D.+Wagner&title=Prominent+role+of+P-selectin+in+the+development+of+advanced+atherosclerosis+in+ApoE-deficient+mice&doi=10.1161%2F01.CIR.101.19.2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prominent role of P-selectin in the development of advanced atherosclerosis in apoE-deficient mice</span></div><div class="casAuthors">Dong, Zhao Ming; Brown, Allison A.; Wagner, Denisa D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2290-2295</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background-Adhesive interactions between leukocytes and endothelial cells are characteristic of the development of atherosclerotic lesions, but the receptors involved remain to be defined.  P-selectin is an adhesion receptor expressed on activated endothelial cells or platelets and was shown to be involved in fatty streak formation in LDL receptor-deficient mice on an atherogenic diet.  The main purpose of this study is to examine the role of P-selectin in the spontaneous development of advanced atherosclerosis in apoE-deficient mice.  Methods and Results-We intercrossed P-selectin-deficient mice with lacking apoE and compared lesion development in apoE-deficient mice with P-selectin (apoE-/-P+/+) and without P-selectin (apoE-/-P-/-) that were fed normal mouse chow.  At 4 mo of age, apoE-/-P-/- mice had 3.5-fold smaller aortic sinus lesions than apoE-/-P+/+ mice.  These were limited to fatty streaks in the apoE-/-P-/- mice, whereas 70% of apoE-/-P+/+ lesions contained smooth muscle cells.  Significantly more of the aortic sinus circumference was covered by lesions in the apoE-/-P+/+ animals.  The P-selectin genotype affected macrophage recruitment, because twice as many mononuclear cells were present in the P-selectin-pos. lesions.  At 15 mo, the lesions progressed to the fibrous plaque stage in both genotypes and spread throughout the aorta, but this process was delayed in apoE-/-P-/- mice.  In the aortic sinus, the lesions of the apoE-/-P-/- mice were 2.6-fold smaller and less calcified.  Conclusions-P-selectin appears to be a key adhesion receptor mediating leukocyte recruitment into lesions and promoting advanced atherosclerosis in apoE-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgs1Mt1ZLGVrVg90H21EOLACvtfcHk0lhiBHm7TNjYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFSrtb4%253D&md5=ed9c5f0f59a11d1d608ad72d6ee0776c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.101.19.2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.101.19.2290%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DZ.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BA.%26aulast%3DWagner%26aufirst%3DD.%2BD.%26atitle%3DProminent%2520role%2520of%2520P-selectin%2520in%2520the%2520development%2520of%2520advanced%2520atherosclerosis%2520in%2520ApoE-deficient%2520mice%26jtitle%3DCirculation%26date%3D2000%26volume%3D101%26spage%3D2290%26epage%3D2295%26doi%3D10.1161%2F01.CIR.101.19.2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Collins, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, A. L.</span><span> </span><span class="NLM_article-title">P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span><span class="refDoi"> DOI: 10.1084/jem.191.1.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1084%2Fjem.191.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10620617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=189-194&author=R.+G.+Collinsauthor=R.+Veljiauthor=N.+V.+Guevaraauthor=M.+J.+Hicksauthor=L.+Chanauthor=A.+L.+Beaudet&title=P-Selectin+or+intercellular+adhesion+molecule+%28ICAM%29-1+deficiency+substantially+protects+against+atherosclerosis+in+apolipoprotein+E-deficient+mice&doi=10.1084%2Fjem.191.1.189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice</span></div><div class="casAuthors">Collins, Robert G.; Velji, Rizwan; Guevara, Natalia V.; Hicks, M. John; Chan, Lawrence; Beaudet, Arthur L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-194</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The expression of leukocyte and endothelial cell adhesion mols. (CAMs) is essential for the emigration of leukocytes during an inflammatory response.  The importance of the inflammatory response in the development of atherosclerosis is indicated by the increased expression of adhesion mols., proinflammatory cytokines, and growth factors in lesions and lesion-prone areas and by protection in mice deficient in various aspects of the inflammatory response.  The authors have quantitated the effect of deficiency for intercellular adhesion mol. (ICAM)-1, P-selectin, or E-selectin on atherosclerotic lesion formation at 20 wk of age in apolipoprotein (apo) E-/- (deficient) mice fed a normal chow diet.  All mice were apo E-/- and CAM+/+ or CAM-/- littermates, and no differences were found in body wt. or cholesterol levels among the various genotypes during the study.  ICAM-1-/- mice had less lesion area than their ICAM-1+/+ littermates: 4.08 mm2 for -/- males vs. 5.87 mm2 for +/+ males, and 3.95 mm2 for -/- females vs. 5.59 mm2 for +/+ females, combined.  An even greater redn. in lesion area was obsd. in P-selectin-/- mice: 3.06 mm2 for -/- males vs. 5.09 mm2 for +/+ males, and 2.85 mm2 for -/- females compared with 5.60 mm2 for +/+ females, combined.  The redn. in lesion area for the E-selectin null mice, although less than that seen for ICAM-1 or P-selectin, was still significant (4.54 mm2 for -/- males vs. 5.92 mm2 for +/+ males, and 4.38 mm2 for -/- females compared with 5.94 mm2 for +/+ females, combined).  These results, coupled with the closely controlled genetics of this study, indicate that redns. in the expression of P-selectin, ICAM-1, or E-selectin provide direct protection from atherosclerotic lesion formation in this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT0KNKK--6rVg90H21EOLACvtfcHk0lheEc__aWm4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFyrug%253D%253D&md5=f52990e7a56e5b56e64323691746bcfd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1084%2Fjem.191.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.191.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DR.%2BG.%26aulast%3DVelji%26aufirst%3DR.%26aulast%3DGuevara%26aufirst%3DN.%2BV.%26aulast%3DHicks%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26atitle%3DP-Selectin%2520or%2520intercellular%2520adhesion%2520molecule%2520%2528ICAM%2529-1%2520deficiency%2520substantially%2520protects%2520against%2520atherosclerosis%2520in%2520apolipoprotein%2520E-deficient%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D189%26epage%3D194%26doi%3D10.1084%2Fjem.191.1.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Blann, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lip, G. Y.</span><span> </span><span class="NLM_article-title">The adhesion molecule P-selectin and cardiovascular disease</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span><span class="refDoi"> DOI: 10.1016/j.ehj.2003.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.ehj.2003.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=14659768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlOisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=2166-2179&author=A.+D.+Blannauthor=S.+K.+Nadarauthor=G.+Y.+Lip&title=The+adhesion+molecule+P-selectin+and+cardiovascular+disease&doi=10.1016%2Fj.ehj.2003.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The adhesion molecule P-selectin and cardiovascular disease</span></div><div class="casAuthors">Blann, Andrew D.; Nadar, Sunil K.; Lip, Gregory Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2166-2179</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The adhesion mol. P-selectin (CD62P) is of interest because of its role in modulating interactions between blood cells and the endothelium, and also because of the possible use of the sol. form as a plasma predictor of adverse cardiovascular events.  Although present on the external cell surface of both activated endothelium and activated platelets, it now seems clear that most, if not all, of the measured plasma P-selectin is of platelet origin.  P-selectin is partially responsible for the adhesion of certain leukocytes and platelets to the endothelium.  Animal models have also shown the important role of P-selectin in the process of atherogenesis.  For example, increased P-selectin expression has been demonstrated on active atherosclerotic plaques; in contrast, fibrotic inactive plaques lack P-selectin expression, and animals lacking P-selectin have a decreased tendency to form atherosclerotic plaques.  Increased levels of sol. P-selectin in the plasma have also been demonstrated in a variety of cardiovascular disorders, including coronary artery disease, hypertension and atrial fibrillation, with some relationship to prognosis.  The objective of this review is to provide an overview of the current literature on this mol. and thus present a concise view of its potential in dissecting the pathophysiol. of atherosclerosis.  In doing so we shall focus primarily on human biol. but will note a small no. of excellent lessons provided by non-human work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhJ-SiUN4nbVg90H21EOLACvtfcHk0lheEc__aWm4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlOisrs%253D&md5=62ef58ccfe557d311a11dd68876f5c50</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ehj.2003.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ehj.2003.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DBlann%26aufirst%3DA.%2BD.%26aulast%3DNadar%26aufirst%3DS.%2BK.%26aulast%3DLip%26aufirst%3DG.%2BY.%26atitle%3DThe%2520adhesion%2520molecule%2520P-selectin%2520and%2520cardiovascular%2520disease%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2003%26volume%3D24%26spage%3D2166%26epage%3D2179%26doi%3D10.1016%2Fj.ehj.2003.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lheEc__aWm4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">DiMinno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, M. J.</span><span> </span><span class="NLM_article-title">Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=6834277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADyaL3sXitV2nu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=1983&pages=57-60&author=G.+DiMinnoauthor=M.+J.+Silver&title=Mouse+antithrombotic+assay%3A+a+simple+method+for+the+evaluation+of+antithrombotic+agents+in+vivo.+Potentiation+of+antithrombotic+activity+by+ethyl+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse antithrombotic assay:  a simple method for the evaluation of antithrombotic agents in vivo.  Potentiation of antithrombotic activity by ethyl alcohol</span></div><div class="casAuthors">DiMinno, Giovanni; Silver, Melvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-60</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">A simple method for screening antithrombotic agents is presented.  When mice were given an i.v. injection of 0.1 mL of a mixt. of collagen (dose, 15 μg/mouse) and epinephrine  [51-43-4] (dose, 1.8 μg/mouse), 94% died within 5 min or remained paralyzed for more than 15 min.  Examples of the use of the system for the study of antithrombotic agents are given.  Solns. of agents were administered to the animals i.p. about 1 h before the thrombotic challenge.  aspirin  [50-78-2] (20 Mg/kg), OKY-1581  [75987-18-7] (30 mg/kg) and EtOH  [64-17-5] (2 g/kg), administered as single agents in aq. medium, protected 40, 50 and 35% of the animals, resp.  heparin  [9005-49-6] (150 U/kg) was ineffective.  Combinations of EtOH with indomethacin  [53-86-1] or indobufen  [63610-08-2] provided complete protection, whereas EtOH plus aspirin protected 84% and EtOH plus OKY-1581 protected 70% of the animals.  dipyridamole  [58-32-2] Alone (3 mg/kg), dipyridamole (1.65 mg/kg) plus EtOH or dipyridamole (1.65 mg/kg) plus aspirin were ineffective.  The method appears well suited for screening potential antithrombotic agents which act primarily against platelet thromboembolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOz6Gt5i2kqbVg90H21EOLACvtfcHk0lgFVQvihk24Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitV2nu74%253D&md5=3d024281f05c800bf8d03caf5101be48</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMinno%26aufirst%3DG.%26aulast%3DSilver%26aufirst%3DM.%2BJ.%26atitle%3DMouse%2520antithrombotic%2520assay%253A%2520a%2520simple%2520method%2520for%2520the%2520evaluation%2520of%2520antithrombotic%2520agents%2520in%2520vivo.%2520Potentiation%2520of%2520antithrombotic%2520activity%2520by%2520ethyl%2520alcohol%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1983%26volume%3D225%26spage%3D57%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Prakash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span> </span><span class="NLM_article-title">Anti-platelet effects of curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.thromres.2010.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.thromres.2010.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21144557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2011&pages=111-118&author=P.+Prakashauthor=A.+Misraauthor=W.+R.+Surinauthor=M.+Jainauthor=R.+S.+Bhattaauthor=R.+Palauthor=K.+Rajauthor=M.+K.+Barthwalauthor=M.+Dikshit&title=Anti-platelet+effects+of+curcuma+oil+in+experimental+models+of+myocardial+ischemia-reperfusion+and+thrombosis&doi=10.1016%2Fj.thromres.2010.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis</span></div><div class="casAuthors">Prakash, Prem; Misra, Ankita; Surin, William R.; Jain, Manish; Bhatta, Rabi S.; Pal, Raghvendra; Raj, Kanwal; Barthwal, Manoj K.; Dikshit, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-118</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Extensive research on the mechanism of action and medicinal importance of curcumin obtained from turmeric (Curcuma longa) has unfolded its potential therapeutic value against many chronic ailments.  Curcuma oil (C.oil), the highly lipophilic component from Curcuma longa has been documented for its neuroprotective efficacy against rat cerebral ischemia-reperfusion injury; however its effect on myocardial reperfusion injury remains unexplored.  In the present study, effect of C.oil (500 mg/kg, po) was evaluated against myocardial ischemia-reperfusion induced injury in the rat model.  C.oil failed to confer protection against cardiac injury, however significant reversal of ADP induced platelet aggregation (p < 0.05) was evident in the same animals.  Moreover, collagen and thrombin induced platelet aggregation (p < 0.001) as well as tyrosine phosphorylation of various proteins in activated platelets was also suppressed.  C.oil also offered significant protection against collagen-epinephrine induced thromboembolism in mice as well as augmented total time to occlusion against FeCl3 induced arterial thrombosis in rats.  C.oil however had no effect on coagulation parameters (TT, PT and aPTT) and exerted a mild effect on the bleeding time.  Bioavailability of C.oil, as assessed by monitoring ar-turmerone, α,β-turmerone and curlone, was 13%, 11% and 7% resp., indicating high systemic exposure.  Moreover, longer mean residence time (MRT) of ar-turmerone (13.2 h), α,β-turmerone (11.6 h) and Curlone (14.0 h) and plasma elimination half lives in the range of 5.5 to 7.2 h correlated with single 500 mg/kg dose regimen of C.oil.  In the present study, C.oil thus seems to be an efficacious and safe anti-platelet agent which was protective against intravascular thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4rO8_w5_3bVg90H21EOLACvtfcHk0lgFVQvihk24Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVartrY%253D&md5=ed1c8d4c6f3f58a9d060c5c08e55c2a1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2010.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2010.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DP.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DSurin%26aufirst%3DW.%2BR.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DPal%26aufirst%3DR.%26aulast%3DRaj%26aufirst%3DK.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26atitle%3DAnti-platelet%2520effects%2520of%2520curcuma%2520oil%2520in%2520experimental%2520models%2520of%2520myocardial%2520ischemia-reperfusion%2520and%2520thrombosis%26jtitle%3DThromb.%2520Res.%26date%3D2011%26volume%3D127%26spage%3D111%26epage%3D118%26doi%3D10.1016%2Fj.thromres.2010.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anil Kumar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandilya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, D. K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.ejmech.2016.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=1-12&author=A.+Misraauthor=K.+S.+Anil+Kumarauthor=M.+Jainauthor=K.+Bajajauthor=S.+Shandilyaauthor=S.+Srivastavaauthor=P.+Shuklaauthor=M.+K.+Barthwalauthor=M.+Dikshitauthor=D.+K.+Dikshit&title=Synthesis+and+evaluation+of+dual+antiplatelet+activity+of+bispidine+derivatives+of+N-substituted+pyroglutamic+acids&doi=10.1016%2Fj.ejmech.2016.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DAnil%2BKumar%26aufirst%3DK.%2BS.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBajaj%26aufirst%3DK.%26aulast%3DShandilya%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26aulast%3DDikshit%26aufirst%3DD.%2BK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520dual%2520antiplatelet%2520activity%2520of%2520bispidine%2520derivatives%2520of%2520N-substituted%2520pyroglutamic%2520acids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D110%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jandrot-Perrus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagrue, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span> </span><span class="NLM_article-title">Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">27035</span><span class="NLM_x">–</span> <span class="NLM_lpage">27041</span><span class="refDoi"> DOI: 10.1074/jbc.272.43.27035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.272.43.27035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=27035-27041&author=M.+Jandrot-Perrusauthor=A.+H.+Lagrueauthor=M.+Okumaauthor=C.+Bon&title=Adhesion+and+activation+of+human+platelets+induced+by+convulxin+involve+glycoprotein+VI+and+integrin+alpha2beta1&doi=10.1074%2Fjbc.272.43.27035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.43.27035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.43.27035%26sid%3Dliteratum%253Aachs%26aulast%3DJandrot-Perrus%26aufirst%3DM.%26aulast%3DLagrue%26aufirst%3DA.%2BH.%26aulast%3DOkuma%26aufirst%3DM.%26aulast%3DBon%26aufirst%3DC.%26atitle%3DAdhesion%2520and%2520activation%2520of%2520human%2520platelets%2520induced%2520by%2520convulxin%2520involve%2520glycoprotein%2520VI%2520and%2520integrin%2520alpha2beta1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D27035%26epage%3D27041%26doi%3D10.1074%2Fjbc.272.43.27035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Dikshit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srimal, R. C.</span><span> </span><span class="NLM_article-title">Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=8510015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADyaK3sXltlKluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=1369-1373&author=M.+Dikshitauthor=R.+Kumariauthor=R.+C.+Srimal&title=Pulmonary+thromboembolism-induced+alterations+in+nitric+oxide+release+from+rat+circulating+neutrophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils</span></div><div class="casAuthors">Dikshit, M.; Kumari, R.; Srimal, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1369-73</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The effect of circulating polymorphonuclear leukocytes (PMNL) isolated from normal and thrombotic rats was studied on platelet aggregation in platelet-rich plasma.  PMNL inhibited the platelet aggregation in a concn.- and time-dependent manner at 37°.  The platelet aggregation inhibitory response of PMNL was more pronounced in the presence of superoxide dismutase and was abolished by Hb and methylene blue.  These observations suggested that the inhibitory effect of PMNL on platelets was mediated by neutrophil-derived relaxing factor.  PMNL, obtained after thromboembolism, inhibited the platelet aggregation response more strongly due to an increased release of NO from them.  It is suggested that PMNL play an important role in the regulation of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcwU-hO3rT7Vg90H21EOLACvtfcHk0lgbmM8bJIiXaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlKluro%253D&md5=c75687d1f06a122209132811eb6751ea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDikshit%26aufirst%3DM.%26aulast%3DKumari%26aufirst%3DR.%26aulast%3DSrimal%26aufirst%3DR.%2BC.%26atitle%3DPulmonary%2520thromboembolism-induced%2520alterations%2520in%2520nitric%2520oxide%2520release%2520from%2520rat%2520circulating%2520neutrophils%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D1369%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bellavite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrioli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arigliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirumbolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santonastaso, C.</span><span> </span><span class="NLM_article-title">A colorimetric method for the measurement of platelet adhesion in microtiter plates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1006/abio.1994.1066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1006%2Fabio.1994.1066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1994&pages=444-450&author=P.+Bellaviteauthor=G.+Andrioliauthor=P.+Guzzoauthor=P.+Ariglianoauthor=S.+Chirumboloauthor=F.+Manzatoauthor=C.+Santonastaso&title=A+colorimetric+method+for+the+measurement+of+platelet+adhesion+in+microtiter+plates&doi=10.1006%2Fabio.1994.1066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1006%2Fabio.1994.1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1994.1066%26sid%3Dliteratum%253Aachs%26aulast%3DBellavite%26aufirst%3DP.%26aulast%3DAndrioli%26aufirst%3DG.%26aulast%3DGuzzo%26aufirst%3DP.%26aulast%3DArigliano%26aufirst%3DP.%26aulast%3DChirumbolo%26aufirst%3DS.%26aulast%3DManzato%26aufirst%3DF.%26aulast%3DSantonastaso%26aufirst%3DC.%26atitle%3DA%2520colorimetric%2520method%2520for%2520the%2520measurement%2520of%2520platelet%2520adhesion%2520in%2520microtiter%2520plates%26jtitle%3DAnal.%2520Biochem.%26date%3D1994%26volume%3D216%26spage%3D444%26epage%3D450%26doi%3D10.1006%2Fabio.1994.1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yacoub, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoret, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Saleh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merhi, Y.</span><span> </span><span class="NLM_article-title">Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">30024</span><span class="NLM_x">–</span> <span class="NLM_lpage">30035</span><span class="refDoi"> DOI: 10.1074/jbc.M604504200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.M604504200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30024-30035&author=D.+Yacoubauthor=J.+F.+Theoretauthor=L.+Villeneuveauthor=H.+Abou-Salehauthor=W.+Mouradauthor=B.+G.+Allenauthor=Y.+Merhi&title=Essential+role+of+protein+kinase+C+delta+in+platelet+signaling%2C+alpha+IIb+beta+3+activation%2C+and+thromboxane+A2+release&doi=10.1074%2Fjbc.M604504200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M604504200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M604504200%26sid%3Dliteratum%253Aachs%26aulast%3DYacoub%26aufirst%3DD.%26aulast%3DTheoret%26aufirst%3DJ.%2BF.%26aulast%3DVilleneuve%26aufirst%3DL.%26aulast%3DAbou-Saleh%26aufirst%3DH.%26aulast%3DMourad%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DB.%2BG.%26aulast%3DMerhi%26aufirst%3DY.%26atitle%3DEssential%2520role%2520of%2520protein%2520kinase%2520C%2520delta%2520in%2520platelet%2520signaling%252C%2520alpha%2520IIb%2520beta%25203%2520activation%252C%2520and%2520thromboxane%2520A2%2520release%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30024%26epage%3D30035%26doi%3D10.1074%2Fjbc.M604504200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambayashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, H.</span><span> </span><span class="NLM_article-title">Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2014</span><span class="refDoi"> DOI: 10.1182/blood-2007-06-097824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2007-06-097824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18056842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVeisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2007-2014&author=S.+Yoshidaauthor=T.+Sudoauthor=M.+Niimiauthor=L.+Taoauthor=B.+Sunauthor=J.+Kambayashiauthor=H.+Watanabeauthor=E.+Luoauthor=H.+Matsuoka&title=Inhibition+of+collagen-induced+platelet+aggregation+by+anopheline+antiplatelet+protein%2C+a+saliva+protein+from+a+malaria+vector+mosquito&doi=10.1182%2Fblood-2007-06-097824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito</span></div><div class="casAuthors">Yoshida, Shigeto; Sudo, Toshiki; Niimi, Masashi; Tao, Lian; Sun, Bing; Kambayashi, Junichi; Watanabe, Hiroyuki; Luo, Enjie; Matsuoka, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2007-2014</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">During blood feeding, mosquitoes inject saliva contg. a mixt. of mols. that inactivate or inhibit various components of the hemostatic response to the bite injury as well as the inflammatory reactions produced by the bite, to facilitate the ingestion of blood.  However, the mol. functions of the individual saliva components remain largely unknown.  Here, the authors describe anopheline antiplatelet protein (AAPP) isolated from the saliva of Anopheles stephensi, a human malaria vector mosquito.  AAPP exhibited a strong and specific inhibitory activity toward collagen-induced platelet aggregation.  The inhibitory mechanism involves direct binding of AAPP to collagen, which blocks platelet adhesion to collagen and inhibits the subsequent increase in intracellular Ca2+ concn. ([Ca2+]i).  The binding of AAPP to collagen effectively blocked platelet adhesion via glycoprotein VI (GPVI) and integrin α2β1.  Cell adhesion assay showed that AAPP inhibited the binding of GPVI to collagen type I and III without direct effect on GPVI.  Moreover, i.v. administered recombinant AAPP strongly inhibited collagen-induced platelet aggregation ex vivo in rats.  In summary, AAPP is a malaria vector mosquito-derived specific antagonist of receptors that mediate the adhesion of platelets to collagen.  The authors' study may provide important insights for elucidating the effects of mosquito blood feeding against host hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcylwgxh9pOrVg90H21EOLACvtfcHk0lj55WmkoP3kvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVeisLs%253D&md5=dc7bbe07d2d1d52b8dd946b835b50419</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-06-097824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-06-097824%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DKambayashi%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DE.%26aulast%3DMatsuoka%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520collagen-induced%2520platelet%2520aggregation%2520by%2520anopheline%2520antiplatelet%2520protein%252C%2520a%2520saliva%2520protein%2520from%2520a%2520malaria%2520vector%2520mosquito%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2007%26epage%3D2014%26doi%3D10.1182%2Fblood-2007-06-097824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>LigPrep, version <span class="NLM_edition">2.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>Protein Preparation Wizard. Schrödinger Suite 2009; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard.+Schr%C3%B6dinger+Suite+2009%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Preparation%2520Wizard.%2520Schr%25C3%25B6dinger%2520Suite%25202009%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>Schrödinger, version <span class="NLM_edition">9.0</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%2C+version+9.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span>Glide, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Holly Foster, Clare Wilson, Helen Philippou, <span class="NLM_string-name hlFld-ContribAuthor">Richard Foster</span>. </span><span class="cited-content_cbyCitation_article-title">Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12213-12242. <a href="https://doi.org/10.1021/acs.jmedchem.0c00262" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Btoward%252Ba%252BGlycoprotein%252BVI%252BModulator%252Bfor%252Bthe%252BTreatment%252Bof%252BThrombosis%26aulast%3DFoster%26aufirst%3DHolly%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12022020%26date%3D30062020%26date%3D28052020%26volume%3D63%26issue%3D21%26spage%3D12213%26epage%3D12242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Jun  Zhou</span>, <span class="hlFld-ContribAuthor ">Yixin  Zhong</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Yuli  Chen</span>, <span class="hlFld-ContribAuthor ">Liming  Deng</span>, <span class="hlFld-ContribAuthor ">Danli  Sheng</span>, <span class="hlFld-ContribAuthor ">Zhigang  Wang</span>, <span class="hlFld-ContribAuthor ">Haitao  Ran</span>, and <span class="hlFld-ContribAuthor ">Dajing  Guo</span>  . </span><span class="cited-content_cbyCitation_article-title">Phase Transition Nanoparticles as Multimodality Contrast Agents for the Detection of Thrombi and for Targeting Thrombolysis: in Vitro and in Vivo Experiments. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2017,</strong> <em>9 </em>
                                    (49)
                                     , 42525-42535. <a href="https://doi.org/10.1021/acsami.7b12689" title="DOI URL">https://doi.org/10.1021/acsami.7b12689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.7b12689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.7b12689%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DPhase%252BTransition%252BNanoparticles%252Bas%252BMultimodality%252BContrast%252BAgents%252Bfor%252Bthe%252BDetection%252Bof%252BThrombi%252Band%252Bfor%252BTargeting%252BThrombolysis%25253A%252Bin%252BVitro%252Band%252Bin%252BVivo%252BExperiments%26aulast%3DXu%26aufirst%3DJie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23082017%26date%3D21112017%26date%3D01122017%26date%3D13122017%26date%3D21112017%26volume%3D9%26issue%3D49%26spage%3D42525%26epage%3D42535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Foteini-Nafsika  Damaskinaki</span>, <span class="hlFld-ContribAuthor ">Luis A.  Moran</span>, <span class="hlFld-ContribAuthor ">Angel  Garcia</span>, <span class="hlFld-ContribAuthor ">Barrie  Kellam</span>, <span class="hlFld-ContribAuthor ">Steve P.  Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2. </span><span class="cited-content_cbyCitation_journal-name">Platelets</span><span> <strong>2021,</strong> <em>21 </em>, 1-9. <a href="https://doi.org/10.1080/09537104.2020.1863939" title="DOI URL">https://doi.org/10.1080/09537104.2020.1863939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/09537104.2020.1863939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F09537104.2020.1863939%26sid%3Dliteratum%253Aachs%26jtitle%3DPlatelets%26atitle%3DOvercoming%252Bchallenges%252Bin%252Bdeveloping%252Bsmall%252Bmolecule%252Binhibitors%252Bfor%252BGPVI%252Band%252BCLEC-2%26aulast%3DDamaskinaki%26aufirst%3DFoteini-Nafsika%26date%3D2021%26date%3D2021%26volume%3D21%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Jinsen  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Jaunarajs</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptoline-based benzothiazoles re-sensitize MRSA to β-lactam antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (21)
                                     , 115095. <a href="https://doi.org/10.1016/j.bmc.2019.115095" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115095%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTryptoline-based%252Bbenzothiazoles%252Bre-sensitize%252BMRSA%252Bto%252B%2525CE%2525B2-lactam%252Bantibiotics%26aulast%3DWang%26aufirst%3DXinfeng%26date%3D2019%26volume%3D27%26issue%3D21%26spage%3D115095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Yongbin  Tian</span>, <span class="hlFld-ContribAuthor ">Lei  Ma</span>, <span class="hlFld-ContribAuthor ">Xiao  Lv</span>, <span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Xufeng  Huang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Kong</span>, <span class="hlFld-ContribAuthor ">Lei  Huang</span>, <span class="hlFld-ContribAuthor ">Bo  Wu</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Developments in inhibiting platelet aggregation based on different design strategies. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (14)
                                     , 1757-1775. <a href="https://doi.org/10.4155/fmc-2018-0345" title="DOI URL">https://doi.org/10.4155/fmc-2018-0345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0345%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopments%252Bin%252Binhibiting%252Bplatelet%252Baggregation%252Bbased%252Bon%252Bdifferent%252Bdesign%252Bstrategies%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2019%26volume%3D11%26issue%3D14%26spage%3D1757%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradipta  Maity</span>, <span class="hlFld-ContribAuthor ">Debasis  Adhikari</span>, <span class="hlFld-ContribAuthor ">Amit Kumar  Jana</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on synthetic entries to tetrahydro-β-carbolines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (8)
                                     , 965-1028. <a href="https://doi.org/10.1016/j.tet.2019.01.004" title="DOI URL">https://doi.org/10.1016/j.tet.2019.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Boverview%252Bon%252Bsynthetic%252Bentries%252Bto%252Btetrahydro-%2525CE%2525B2-carbolines%26aulast%3DMaity%26aufirst%3DPradipta%26date%3D2019%26volume%3D75%26issue%3D8%26spage%3D965%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard C.  Becker</span>, <span class="hlFld-ContribAuthor ">Travis  Sexton</span>, <span class="hlFld-ContribAuthor ">Susan S.  Smyth</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Implications of Platelets as Vascular First Responders. </span><span class="cited-content_cbyCitation_journal-name">Circulation Research</span><span> <strong>2018,</strong> <em>122 </em>
                                    (3)
                                     , 506-522. <a href="https://doi.org/10.1161/CIRCRESAHA.117.310939" title="DOI URL">https://doi.org/10.1161/CIRCRESAHA.117.310939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCRESAHA.117.310939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCRESAHA.117.310939%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%2520Research%26atitle%3DTranslational%252BImplications%252Bof%252BPlatelets%252Bas%252BVascular%252BFirst%252BResponders%26aulast%3DBecker%26aufirst%3DRichard%2BC.%26date%3D2018%26volume%3D122%26issue%3D3%26spage%3D506%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankita  Misra</span>, <span class="hlFld-ContribAuthor ">Prem  Prakash</span>, <span class="hlFld-ContribAuthor ">Hobby  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Priyanka  Dhankani</span>, <span class="hlFld-ContribAuthor ">Sachin  Kumar</span>, <span class="hlFld-ContribAuthor ">Chandra Prakash  Pandey</span>, <span class="hlFld-ContribAuthor ">Nicholas  Pugh</span>, <span class="hlFld-ContribAuthor ">Dominique  Bihan</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Barthwal</span>, <span class="hlFld-ContribAuthor ">Richard W.  Farndale</span>, <span class="hlFld-ContribAuthor ">Dinesh Kumar  Dikshit</span>, <span class="hlFld-ContribAuthor ">Madhu  Dikshit</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>148 </em>, 288-297. <a href="https://doi.org/10.1016/j.bcp.2018.01.013" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DAnti-thrombotic%252Befficacy%252Bof%252BS007-867%25253A%252BPre-clinical%252Bevaluation%252Bin%252Bexperimental%252Bmodels%252Bof%252Bthrombosis%252Bin%252Bvivo%252Band%252Bin%252Bvitro%26aulast%3DMisra%26aufirst%3DAnkita%26date%3D2018%26volume%3D148%26spage%3D288%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. S.  Bhunia</span>, <span class="hlFld-ContribAuthor ">A. K.  Saxena</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modelling studies in explaining the higher GPVI antagonistic activity of the racemic 2-(4-methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide than its enantiomers. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (10)
                                     , 783-799. <a href="https://doi.org/10.1080/1062936X.2017.1396247" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1396247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1396247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1396247%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bmodelling%252Bstudies%252Bin%252Bexplaining%252Bthe%252Bhigher%252BGPVI%252Bantagonistic%252Bactivity%252Bof%252Bthe%252Bracemic%252B2-%2525284-methoxyphenylsulfonyl%252529-2%25252C3%25252C4%25252C9-tetrahydro-1H-pyrido%25255B3%25252C4-b%25255Dindole-3-carboxamide%252Bthan%252Bits%252Benantiomers%26aulast%3DBhunia%26aufirst%3DS.%2BS.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D10%26spage%3D783%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristell  Lebozec</span>, <span class="hlFld-ContribAuthor ">Martine  Jandrot-Perrus</span>, <span class="hlFld-ContribAuthor ">Gilles  Avenard</span>, <span class="hlFld-ContribAuthor ">Olivier  Favre-Bulle</span>, <span class="hlFld-ContribAuthor ">Philippe  Billiald</span>. </span><span class="cited-content_cbyCitation_article-title">Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks. </span><span class="cited-content_cbyCitation_journal-name">mAbs</span><span> <strong>2017,</strong> <em>9 </em>
                                    (6)
                                     , 945-958. <a href="https://doi.org/10.1080/19420862.2017.1336592" title="DOI URL">https://doi.org/10.1080/19420862.2017.1336592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/19420862.2017.1336592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F19420862.2017.1336592%26sid%3Dliteratum%253Aachs%26jtitle%3DmAbs%26atitle%3DDesign%25252C%252Bdevelopment%252Band%252Bcharacterization%252Bof%252BACT017%25252C%252Ba%252Bhumanized%252BFab%252Bthat%252Bblocks%252Bplatelet%252527s%252Bglycoprotein%252BVI%252Bfunction%252Bwithout%252Bcausing%252Bbleeding%252Brisks%26aulast%3DLebozec%26aufirst%3DKristell%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D6%26spage%3D945%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the compounds that prevent collagen mediated platelet aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reagents and conditions: (a) SOCl<sub>2</sub>, dry methanol, −10 to 30 °C; (b) HCHO, MeOH, H<sub>2</sub>O; (c) NaHCO<sub>3</sub> saturated solution; (d) R-SO<sub>2</sub>-Cl, dry acetone, TEA; (e) MeOH,NH<sub>3</sub>; (f) 2 N NaOH, H<sub>2</sub>O, 1,4-dioxane; (g) COCl<sub>2</sub>, dry THF; (h) TEA, R-NH<sub>2</sub>, dry THF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>6b</b> on collagen–epinephrine induced pulmonary thromboembolism in mice in (a) time dependent study and (b) dose dependent study. Results are expressed as the mean ± SEM (<i>n</i> = 5, 10 animals/group/experiment). (c) Effect of compound <b>6b</b> on bleeding time (aspirin, 170 μmol/kg; clopidogel, 70 μmol/kg; losartan, 100 μmol/kg; <b>6b</b>, 30 μmol/kg). Effect of compound <b>6b</b> on coagulation cascade in human plasma (in vitro) at various concentrations: (d) thrombin time, (e) prothrombin time, (f) activated partial thromboplastin time (<i>n</i> = 3). Results are expressed as the mean ± SEM. (g) Effect of compound <b>6b</b> on human platelet adhesion (in vitro) on collagen coated surface in presence and absence of Mg<sup>2+</sup> (<i>n</i> = 3). Data are shown as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs control. (h) Effect of compound <b>6b</b> on aggregation of human platelets (in vitro) induced by TRAP (thrombin receptor activating peptide), ristocetin, arachidonic acid, and ADP (<i>n</i> = 3). Results are expressed as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs vehicle. Effect of compounds <b>6b</b>, <b>6d</b>, and <b>6c</b> on aggregation of human platelet rich plasma (in vitro) induced by (i) collagen, (j) convulxin, and (k) CRP-XL. (l) Effect of compound <b>6b</b> on collagen, CRP-XL, and convulxin induced aggregation in human platelet rich plasma (in vitro).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Effect of compounds <b>6b</b>, <b>6d</b>, and <b>6c</b> on platelet P-selectin expression in human platelet rich plasma (in vitro) induced by collagen. <i>n</i> = 4. Results are expressed as the mean ± SEM: control = unstimulated platelets; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle. (b) Effect of compound <b>6b</b> at different concentrations on collagen induced P-selectin expression of human platelets. <i>n</i> = 3. Data are shown as the mean ± SEM: control = unstimulated platelets; (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01 vs vehicle. Effect of compound <b>6b</b> at different concentrations on (c) collagen induced ATP release from human platelets, (d) collagen induced thromboxane A<sub>2</sub> release from human platelets. <i>n</i> = 3. Data are shown as the mean ± SEM: (∗∗∗) <i>p</i> < 0.001, (∗∗) <i>p</i> < 0.01, (∗) <i>p</i> < 0.05 vs control. (e, f) Effect of <b>6b</b> at different concentrations on collagen induced intraplatelet calcium mobilization in Fura-2AM loaded human platelets. Effect of compound <b>6b</b> at different concentrations on collagen induced (g) global tyrosine phosphorylation of platelet proteins, (h) tyrosine phoshorylation of PLC-γ2. Washed platelets preincubated at 37 °C with vehicle or various concentrations of <b>6b</b> for 5 min were further stimulated with collagen (2 μg/mL). Blots are representative of three separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/medium/jm-2016-01360m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Best conformation of compound <b>6c</b> at the primary binding site of GPVI (site 1). (b) Best conformation of <b>6d</b> at the primary binding site of GPVI (site 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01360/20170106/images/large/jm-2016-01360m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01360&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Geisler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdeg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2007.02812.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2007.02812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17949474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslOrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=54-61&author=T.+Geislerauthor=D.+Grassauthor=B.+Bigalkeauthor=K.+Stellosauthor=T.+Droschauthor=K.+Dietzauthor=C.+Herdegauthor=M.+Gawaz&title=The+residual+platelet+aggregation+after+deployment+of+intracoronary+stent+%28PREDICT%29+score&doi=10.1111%2Fj.1538-7836.2007.02812.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score</span></div><div class="casAuthors">Geisler, T.; Grab, D.; Bigalke, B.; Stellos, K.; Drosch, T.; Dietz, K.; Herdeg, C.; Gawaz, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Recent studies suggest a high interindividual variability of response to clopidogrel assocd. with adverse cardiovascular outcome.  Different clin. factors are considered to influence a persistent residual platelet aggregation (RPA) despite conventional antiplatelet therapy.  Objectives: To investigate clin. factors that affect RPA after 600-mg clopidogrel loading in a large unselected cohort of patients with symptomatic CAD.  Methods: The study population included a consecutive cohort of 1092 patients treated with coronary stenting for stable angina and acute coronary syndromes (ACS).  Residual platelet activity was assessed by ADP (20 μmol L-1)-induced platelet aggregation ≥ 6 h after LD.  Eleven clin. factors were included in the primary anal.  Results: In multivariate regression anal. increased RPA was significantly influenced by ACS, reduced LV-function, diabetes mellitus, renal failure (creatinine > 1.5 mg dL-1), and age > 65 years.  In a factor-weighed model the risk for high RPA increased with higher score levels (OR for patients with a score of 1-3, 1.21, 95% CI 0.7-2.1; score 4-6, OR 2.0, 95% CI 1.17-3.5; P = 0.01; score 7-9, OR 3.3, 95% CI 1.8-6.0).  During a 30-day follow-up the incidence of major adverse events was higher in patients with RPA in the upper tertile (4.8% vs. 2.5% in the 2nd and 1.5% in the 1st tertile; P < 0.05).  Conclusions: The PREDICT score provides a good tool to est. residual platelet activity after clopidogrel LD by easily available patient details.  Addnl., we demonstrate its assocn. with short-term outcome.  Thus, patients with a high score may benefit from intensified antiplatelet therapy by improved platelet inhibition and risk redn. for thromboischemic events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJmBpBhQ9J97Vg90H21EOLACvtfcHk0li7QqGC1LSprg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslOrt7s%253D&md5=bac965b5613e701c117c2074386615a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02812.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeisler%26aufirst%3DT.%26aulast%3DGrass%26aufirst%3DD.%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DDrosch%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DK.%26aulast%3DHerdeg%26aufirst%3DC.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520residual%2520platelet%2520aggregation%2520after%2520deployment%2520of%2520intracoronary%2520stent%2520%2528PREDICT%2529%2520score%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2008%26volume%3D6%26spage%3D54%26epage%3D61%26doi%3D10.1111%2Fj.1538-7836.2007.02812.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">Platelet-collagen interaction: is GPVI the central receptor?</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1182/blood-2002-12-3882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2002-12-3882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=12649139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=449-461&author=B.+Nieswandtauthor=S.+P.+Watson&title=Platelet-collagen+interaction%3A+is+GPVI+the+central+receptor%3F&doi=10.1182%2Fblood-2002-12-3882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-collagen interaction: Is GPVI the central receptor?</span></div><div class="casAuthors">Nieswandt, Bernhard; Watson, Steve P.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-461</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  At sites of vascular injury, platelets come into contact with subendothelial collagen, which triggers their activation and the formation of a hemostatic plug.  Besides glycoprotein Ib (GPIb) and αIIbβ3 integrin, which indirectly interact with collagen via von Willebrand factor (VWF), several collagen receptors have been identified on platelets, most notably α2β1 integrin and the Ig (Ig) superfamily member GPVI.  Within the last few years, major advances have been made in understanding platelet-collagen interactions including the mol. cloning of GPVI, the generation of mouse strains lacking individual collagen receptors, and the development of collagen receptor-specific antibodies and synthetic peptides.  It is now recognized that platelet adhesion to collagen requires prior activation of integrins through "inside-out" signals generated by GPVI and reinforced by released second-wave mediators ADP (ADP) and thromboxane A2.  These developments have led to revision of the original "2-site, 2-step" model, which now places GPVI in a central position in the complex processes of platelet tethering, activation, adhesion, aggregation, degranulation, and procoagulant activity on collagen.  This review discusses these recent developments and proposes possible mechanisms for how GPVI acts in concert with other receptors and signaling pathways to initiate hemostasis and arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0gKlek4-__bVg90H21EOLACvtfcHk0li7QqGC1LSprg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGitrw%253D&md5=26909f5bdfe8c7c21f57497ffbc79532</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-12-3882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-12-3882%26sid%3Dliteratum%253Aachs%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DPlatelet-collagen%2520interaction%253A%2520is%2520GPVI%2520the%2520central%2520receptor%253F%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D449%26epage%3D461%26doi%3D10.1182%2Fblood-2002-12-3882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melms, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1111/j.1468-1331.2009.02754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1468-1331.2009.02754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19686349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3czitleqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=111-117&author=B.+Bigalkeauthor=K.+Stellosauthor=T.+Geislerauthor=E.+Kremmerauthor=P.+Seizerauthor=A.+E.+Mayauthor=S.+Lindemannauthor=A.+Melmsauthor=A.+Luftauthor=M.+Gawaz&title=Expression+of+platelet+glycoprotein+VI+is+associated+with+transient+ischemic+attack+and+stroke&doi=10.1111%2Fj.1468-1331.2009.02754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke</span></div><div class="casAuthors">Bigalke B; Stellos K; Geisler T; Kremmer E; Seizer P; May A E; Lindemann S; Melms A; Luft A; Gawaz M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Platelet collagen receptor glycoprotein VI (GPVI) contributes significantly to platelet adhesion and thrombus formation.  We aimed to investigate GPVI in patients presenting with symptoms of acute cerebrovascular disease and to define GPVI as biomarker for acute stroke.  METHODS:  We consecutively evaluated 205 patients, who admitted the stroke unit with symptoms for stroke.  Surface expression of the platelet activation markers (GPVI, CD62P, GPIb) was determined by two-color whole blood flow cytometry.  RESULTS:  Patients with transient ischemic attack (TIA) (n = 18; 8.8%) as well as with stroke (n = 133; 64.9%) showed a significantly enhanced GPVI expression (mean fluorescence intensity +/- SD) on admission compared to patients with non-ischemic (NI) events (n = 54; 26.3%) (TIA: 20.9 +/- 7.1 vs.  NI: 16.2 +/- 3.9; P = 0.002; stroke: 20.4 +/- 5.7 vs.  NI; P = 0.002).  Neither CD62P nor GPIb surface expression showed a significant difference.  Logistic regression analysis revealed that on admission GPVI was associated with stroke independent of conventional laboratory markers such as C-reactive protein, blood glucose, and creatine kinase.  Using a receiver operating characteristic curve on GPVI, we have determined the cut off value of 18.2 for stroke.  Thus, patients with enhanced GPVI expression levels (>or=18.2) had a 2.4-fold relative risk for stroke.  Patients with elevated platelet GPVI expression level had a poorer clinical outcome in cumulative event-free survival for stroke, myocardial infarction, and cerebro-/cardiovascular death at 3-month follow-up (log rank; P = 0.045).  CONCLUSIONS:  These findings indicate that platelet GPVI surface expression is significantly enhanced in patients with TIA and stroke compared to patients with NI events.  Determination of platelet-specific GPVI may be useful as an early biomarker for cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo1pDLexOcHny-c-E1v-fmfW6udTcc2eYdfD4brhXqBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czitleqtA%253D%253D&md5=85228796b4b8cbd41cc9923ae9a1039e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2009.02754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2009.02754.x%26sid%3Dliteratum%253Aachs%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DGeisler%26aufirst%3DT.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DA.%2BE.%26aulast%3DLindemann%26aufirst%3DS.%26aulast%3DMelms%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DA.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DExpression%2520of%2520platelet%2520glycoprotein%2520VI%2520is%2520associated%2520with%2520transient%2520ischemic%2520attack%2520and%2520stroke%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2010%26volume%3D17%26spage%3D111%26epage%3D117%26doi%3D10.1111%2Fj.1468-1331.2009.02754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigalke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stakos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkelmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2009.03659.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2009.03659.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19874461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=205-207&author=K.+Stellosauthor=B.+Bigalkeauthor=D.+Stakosauthor=N.+Henkelmannauthor=M.+Gawaz&title=Platelet-bound+P-selectin+expression+in+patients+with+coronary+artery+disease%3A+impact+on+clinical+presentation+and+myocardial+necrosis%2C+and+effect+of+diabetes+mellitus+and+anti-platelet+medication&doi=10.1111%2Fj.1538-7836.2009.03659.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication</span></div><div class="casAuthors">Stellos, K.; Bigalke, B.; Stakos, D.; Henkelmann, N.; Gawaz, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-207</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study tried to explore the possible assocns. between platelet P-selectin and extent of myocardial injury, measured by troponin I (Tn-I) and creatine kinase-MB (CK-MB), and to investigate the relationship between P-selectin expression and clin. presentation in patients with coronary artery disease (CAD).  There was a link between platelet P-selectin and markers of myocardial necrosis (Tn-I and CK-MB) in patients with ACS.  It was also found that improved platelet activation is indicative of the degree of myocardial damage well before peak levels of CK-MB and Tn-I are reached.  In addn., results showed that in a clin. setting of enhanced platelet activity, cardiovascular risk factors such as diabetes or conventional anti-platelet drugs may not have the same effect in platelet activation/inhibition as in patients with stable CAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWvrJspf8aLVg90H21EOLACvtfcHk0lg2tV5olQM-1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltL0%253D&md5=2532cdd625b23c17ac60a2675cabd2c5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2009.03659.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2009.03659.x%26sid%3Dliteratum%253Aachs%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DBigalke%26aufirst%3DB.%26aulast%3DStakos%26aufirst%3DD.%26aulast%3DHenkelmann%26aufirst%3DN.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DPlatelet-bound%2520P-selectin%2520expression%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%253A%2520impact%2520on%2520clinical%2520presentation%2520and%2520myocardial%2520necrosis%252C%2520and%2520effect%2520of%2520diabetes%2520mellitus%2520and%2520anti-platelet%2520medication%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2010%26volume%3D8%26spage%3D205%26epage%3D207%26doi%3D10.1111%2Fj.1538-7836.2009.03659.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Horii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, A. B.</span><span> </span><span class="NLM_article-title">Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span><span class="refDoi"> DOI: 10.1182/blood-2006-01-010215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2006-01-010215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=16861347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=936-942&author=K.+Horiiauthor=M.+L.+Kahnauthor=A.+B.+Herr&title=Structural+basis+for+platelet+collagen+responses+by+the+immune-type+receptor+glycoprotein+VI&doi=10.1182%2Fblood-2006-01-010215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI</span></div><div class="casAuthors">Horii, Katsunori; Kahn, Mark L.; Herr, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">936-942</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Activation of circulating platelets by exposed vessel wall collagen is a primary step in the pathogenesis of heart attack and stroke, and drugs to block platelet activation have successfully reduced cardiovascular morbidity and mortality.  In humans and mice, collagen activation of platelets is mediated by glycoprotein VI (GPVI), a receptor that is homologous to immune receptors but bears little sequence similarity to known matrix protein adhesion receptors.  Here the authors present the crystal structure of the collagen-binding domain of human GPVI and characterize its interaction with a collagen-related peptide.  Like related immune receptors, GPVI contains 2 Ig-like domains arranged in a perpendicular orientation.  Significantly, GPVI forms a back-to-back dimer in the crystal, an arrangement that could explain data previously obtained from cell-surface GPVI inhibition studies.  Docking algorithms identify 2 parallel grooves on the GPVI dimer surface as collagen-binding sites, and the orientation and spacing of these grooves precisely match the dimensions of an intact collagen fiber.  These findings provide a structural basis for the ability of an immune-type receptor to generate signaling responses to collagen and for the development of GPVI inhibitors as new therapies for human cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUNnaUajDU-7Vg90H21EOLACvtfcHk0lg2tV5olQM-1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFajtLo%253D&md5=ea2e412b4f43f072c04dc2aa84009332</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-01-010215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-01-010215%26sid%3Dliteratum%253Aachs%26aulast%3DHorii%26aufirst%3DK.%26aulast%3DKahn%26aufirst%3DM.%2BL.%26aulast%3DHerr%26aufirst%3DA.%2BB.%26atitle%3DStructural%2520basis%2520for%2520platelet%2520collagen%2520responses%2520by%2520the%2520immune-type%2520receptor%2520glycoprotein%2520VI%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26spage%3D936%26epage%3D942%26doi%3D10.1182%2Fblood-2006-01-010215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Andrews, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiguti, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlanga, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theakston, R. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The use of snake venom toxins as tools to study platelet receptors for collagen and von Willebrand factor</span> <span class="citation_source-journal">Pathophysiol. Haemostasis Thromb.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1159/000048059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1159%2F000048059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=155-172&author=R.+K.+Andrewsauthor=A.+S.+Kamigutiauthor=O.+Berlangaauthor=M.+Leducauthor=R.+D.+G.+Theakstonauthor=S.+P.+Watson&title=The+use+of+snake+venom+toxins+as+tools+to+study+platelet+receptors+for+collagen+and+von+Willebrand+factor&doi=10.1159%2F000048059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000048059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000048059%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DR.%2BK.%26aulast%3DKamiguti%26aufirst%3DA.%2BS.%26aulast%3DBerlanga%26aufirst%3DO.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DTheakston%26aufirst%3DR.%2BD.%2BG.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520use%2520of%2520snake%2520venom%2520toxins%2520as%2520tools%2520to%2520study%2520platelet%2520receptors%2520for%2520collagen%2520and%2520von%2520Willebrand%2520factor%26jtitle%3DPathophysiol.%2520Haemostasis%2520Thromb.%26date%3D2002%26volume%3D31%26spage%3D155%26epage%3D172%26doi%3D10.1159%2F000048059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, P. G.</span><span> </span><span class="NLM_article-title">The role of collagen in thrombosis and hemostasis</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2004.00665.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2004.00665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=15102010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslWntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=561-573&author=R.+W.+Farndaleauthor=J.+J.+Sixmaauthor=M.+J.+Barnesauthor=P.+G.+de+Groot&title=The+role+of+collagen+in+thrombosis+and+hemostasis&doi=10.1111%2Fj.1538-7836.2004.00665.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of collagen in thrombosis and hemostasis</span></div><div class="casAuthors">Farndale, R. W.; Sixma, J. J.; Barnes, M. J.; De Groot, P. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-573</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review discusses the role of collagen in the regulation of hemostasis, embracing both coagulation and platelet aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeIjtjelL_bVg90H21EOLACvtfcHk0lhQt8RG1MncsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslWntLs%253D&md5=fe4872a5eaa997a7dcc4ae974820cfc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2004.00665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2004.00665.x%26sid%3Dliteratum%253Aachs%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DSixma%26aufirst%3DJ.%2BJ.%26aulast%3DBarnes%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BGroot%26aufirst%3DP.%2BG.%26atitle%3DThe%2520role%2520of%2520collagen%2520in%2520thrombosis%2520and%2520hemostasis%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2004%26volume%3D2%26spage%3D561%26epage%3D573%26doi%3D10.1111%2Fj.1538-7836.2004.00665.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navdaev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, K. J.</span><span> </span><span class="NLM_article-title">Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span><span class="refDoi"> DOI: 10.1016/j.toxicon.2005.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.toxicon.2005.02.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1089-1098&author=Q.+Luauthor=A.+Navdaevauthor=J.+M.+Clemetsonauthor=K.+J.+Clemetson&title=Snake+venom+C-type+lectins+interacting+with+platelet+receptors.+Structure-function+relationships+and+effects+on+haemostasis&doi=10.1016%2Fj.toxicon.2005.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2005.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2005.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DNavdaev%26aufirst%3DA.%26aulast%3DClemetson%26aufirst%3DJ.%2BM.%26aulast%3DClemetson%26aufirst%3DK.%2BJ.%26atitle%3DSnake%2520venom%2520C-type%2520lectins%2520interacting%2520with%2520platelet%2520receptors.%2520Structure-function%2520relationships%2520and%2520effects%2520on%2520haemostasis%26jtitle%3DToxicon%26date%3D2005%26volume%3D45%26spage%3D1089%26epage%3D1098%26doi%3D10.1016%2Fj.toxicon.2005.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Niedergang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francischetti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span> </span><span class="NLM_article-title">Convulxin binding to platelet receptor GPVI: competition with collagen related peptides</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1006/bbrc.2000.2940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1006%2Fbbrc.2000.2940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10873594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1KmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2000&pages=246-250&author=F.+Niedergangauthor=A.+Alcoverauthor=C.+G.+Knightauthor=R.+W.+Farndaleauthor=M.+J.+Barnesauthor=I.+M.+Francischettiauthor=C.+Bonauthor=M.+Leduc&title=Convulxin+binding+to+platelet+receptor+GPVI%3A+competition+with+collagen+related+peptides&doi=10.1006%2Fbbrc.2000.2940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Convulxin Binding to Platelet Receptor GPVI: Competition with Collagen Related Peptides</span></div><div class="casAuthors">Niedergang, F.; Alcover, A.; Knight, C. G.; Farndale, R. W.; Barnes, M. J.; Francischetti, I. M. B.; Bon, C.; Leduc, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-250</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Convulxin (CVX), a potent platelet aggregating protein from the venom of the snake Crotalus durissus terrificus, is known to bind to the platelet collagen receptor, glycoprotein VI (GPVI).  CVX binding to human platelets was investigated by flow cytometry, using fluorescein labeled convulxin (FITC-CVX).  Scatchard anal. indicated high and low affinity binding sites with Kd values of 0.6 and 4 nM and Bmax values of 1200 and 2000 binding sites per platelet.  FITC-CVX binding was inhibited by collagen related peptides (CRPs) comprising a repeated GPO sequence, namely GCO(GPO)10GCOGNH2 and GKO(GPO)10GKOGNH2, which also bind to receptor GPVI.  These peptides (monomeric or cross-linked forms) gave a high affinity inhibition of 10-20% for concns. between 10 ng/mL and 5 μg/mL, followed by a second phase of inhibition at concns. greater than 5 μg/mL.  It was shown also that the inhibition of FITC-CVX binding by CRPs was independent on the time of preincubation of platelets with CRPs, and the same percentage of inhibition was seen with various concns. of convulxin.  Confocal microscopy of the distribution of FITC-CVX binding sites on platelets showed an homogeneous distribution of FITC-CVX bound to GPVI, although some limited clustering may exist.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-SwyDZZ7wbVg90H21EOLACvtfcHk0lhQt8RG1MncsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1KmsLo%253D&md5=c7d56407efe174441a3395909c4df8d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2000.2940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2000.2940%26sid%3Dliteratum%253Aachs%26aulast%3DNiedergang%26aufirst%3DF.%26aulast%3DAlcover%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DC.%2BG.%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DBarnes%26aufirst%3DM.%2BJ.%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DLeduc%26aufirst%3DM.%26atitle%3DConvulxin%2520binding%2520to%2520platelet%2520receptor%2520GPVI%253A%2520competition%2520with%2520collagen%2520related%2520peptides%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D273%26spage%3D246%26epage%3D250%26doi%3D10.1006%2Fbbrc.2000.2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schulz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1007/s00395-008-0722-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1007%2Fs00395-008-0722-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18431526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2008&pages=356-367&author=C.+Schulzauthor=S.+Penzauthor=C.+Hoffmannauthor=H.+Langerauthor=A.+Gillitzerauthor=S.+Schneiderauthor=R.+Brandlauthor=S.+Seidlauthor=S.+Massbergauthor=B.+Pichlerauthor=E.+Kremmerauthor=K.+Stellosauthor=T.+Schonbergerauthor=W.+Siessauthor=M.+Gawaz&title=Platelet+GPVI+binds+to+collagenous+structures+in+the+core+region+of+human+atheromatous+plaque+and+is+critical+for+atheroprogression+in+vivo&doi=10.1007%2Fs00395-008-0722-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo</span></div><div class="casAuthors">Schulz, Christian; Penz, Sandra; Hoffmann, Christof; Langer, Harald; Gillitzer, Angelika; Schneider, Simon; Brandl, Richard; Seidl, Stefan; Massberg, Steffen; Pichler, Bernd; Kremmer, Elisabeth; Stellos, Konstantinos; Schoenberger, Tanja; Siess, Wolfgang; Gawaz, Meinrad</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-367</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Platelet adhesion to the atherosclerotic vascular wall induces thrombosis and boosters vascular inflammation and atheroprogression.  In the present study we studied the binding of the platelet collagen receptor glycoprotein (GP) VI to human atherosclerotic plaques (AP) and the role of GPVI-mediated platelet adhesion for atheroprogression.  Sol. GPVI-Fc fusion protein bound to immobilized collagen type I, collagen type III, and predominantly to the core region of human carotid atheromatous plaques.  The pattern of GPVI-Fc binding was similar to the immunostaining pattern of collagen type III and differed from the immunostaining of collagen type I, which was more intense in the cap than in the core.  Plaque-induced platelet aggregation in stirred blood and platelet adhesion/aggregate formation under flow were inhibited by the anti-GPVI monoclonal antibody 5C4 or by pretreatment of plaques with anti-collagen type I and anti-collagen type III antibody, or GPVI-Fc.  However, there was no correlation between GPVI-Fc binding and platelet aggregating activity of individual plaques.  GPVI bound also to atherosclerotic arteries of ApoE-deficient mice in vivo as assessed by small animal positron emission tomog. (PET).  Prolonged administration of sol. GPVI attenuated atheroprogression in ApoE-deficient mice.  In humans, GPVI binding to collagenous type I and type III structures of the plaque core region mediates plaque-induced platelet adhesion and aggregation, but GPVI binding is not the sole platelet-activating determinant of plaques.  In mice, GPVI-mediated platelet adhesion to the atherosclerotic vascular wall is involved in an atheroprogression in vivo.  Taken together, our data suggests that GPVI is a relevant target to prevent atherothrombotic events and atheroprogression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-k6AdKeGgGLVg90H21EOLACvtfcHk0lhQt8RG1MncsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVWju78%253D&md5=d1e51ec6db43cde3c0882d5bc499ebb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00395-008-0722-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-008-0722-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DPenz%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DH.%26aulast%3DGillitzer%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DBrandl%26aufirst%3DR.%26aulast%3DSeidl%26aufirst%3DS.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DPichler%26aufirst%3DB.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DSiess%26aufirst%3DW.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DPlatelet%2520GPVI%2520binds%2520to%2520collagenous%2520structures%2520in%2520the%2520core%2520region%2520of%2520human%2520atheromatous%2520plaque%2520and%2520is%2520critical%2520for%2520atheroprogression%2520in%2520vivo%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2008%26volume%3D103%26spage%3D356%26epage%3D367%26doi%3D10.1007%2Fs00395-008-0722-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bultmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2010.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.yjmcc.2010.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20430036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3cjkvFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=532-542&author=A.+Bultmannauthor=Z.+Liauthor=S.+Wagnerauthor=M.+Pelusoauthor=T.+Schonbergerauthor=C.+Weisauthor=I.+Konradauthor=K.+Stellosauthor=S.+Massbergauthor=B.+Nieswandtauthor=M.+Gawazauthor=M.+Ungererauthor=G.+Munch&title=Impact+of+glycoprotein+VI+and+platelet+adhesion+on+atherosclerosis%2D%2Da+possible+role+of+fibronectin&doi=10.1016%2Fj.yjmcc.2010.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin</span></div><div class="casAuthors">Bultmann Andreas; Li Zhongmin; Wagner Silvia; Peluso Mario; Schonberger Tanja; Weis Carla; Konrad Ildiko; Stellos Konstantinos; Massberg Steffen; Nieswandt Bernhard; Gawaz Meinrad; Ungerer Martin; Munch Gotz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular and cellular cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glycoprotein VI (GPVI) mediates binding of platelets to subendothelial collagen during acute arterial thrombosis.  GPVI interactions with the activated atherosclerotic vascular endothelium during early atherosclerosis, however, are not well understood.  In ApoE-/- mice, platelet adhesion to atherosclerotic arteries was increased, as measured by intravital microscopy.  This platelet adhesion was significantly inhibited by IV injection of GPVI-Fc (1 mg/kg body weight).  Atherosclerosis in ApoE-/- mice was attenuated both after 7 and 10 weeks of treatment with the anti-GPVI antibody JAQ1 (2 mg/kg body weight i.p. twice weekly).  Binding of GPVI-Fc (1 mg/kg IV) occurred to deeper layers, but also to the luminal site of plaques in atherosclerotic rabbits, but not to the vessel wall of healthy littermates.  Gene transfer of GPVI-Fc to the carotid vascular wall significantly attenuated athero-progression and endothelial dysfunction in atherosclerotic rabbits in vivo.  Specific binding of the soluble GPVI receptor (GPVI-Fc) to fibronectin was found in vitro to coated ELISA plates.  Platelet adhesion to fibronectin was significantly inhibited both by GPVI-Fc and by the anti-GPVI antibody 5C4 ex vivo in flow chamber experiments.  GPVI plays a role in platelet adhesion to atherosclerotic endothelium in the absence of plaque rupture.  Inhibition of GPVI both via GPVI-Fc and anti-GPVI-antibodies results in protection against atherosclerosis in both cholesterol-fed rabbits and ApoE-/- mice.  This novel mechanism of GPVI-mediated platelet adhesion-possibly via fibronectin-could relevantly contribute to platelet-triggered atheroprogression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpD8JD25GoV1VwdslNBF-tfW6udTcc2eaB8DuJum6vHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjkvFymsg%253D%253D&md5=bf428a60f82f51274c4f1aa1c274d76d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2010.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2010.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBultmann%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DPeluso%26aufirst%3DM.%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DWeis%26aufirst%3DC.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DGawaz%26aufirst%3DM.%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DImpact%2520of%2520glycoprotein%2520VI%2520and%2520platelet%2520adhesion%2520on%2520atherosclerosis--a%2520possible%2520role%2520of%2520fibronectin%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2010%26volume%3D49%26spage%3D532%26epage%3D542%26doi%3D10.1016%2Fj.yjmcc.2010.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel-Axel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judenhofer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reischl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE–/– mice</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1093/cvr/cvn169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1093%2Fcvr%2Fcvn169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=131-137&author=T.+Schonbergerauthor=D.+Siegel-Axelauthor=R.+Busslauthor=S.+Richterauthor=M.+S.+Judenhoferauthor=R.+Haubnerauthor=G.+Reischlauthor=K.+Klingelauthor=G.+Munchauthor=P.+Seizerauthor=B.+J.+Pichlerauthor=M.+Gawaz&title=The+immunoadhesin+glycoprotein+VI-Fc+regulates+arterial+remodelling+after+mechanical+injury+in+ApoE%E2%80%93%2F%E2%80%93+mice&doi=10.1093%2Fcvr%2Fcvn169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvn169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvn169%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DSiegel-Axel%26aufirst%3DD.%26aulast%3DBussl%26aufirst%3DR.%26aulast%3DRichter%26aufirst%3DS.%26aulast%3DJudenhofer%26aufirst%3DM.%2BS.%26aulast%3DHaubner%26aufirst%3DR.%26aulast%3DReischl%26aufirst%3DG.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DMunch%26aufirst%3DG.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DPichler%26aufirst%3DB.%2BJ.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520immunoadhesin%2520glycoprotein%2520VI-Fc%2520regulates%2520arterial%2520remodelling%2520after%2520mechanical%2520injury%2520in%2520ApoE%25E2%2580%2593%252F%25E2%2580%2593%2520mice%26jtitle%3DCardiovasc.%2520Res.%26date%3D2008%26volume%3D80%26spage%3D131%26epage%3D137%26doi%3D10.1093%2Fcvr%2Fcvn169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schonberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seizer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preissner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">C757</span><span class="NLM_x">–</span> <span class="NLM_lpage">C766</span><span class="refDoi"> DOI: 10.1152/ajpcell.00060.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1152%2Fajpcell.00060.2012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=C757-C766&author=T.+Schonbergerauthor=M.+Zieglerauthor=O.+Borstauthor=I.+Konradauthor=B.+Nieswandtauthor=S.+Massbergauthor=C.+Ochmannauthor=T.+Jurgensauthor=P.+Seizerauthor=H.+Langerauthor=G.+Munchauthor=M.+Ungererauthor=K.+T.+Preissnerauthor=M.+Elversauthor=M.+Gawaz&title=The+dimeric+platelet+collagen+receptor+GPVI-Fc+reduces+platelet+adhesion+to+activated+endothelium+and+preserves+myocardial+function+after+transient+ischemia+in+mice&doi=10.1152%2Fajpcell.00060.2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00060.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00060.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberger%26aufirst%3DT.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DBorst%26aufirst%3DO.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DOchmann%26aufirst%3DC.%26aulast%3DJurgens%26aufirst%3DT.%26aulast%3DSeizer%26aufirst%3DP.%26aulast%3DLanger%26aufirst%3DH.%26aulast%3DMunch%26aufirst%3DG.%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26aulast%3DElvers%26aufirst%3DM.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DThe%2520dimeric%2520platelet%2520collagen%2520receptor%2520GPVI-Fc%2520reduces%2520platelet%2520adhesion%2520to%2520activated%2520endothelium%2520and%2520preserves%2520myocardial%2520function%2520after%2520transient%2520ischemia%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2012%26volume%3D303%26spage%3DC757%26epage%3DC766%26doi%3D10.1152%2Fajpcell.00060.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Moroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinmyozu, K.</span><span> </span><span class="NLM_article-title">A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span><span class="refDoi"> DOI: 10.1172/JCI114318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1172%2FJCI114318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=2808700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK3c%252FjslGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1989&pages=1440-1445&author=M.+Moroiauthor=S.+M.+Jungauthor=M.+Okumaauthor=K.+Shinmyozu&title=A+patient+with+platelets+deficient+in+glycoprotein+VI+that+lack+both+collagen-induced+aggregation+and+adhesion&doi=10.1172%2FJCI114318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion</span></div><div class="casAuthors">Moroi M; Jung S M; Okuma M; Shinmyozu K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1440-5</span>
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Molecular level studies on platelets deficient in collagen-induced aggregation provide evidence for identifying possible platelet collagen receptors.  We investigated platelets from a patient with mild bleeding time prolongation, but otherwise normal coagulation data.  Her platelets lacked collagen-induced aggregation and adhesion, but retained normal aggregation and release by other agonists.  Labeling her platelets with 125I or 3H and analysis by SDS-PAGE/autoradiography showed normal levels of glycoproteins Ia, Ib, IIa, IIb, IIIa, and IV.  However, there were significantly decreased incorporations of both radioactivities into a 61-kD membrane glycoprotein (GP), which was identified as GPVI from its mobility on unreduced-reduced, two-dimensional SDS-PAGE.  Sugiyama et al. (1987.  Blood. 69: 1712) reported that the serum from an idiopathic thrombocytopenic purpura (ITP) patient contained an antibody against a 62-kD platelet protein.  Our patient's platelets lacked the antigen for the ITP patient's antibody, demonstrating that the ITP serum contains a specific antibody against GPVI.  The patient's parents' platelets contained approximately 50% the normal amount of GPVI, but still had normal collagen-induced aggregation and adhesion.  The patient's platelets did not bind to types I and III collagen fibrils.  Our results suggest that GPVI functions as a collagen receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBfTgYLLhhajjk2McQZ6XmfW6udTcc2eZGj19IRfKSNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c%252FjslGltA%253D%253D&md5=9c521d6fc2f6e7bc0fa5c009cfcc91c1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1172%2FJCI114318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114318%26sid%3Dliteratum%253Aachs%26aulast%3DMoroi%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DOkuma%26aufirst%3DM.%26aulast%3DShinmyozu%26aufirst%3DK.%26atitle%3DA%2520patient%2520with%2520platelets%2520deficient%2520in%2520glycoprotein%2520VI%2520that%2520lack%2520both%2520collagen-induced%2520aggregation%2520and%2520adhesion%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1989%26volume%3D84%26spage%3D1440%26epage%3D1445%26doi%3D10.1172%2FJCI114318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ryo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugano, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span> </span><span class="NLM_article-title">Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation</span> <span class="citation_source-journal">Am. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1002/ajh.2830390107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fajh.2830390107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1311144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK387mtVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1992&pages=25-31&author=R.+Ryoauthor=A.+Yoshidaauthor=W.+Suganoauthor=M.+Yasunagaauthor=K.+Nakayamaauthor=K.+Saigoauthor=M.+Adachiauthor=N.+Yamaguchiauthor=M.+Okuma&title=Deficiency+of+P62%2C+a+putative+collagen+receptor%2C+in+platelets+from+a+patient+with+defective+collagen-induced+platelet+aggregation&doi=10.1002%2Fajh.2830390107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation</span></div><div class="casAuthors">Ryo R; Yoshida A; Sugano W; Yasunaga M; Nakayama K; Saigo K; Adachi M; Yamaguchi N; Okuma M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of hematology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>
        ISSN:<span class="NLM_cas:issn">0361-8609</span>.
    </div><div class="casAbstract">Recently, we described a platelet antibody against a putative collagen receptor (P62), which was found in a patient with idiopathic thrombocytopenic purpura (ITP) (Blood 69:1712).  We now report a deficiency of the P62 receptor in a young man whose platelets showed defective collagen-induced platelet aggregation.  He had a mild bleeding tendency and slight thrombocytopenia.  The results of coagulation and fibrinolysis studies were normal.  The patient's platelets were partially unresponsive to collagen, although aggregation in response to ADP, thrombin, ristocetin, and calcium ionophore (A23187) was almost normal.  Adhesion of his platelets to bovine collagen was markedly reduced.  Addition of collagen caused no synthesis of thromboxane (TX)B2 in platelet rich plasma (PRP) from this patient.  Furthermore, collagen produced no rise of cytosolic free calcium ([Ca2+]i) in fura2-loaded platelets.  In contrast, thrombin caused TXB2 formation and an increase of [Ca2+]i in his platelets.  These results suggest defective interaction between the platelets and collagen.  The IgG from the ITP-patient induced irreversible aggregation in normal PRP, but caused no aggregation of the young man's platelets.  Immunoblot studies showed that normal platelets had antigens with a molecular weight of 62 KDa under reducing conditions and of 57 KDa under nonreducing conditions.  In contrast, the young man's platelets had no P62 band, although GPIa/IIa and thrombospondin were normally present.  These results indicate that impaired collagen-induced aggregation in the patient's platelets was due to a deficiency of P62 and confirm that P62 may play a crucial role as a collagen receptor in platelet activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSBf12Xn8tbtbHMBt0mMIXfW6udTcc2eb7l53ZOeYeUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387mtVOltQ%253D%253D&md5=397b2ecba2ba7635914cc55667fb2559</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fajh.2830390107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajh.2830390107%26sid%3Dliteratum%253Aachs%26aulast%3DRyo%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DSugano%26aufirst%3DW.%26aulast%3DYasunaga%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DYamaguchi%26aufirst%3DN.%26aulast%3DOkuma%26aufirst%3DM.%26atitle%3DDeficiency%2520of%2520P62%252C%2520a%2520putative%2520collagen%2520receptor%252C%2520in%2520platelets%2520from%2520a%2520patient%2520with%2520defective%2520collagen-induced%2520platelet%2520aggregation%26jtitle%3DAm.%2520J.%2520Hematol.%26date%3D1992%26volume%3D39%26spage%3D25%26epage%3D31%26doi%3D10.1002%2Fajh.2830390107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Arai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoue, K.</span><span> </span><span class="NLM_article-title">Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.1995.tb08900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1365-2141.1995.tb08900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=7530476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADyaK2M7jsVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1995&pages=124-130&author=M.+Araiauthor=N.+Yamamotoauthor=M.+Moroiauthor=N.+Akamatsuauthor=K.+Fukutakeauthor=K.+Tanoue&title=Platelets+with+10%25+of+the+normal+amount+of+glycoprotein+VI+have+an+impaired+response+to+collagen+that+results+in+a+mild+bleeding+tendency&doi=10.1111%2Fj.1365-2141.1995.tb08900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency</span></div><div class="casAuthors">Arai M; Yamamoto N; Moroi M; Akamatsu N; Fukutake K; Tanoue K</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-30</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">Platelet glycoprotein VI (GPVI), a 62kD membrane protein, has been identified as one of the platelet receptors for collagen, since GPVI-deficient platelets exhibit abnormal responses to collagen and an abnormal bleeding tendency.  We report a female patient with a mild bleeding history whose platelets expressed 10% GPVI of normal platelets.  Shape change, aggregation and ATP release of the patient's platelets were completely absent in response to 1-5 micrograms/ml collagen but present normally in response to ADP and Ca2+ ionophore A23187.  Adhesion of the patient's platelets to coated collagen was mildly affected (40-60% of normal platelets) in spite of only 10% expression of GPVI.  Flow cytometrical studies revealed that the patient's platelets expressed normal amounts of the GPIa/IIa complex.  These results suggest that platelet GPVI is less involved in adhesion to collagen than shape change and aggregation induced by collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFDOy1mMTTRfKb6ELK8t0fW6udTcc2eb7l53ZOeYeUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7jsVKmsw%253D%253D&md5=36557c1a1f65ca0829c1ac2ae2b5a287</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1995.tb08900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1995.tb08900.x%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DMoroi%26aufirst%3DM.%26aulast%3DAkamatsu%26aufirst%3DN.%26aulast%3DFukutake%26aufirst%3DK.%26aulast%3DTanoue%26aufirst%3DK.%26atitle%3DPlatelets%2520with%252010%2525%2520of%2520the%2520normal%2520amount%2520of%2520glycoprotein%2520VI%2520have%2520an%2520impaired%2520response%2520to%2520collagen%2520that%2520results%2520in%2520a%2520mild%2520bleeding%2520tendency%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1995%26volume%3D89%26spage%3D124%26epage%3D130%26doi%3D10.1111%2Fj.1365-2141.1995.tb08900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Grothusen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbreen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teebken, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchtefeld, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span> </span><span class="NLM_article-title">EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span><span class="refDoi"> DOI: 10.1161/ATVBAHA.106.138693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2FATVBAHA.106.138693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17347483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFagur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1184-1190&author=C.+Grothusenauthor=S.+Umbreenauthor=I.+Konradauthor=K.+Stellosauthor=C.+Schulzauthor=B.+Schmidtauthor=E.+Kremmerauthor=O.+Teebkenauthor=S.+Massbergauthor=M.+Luchtefeldauthor=B.+Schiefferauthor=M.+Gawaz&title=EXP3179+inhibits+collagen-dependent+platelet+activation+via+glycoprotein+receptor-VI+independent+of+AT1-receptor+antagonism%3A+potential+impact+on+atherothrombosis&doi=10.1161%2FATVBAHA.106.138693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">EXP3179 Inhibits Collagen-Dependent Platelet Activation via Glycoprotein Receptor-VI Independent of AT1-Receptor Antagonism</span></div><div class="casAuthors">Grothusen, Christina; Umbreen, Sumaira; Konrad, Ildiko; Stellos, Konstantinos; Schulz, Christian; Schmidt, Boris; Kremmer, Elisabeth; Teebken, Omke; Massberg, Steffen; Luchtefeld, Maren; Schieffer, Bernhard; Gawaz, Meinrad</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1184-1190</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Thrombus formation after atherosclerotic plaque rupture critically involves the platelet collagen receptor glycoprotein (GP) VI.  The authors investigated the impact of EXP3179, an active metabolite of the angiotensin II type 1 (AT1)-receptor antagonist Losartan (LOS) on GPVI-dependent platelet activation.  EXP3179 and LOS but not EXP3174-the major AT1-receptor blocking metabolite of LOS-dose-dependently inhibited collagen-I (P<0.01) and GPVI-dependent platelet aggregation (P<0.01) analyzed by optical aggregometry.  Platelet activation was further detd. by flow cytometry measuring the expression of platelet PAC-1, an epitope of the activated fibrinogen-receptor complex.  EXP3179 and LOS inhibited collagen-I (P<0.01) and GPVI-dependent PAC-1 expression (P<0.01).  EXP3179 and LOS but not EXP3174 decreased the adhesion of GPVI-receptor expressing Chinese hamster ovarian cells on collagen-I under arterial shear conditions detd. by flow chamber anal. (P<0.01 and P<0.05).  EXP3179 also reduced human atherosclerotic plaque material-induced platelet aggregation (P<0.01) in vitro and murine platelet adhesion after acute vessel injury in vivo as detd. by intravital microscopy (P<0.01).  EXP3179 acts as a specific inhibitor of the platelet collagen receptor GPVI independent of AT1-receptor antagonism.  Further investigations may clarify its individual potential as a novel pharmacol. approach to specifically inhibit atherothrombotic events by GPVI-receptor blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRZHgB-iLrrVg90H21EOLACvtfcHk0lhGBsJ4cXhu9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFagur8%253D&md5=ca8b22fcc9d3ac66262f3c5ba772102b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.106.138693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.106.138693%26sid%3Dliteratum%253Aachs%26aulast%3DGrothusen%26aufirst%3DC.%26aulast%3DUmbreen%26aufirst%3DS.%26aulast%3DKonrad%26aufirst%3DI.%26aulast%3DStellos%26aufirst%3DK.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DTeebken%26aufirst%3DO.%26aulast%3DMassberg%26aufirst%3DS.%26aulast%3DLuchtefeld%26aufirst%3DM.%26aulast%3DSchieffer%26aufirst%3DB.%26aulast%3DGawaz%26aufirst%3DM.%26atitle%3DEXP3179%2520inhibits%2520collagen-dependent%2520platelet%2520activation%2520via%2520glycoprotein%2520receptor-VI%2520independent%2520of%2520AT1-receptor%2520antagonism%253A%2520potential%2520impact%2520on%2520atherothrombosis%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2007%26volume%3D27%26spage%3D1184%26epage%3D1190%26doi%3D10.1161%2FATVBAHA.106.138693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span><span class="refDoi"> DOI: 10.1021/jm901534d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901534d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvF2ktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2087-2093&author=K.+Onoauthor=H.+Uedaauthor=Y.+Yoshizawaauthor=D.+Akazawaauthor=R.+Tanimuraauthor=I.+Shimadaauthor=H.+Takahashi&title=Structural+basis+for+platelet+antiaggregation+by+angiotensin+II+type+1+receptor+antagonist+losartan+%28DuP-753%29+via+glycoprotein+VI&doi=10.1021%2Fjm901534d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Platelet Antiaggregation by Angiotensin II Type 1 Receptor Antagonist Losartan (DuP-753) via Glycoprotein VI</span></div><div class="casAuthors">Ono, Katsuki; Ueda, Hiroshi; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPVI is a key receptor for collagen-induced platelet activation.  Loss or inhibition of GPVI causes only mildly prolonged bleeding times but prevents arterial thrombus formation in animal models.  Therefore, GPVI is considered to be a potent target mol. for therapy of thrombotic diseases.  Recently, it was reported that the AT1-receptor antagonist losartan (DuP-753) and EXP3179 inhibit platelet adhesion and aggregation via GPVI.  However, it is still not clear how losartan is assocd. with inhibition of binding between GPVI and collagen at the mol. level.  Here, we show by NMR that losartan directly interacts with the hydrophobic region consisting of strands C' and E in the N-terminal Ig-like domain of GPVI.  A reliable GPVI-losartan complex model is presented by using a combination of NMR data and in silico tools.  These data indicated that the Ph group with the tetrazole ring in losartan plays a crucial role in the interaction with GPVI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuEFkCuItyhrVg90H21EOLACvtfcHk0lhGBsJ4cXhu9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvF2ktbo%253D&md5=5e8b207328c57117e78a33c174818e14</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901534d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901534d%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DH.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAkazawa%26aufirst%3DD.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520platelet%2520antiaggregation%2520by%2520angiotensin%2520II%2520type%25201%2520receptor%2520antagonist%2520losartan%2520%2528DuP-753%2529%2520via%2520glycoprotein%2520VI%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2087%26epage%3D2093%26doi%3D10.1021%2Fjm901534d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchitchinadze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ropers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jondeau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandrot-Perrus, M.</span><span> </span><span class="NLM_article-title">Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses: The example of losartan</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128744</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0128744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=26052700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128744&author=P.+Jiangauthor=S.+Loyauauthor=M.+Tchitchinadzeauthor=J.+Ropersauthor=G.+Jondeauauthor=M.+Jandrot-Perrus&title=Inhibition+of+glycoprotein+VI+clustering+by+collagen+as+a+mechanism+of+inhibiting+collagen-induced+platelet+responses%3A+The+example+of+losartan&doi=10.1371%2Fjournal.pone.0128744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses: the example of losartan</span></div><div class="casAuthors">Jiang, Peng; Loyau, Stephane; Tchitchinadze, Maria; Ropers, Jacques; Jondeau, Guillaume; Jandrot-Perrus, Martine</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0128744/1-e0128744/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Exposure of platelets to collagen triggers the formation of a platelet clot.  Pharmacol. agents capable of inhibiting platelet activation by collagen are thus of potential therapeutic interest.  Thrombus formation is initiated by the interaction of the GPIb-V-IX complex with collagen-bound vWF, while GPVI interaction with collagen triggers platelet activation that is reinforced by ADP and thromboxane A2.  Losartan is an angiotensin II (Ang II) type I receptor (AT1R) antagonist proposed to have an antiplatelet activity via the inhibition of both the thromboxane A2 (TXA2) receptor (TP) and the glycoprotein VI (GPVI).  Here, we characterized in vitro the effects of losartan at different doses on platelet responses: losartan inhibited platelet aggregation and secretion induced by 1 μg.mL-1 and 10 μg.mL-1 of collagen with an IC50 of ∼ 6 μM.  Losartan inhibited platelet responses induced by the GPVI specific collagen related peptide but not by the α2β1 specific peptide.  However, losartan did not inhibit the binding of recombinant GPVI to collagen, which is not in favor of a simple competition.  Indeed, the clustering of GPVI obsd. in flow cytometry and using the Duolink methodol., was inhibited by losartan.  The impact of a therapeutic dose of losartan (100 mg/day) on platelet responses was analyzed ex vivo in a double blind study.  No statistically significant differences were obsd. between losartan-treated (n = 25) and non-treated (n = 30) patients in terms of collagen and U46619-induced platelet activation.  These data indicate that in treated patients, losartan does not achieve a measurable antiplatelet effect but provide the proof of concept that inhibiting collagen-induced GPVI clustering is of pharmacol. interest to obtain an antithrombotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgPOpJVtnEbVg90H21EOLACvtfcHk0lhGBsJ4cXhu9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFansLc%253D&md5=0c6b5242fe698b82c22e023eebf6035f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128744%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLoyau%26aufirst%3DS.%26aulast%3DTchitchinadze%26aufirst%3DM.%26aulast%3DRopers%26aufirst%3DJ.%26aulast%3DJondeau%26aufirst%3DG.%26aulast%3DJandrot-Perrus%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520glycoprotein%2520VI%2520clustering%2520by%2520collagen%2520as%2520a%2520mechanism%2520of%2520inhibiting%2520collagen-induced%2520platelet%2520responses%253A%2520The%2520example%2520of%2520losartan%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128744%26doi%3D10.1371%2Fjournal.pone.0128744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Taylor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C. H.</span><span> </span><span class="NLM_article-title">Discovery of novel GPVI receptor antagonists by structure-based repurposing</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e101209</span><span class="refDoi"> DOI: 10.1371/journal.pone.0101209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0101209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=24971515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1amtr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e101209&author=L.+Taylorauthor=S.+R.+Vasudevanauthor=C.+I.+Jonesauthor=J.+M.+Gibbinsauthor=G.+C.+Churchillauthor=R.+D.+Campbellauthor=C.+H.+Coxon&title=Discovery+of+novel+GPVI+receptor+antagonists+by+structure-based+repurposing&doi=10.1371%2Fjournal.pone.0101209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel GPVI receptor antagonists by structure-based repurposing</span></div><div class="casAuthors">Taylor, Lewis; Vasudevan, Sridhar R.; Jones, Chris I.; Gibbins, Jonathan M.; Churchill, Grant C.; Campbell, R. Duncan; Coxon, Carmen H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e101209/1-e101209/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inappropriate platelet aggregation creates a cardiovascular risk that is largely managed with thienopyridines and aspirin.  Although effective, these drugs carry risks of increased bleeding and drug 'resistance', underpinning a drive for new antiplatelet agents.  To discover such drugs, one strategy is to identify a suitable druggable target and then find small mols. that modulate it.  A good and unexploited target is the platelet collagen receptor, GPVI, which promotes thrombus formation.  To identify inhibitors of GPVI that are safe and bioavailable, we docked a FDA-approved drug library into the GPVI collagen-binding site in silico.  We now report that losartan and cinanserin inhibit GPVI-mediated platelet activation in a selective, competitive and dose-dependent manner.  This mechanism of action likely underpins the cardioprotective effects of losartan that could not be ascribed to its antihypertensive effects.  We have, therefore, identified small mol. inhibitors of GPVI-mediated platelet activation, and also demonstrated the utility of structure-based repurposing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Pe9roY0HMbVg90H21EOLACvtfcHk0ljmU9cWEG_MDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1amtr7M&md5=efa85474cb4a35a6f30a55b40342477f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0101209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0101209%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DJones%26aufirst%3DC.%2BI.%26aulast%3DGibbins%26aufirst%3DJ.%2BM.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%2BD.%26aulast%3DCoxon%26aufirst%3DC.%2BH.%26atitle%3DDiscovery%2520of%2520novel%2520GPVI%2520receptor%2520antagonists%2520by%2520structure-based%2520repurposing%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De101209%26doi%3D10.1371%2Fjournal.pone.0101209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span> </span><span class="NLM_article-title">Modulation of platelet activation and thrombus formation using a Pan-PI3K inhibitor S14161</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e102394</span><span class="refDoi"> DOI: 10.1371/journal.pone.0102394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1371%2Fjournal.pone.0102394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e102394&author=W.+Yiauthor=Q.+Liauthor=J.+Shenauthor=L.+Renauthor=X.+Liuauthor=Q.+Wangauthor=S.+Heauthor=Q.+Wuauthor=H.+Huauthor=X.+Maoauthor=L.+Zhu&title=Modulation+of+platelet+activation+and+thrombus+formation+using+a+Pan-PI3K+inhibitor+S14161&doi=10.1371%2Fjournal.pone.0102394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0102394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0102394%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DL.%26atitle%3DModulation%2520of%2520platelet%2520activation%2520and%2520thrombus%2520formation%2520using%2520a%2520Pan-PI3K%2520inhibitor%2520S14161%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De102394%26doi%3D10.1371%2Fjournal.pone.0102394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kato-Takagaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akazawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span> </span><span class="NLM_article-title">Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">10720</span><span class="NLM_x">–</span> <span class="NLM_lpage">10727</span><span class="refDoi"> DOI: 10.1074/jbc.M808563200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.M808563200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=19228693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlGrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=10720-10727&author=K.+Kato-Takagakiauthor=Y.+Mizukoshiauthor=Y.+Yoshizawaauthor=D.+Akazawaauthor=Y.+Toriiauthor=K.+Onoauthor=R.+Tanimuraauthor=I.+Shimadaauthor=H.+Takahashi&title=Structural+and+interaction+analysis+of+glycoprotein+VI-binding+peptide+selected+from+a+phage+display+library&doi=10.1074%2Fjbc.M808563200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library</span></div><div class="casAuthors">Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Torii, Yuichi; Ono, Katsuki; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10720-10727</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glycoprotein VI (GPVI) is a major collagen receptor on the platelet surface that recognizes the glycine-proline-hydroxyproline (GPO) sequence in the collagen mol. and plays a crucial role in thrombus formation.  Inhibitors that block the interaction of GPVI with collagen have potential for use as antithrombotic drugs.  For low mol. wt. drug design for GPVI, it is essential to obtain precise structural and interaction information about GPVI-binding ligands.  However, exptl. obtained structural and interaction information of small ligands, such as peptides, in the GPVI-bound state has not been reported.  In this study, by screening a phage-displayed peptide library, we discovered a novel peptide ligand (pep-10L; YSDTDWLYFSTS) without any similarities to the sequence of collagen that inhibits GPVI-GPO binding.  Systematic Ala scanning in surface plasmon resonance expts. and a satn. transfer difference NMR expt. revealed that Trp6, Leu7, Phe9, and Ser10 residues in the pep-10L peptide interacted with GPVI.  Furthermore, the GPVI-bound conformation of the pep-10L peptide was detd. using transferred nuclear Overhauser effect anal.  The obtained structure has revealed that the central part of pep-10L (Asp5-Phe9) has a helical conformation, the side chains of Trp6, Leu7, and Phe9 form a hydrophobic side in the helix, and the Tyr8 side chain faces the opposite direction from the hydrophobic side.  Computational docking prediction has shown that the hydrophobic side of pep-10L sticks in the hydrophobic groove on the GPVI surface, which corresponds to the putative collagen-related peptide binding groove.  These data could enable the structure-guided development of a small mol. GPVI antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNeNnQfTGHArVg90H21EOLACvtfcHk0ljmU9cWEG_MDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlGrs70%253D&md5=4d73d7d531ac5958570b63b308c4ed2e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808563200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808563200%26sid%3Dliteratum%253Aachs%26aulast%3DKato-Takagaki%26aufirst%3DK.%26aulast%3DMizukoshi%26aufirst%3DY.%26aulast%3DYoshizawa%26aufirst%3DY.%26aulast%3DAkazawa%26aufirst%3DD.%26aulast%3DTorii%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DTanimura%26aufirst%3DR.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DH.%26atitle%3DStructural%2520and%2520interaction%2520analysis%2520of%2520glycoprotein%2520VI-binding%2520peptide%2520selected%2520from%2520a%2520phage%2520display%2520library%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D10720%26epage%3D10727%26doi%3D10.1074%2Fjbc.M808563200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span> </span><span class="NLM_article-title">Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4761</span><span class="NLM_x">–</span> <span class="NLM_lpage">4774</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.bmc.2006.03.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4761-4774&author=M.+Zhaoauthor=L.+Biauthor=W.+Biauthor=C.+Wangauthor=Z.+Yangauthor=J.+Juauthor=S.+Peng&title=Synthesis+of+new+class+dipeptide+analogues+with+improved+permeability+and+antithrombotic+activity&doi=10.1016%2Fj.bmc.2006.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DL.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520new%2520class%2520dipeptide%2520analogues%2520with%2520improved%2520permeability%2520and%2520antithrombotic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4761%26epage%3D4774%26doi%3D10.1016%2Fj.bmc.2006.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Im, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, Y. P.</span><span> </span><span class="NLM_article-title">Antiplatelet activity of beta-carboline alkaloids from <i>Perganum harmala</i>: a possible mechanism through inhibiting PLCgamma2 phosphorylation</span> <span class="citation_source-journal">Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.vph.2008.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.vph.2008.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=147-152&author=J.+H.+Imauthor=Y.+R.+Jinauthor=J.+J.+Leeauthor=J.+Y.+Yuauthor=X.+H.+Hanauthor=S.+H.+Imauthor=J.+T.+Hongauthor=H.+S.+Yooauthor=M.+Y.+Pyoauthor=Y.+P.+Yun&title=Antiplatelet+activity+of+beta-carboline+alkaloids+from+Perganum+harmala%3A+a+possible+mechanism+through+inhibiting+PLCgamma2+phosphorylation&doi=10.1016%2Fj.vph.2008.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2008.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2008.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DJ.%2BH.%26aulast%3DJin%26aufirst%3DY.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DYu%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DX.%2BH.%26aulast%3DIm%26aufirst%3DS.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DPyo%26aufirst%3DM.%2BY.%26aulast%3DYun%26aufirst%3DY.%2BP.%26atitle%3DAntiplatelet%2520activity%2520of%2520beta-carboline%2520alkaloids%2520from%2520Perganum%2520harmala%253A%2520a%2520possible%2520mechanism%2520through%2520inhibiting%2520PLCgamma2%2520phosphorylation%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2009%26volume%3D50%26spage%3D147%26epage%3D152%26doi%3D10.1016%2Fj.vph.2008.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tsuchiya, H.</span><span> </span><span class="NLM_article-title">Comparative effects of α-, β-, and γ-carbolines on platelet aggregation and lipid membranes</span> <span class="citation_source-journal">J. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">151596</span><span class="refDoi"> DOI: 10.1155/2011/151596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1155%2F2011%2F151596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21876689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A280%3ADC%252BC3MjpslKnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=151596&author=H.+Tsuchiya&title=Comparative+effects+of+%CE%B1-%2C+%CE%B2-%2C+and+%CE%B3-carbolines+on+platelet+aggregation+and+lipid+membranes&doi=10.1155%2F2011%2F151596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Effects of α-, β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes</span></div><div class="casAuthors">Tsuchiya Hironori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151596</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cigarette smoking and alcohol consumption possibly affect platelet functions.  To verify the hypothesis that some α-, β-, and γ-carboline components in cigarette smoke and alcoholic beverages may change platelet aggregability, their effects on human platelets were determined by aggregometry together with investigating their membrane effects by turbidimetry.  Carbolines inhibited platelet aggregation induced by five agents with the potency being 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole > 3-amino-1-methyl-5H-pyrido[4,3-b]indole > 1-methyl-9H-pyrido[3,4-b]indole.  The most potent 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole showed 50% aggregation-inhibitory concentrations of 6-172 μM.  Both γ-carbolines interacted with phosphatidylcholine membranes to lower the lipid phase transition temperature with the potency correlating to the antiplatelet activity, suggesting that the interaction with platelet membranes to increase their fluidity underlies antiplatelet effects.  Given their possible concentration and accumulation in platelets, γ- and β-carbolines would provide cigarette smokers and alcohol drinkers with reduced platelet aggregability, and they may be responsible for the occurrence of hemorrhagic diseases associated with heavy smoking and alcoholics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1jHmAg29Abrt7lRqEFUJVfW6udTcc2ebbtwPlGU9g07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjpslKnsQ%253D%253D&md5=216de43b1163d6bfd4b3c2e9c3b2a155</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1155%2F2011%2F151596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F151596%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DH.%26atitle%3DComparative%2520effects%2520of%2520%25CE%25B1-%252C%2520%25CE%25B2-%252C%2520and%2520%25CE%25B3-carbolines%2520on%2520platelet%2520aggregation%2520and%2520lipid%2520membranes%26jtitle%3DJ.%2520Toxicol.%26date%3D2011%26volume%3D2011%26spage%3D151596%26doi%3D10.1155%2F2011%2F151596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dua, P. R.</span><span> </span><span class="NLM_article-title">Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino [2′,1′:6,1]pyrido[3,4-b]indoles. New class of central nervous system depressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1021/jm00263a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00263a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=560-564&author=A.+K.+Saxenaauthor=P.+C.+Jainauthor=N.+Anandauthor=P.+R.+Dua&title=Agents+acting+on+the+central+nervous+system.+15.+2-Substituted+1%2C2%2C3%2C4%2C6%2C7%2C12%2C12a-octahydropyrazino+%5B2%E2%80%B2%2C1%E2%80%B2%3A6%2C1%5Dpyrido%5B3%2C4-b%5Dindoles.+New+class+of+central+nervous+system+depressants&doi=10.1021%2Fjm00263a036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00263a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00263a036%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DJain%26aufirst%3DP.%2BC.%26aulast%3DAnand%26aufirst%3DN.%26aulast%3DDua%26aufirst%3DP.%2BR.%26atitle%3DAgents%2520acting%2520on%2520the%2520central%2520nervous%2520system.%252015.%25202-Substituted%25201%252C2%252C3%252C4%252C6%252C7%252C12%252C12a-octahydropyrazino%2520%255B2%25E2%2580%25B2%252C1%25E2%2580%25B2%253A6%252C1%255Dpyrido%255B3%252C4-b%255Dindoles.%2520New%2520class%2520of%2520central%2520nervous%2520system%2520depressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D560%26epage%3D564%26doi%3D10.1021%2Fjm00263a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Saxena, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prathipati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span> </span><span class="NLM_article-title">Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8249</span><span class="NLM_x">–</span> <span class="NLM_lpage">8258</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.bmc.2006.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=17010624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOjt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8249-8258&author=M.+Saxenaauthor=S.+Gaurauthor=P.+Prathipatiauthor=A.+K.+Saxena&title=Synthesis+of+some+substituted+pyrazinopyridoindoles+and+3D+QSAR+studies+along+with+related+compounds%3A+piperazines%2C+piperidines%2C+pyrazinoisoquinolines%2C+and+diphenhydramine%2C+and+its+semi-rigid+analogs+as+antihistamines+%28H1%29&doi=10.1016%2Fj.bmc.2006.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: Piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1)</span></div><div class="casAuthors">Saxena, Mridula; Gaur, Stuti; Prathipati, Philip; Saxena, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8249-8258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">3D QSAR studies on the title compds. led to the development of a model with three biophoric sites and six secondary sites viz.  H-acceptor (ACC), H-donor (DON), heteroatom (presence), hydrophobic (hydrophobicity), steric (refractivity), and a ring (presence) along with total hydrophobicity and total refractivity as global properties.  The model predicted the test set of compds. reasonably well.  Three of the five newly synthesized 2-substituted octahydropyrazinopyridoindoles have shown potent antihistaminic H1 activity with less toxicity and sedation potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowk39v6uAhWLVg90H21EOLACvtfcHk0lgL73VNbzgKUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOjt7zI&md5=ed714e960dfa30d6be42edb200dc0e5f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DM.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPrathipati%26aufirst%3DP.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520of%2520some%2520substituted%2520pyrazinopyridoindoles%2520and%25203D%2520QSAR%2520studies%2520along%2520with%2520related%2520compounds%253A%2520piperazines%252C%2520piperidines%252C%2520pyrazinoisoquinolines%252C%2520and%2520diphenhydramine%252C%2520and%2520its%2520semi-rigid%2520analogs%2520as%2520antihistamines%2520%2528H1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8249%26epage%3D8258%26doi%3D10.1016%2Fj.bmc.2006.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nieswandt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakebusch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari-Nejad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heemskerk, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirngibl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassler, R.</span><span> </span><span class="NLM_article-title">Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2120</span><span class="NLM_x">–</span> <span class="NLM_lpage">2130</span><span class="refDoi"> DOI: 10.1093/emboj/20.9.2120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1093%2Femboj%2F20.9.2120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=2120-2130&author=B.+Nieswandtauthor=C.+Brakebuschauthor=W.+Bergmeierauthor=V.+Schulteauthor=D.+Bouvardauthor=R.+Mokhtari-Nejadauthor=T.+Lindhoutauthor=J.+W.+Heemskerkauthor=H.+Zirngiblauthor=R.+Fassler&title=Glycoprotein+VI+but+not+alpha2beta1+integrin+is+essential+for+platelet+interaction+with+collagen&doi=10.1093%2Femboj%2F20.9.2120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.9.2120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.9.2120%26sid%3Dliteratum%253Aachs%26aulast%3DNieswandt%26aufirst%3DB.%26aulast%3DBrakebusch%26aufirst%3DC.%26aulast%3DBergmeier%26aufirst%3DW.%26aulast%3DSchulte%26aufirst%3DV.%26aulast%3DBouvard%26aufirst%3DD.%26aulast%3DMokhtari-Nejad%26aufirst%3DR.%26aulast%3DLindhout%26aufirst%3DT.%26aulast%3DHeemskerk%26aufirst%3DJ.%2BW.%26aulast%3DZirngibl%26aufirst%3DH.%26aulast%3DFassler%26aufirst%3DR.%26atitle%3DGlycoprotein%2520VI%2520but%2520not%2520alpha2beta1%2520integrin%2520is%2520essential%2520for%2520platelet%2520interaction%2520with%2520collagen%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D2120%26epage%3D2130%26doi%3D10.1093%2Femboj%2F20.9.2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Francischetti, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saliou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leduc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span> </span><span class="NLM_article-title">Convulxin, a potent platelet-aggregating protein from <i>Crotalus durissus terrificus</i> venom, specifically binds to platelets</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span><span class="refDoi"> DOI: 10.1016/S0041-0101(97)00021-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2FS0041-0101%2897%2900021-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1997&pages=1217-1228&author=I.+M.+Francischettiauthor=B.+Saliouauthor=M.+Leducauthor=C.+R.+Carliniauthor=M.+Hatmiauthor=J.+Randonauthor=A.+Failiauthor=C.+Bon&title=Convulxin%2C+a+potent+platelet-aggregating+protein+from+Crotalus+durissus+terrificus+venom%2C+specifically+binds+to+platelets&doi=10.1016%2FS0041-0101%2897%2900021-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0041-0101%2897%2900021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-0101%252897%252900021-4%26sid%3Dliteratum%253Aachs%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%26aulast%3DSaliou%26aufirst%3DB.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DCarlini%26aufirst%3DC.%2BR.%26aulast%3DHatmi%26aufirst%3DM.%26aulast%3DRandon%26aufirst%3DJ.%26aulast%3DFaili%26aufirst%3DA.%26aulast%3DBon%26aufirst%3DC.%26atitle%3DConvulxin%252C%2520a%2520potent%2520platelet-aggregating%2520protein%2520from%2520Crotalus%2520durissus%2520terrificus%2520venom%252C%2520specifically%2520binds%2520to%2520platelets%26jtitle%3DToxicon%26date%3D1997%26volume%3D35%26spage%3D1217%26epage%3D1228%26doi%3D10.1016%2FS0041-0101%2897%2900021-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Polgár, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrel, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnenat, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, T. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemetson, K. J.</span><span> </span><span class="NLM_article-title">Platelet activation and signal transduction by convulxin, a C-type lectin from <i>Crotalus durissus terrificus</i> (tropical rattlesnake) venom via the p62/GPVI collagen receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">13576</span><span class="NLM_x">–</span> <span class="NLM_lpage">13583</span><span class="refDoi"> DOI: 10.1074/jbc.272.21.13576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.272.21.13576" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=13576-13583&author=J.+Polg%C3%A1rauthor=J.+M.+Clemetsonauthor=B.+E.+Kehrelauthor=M.+Wiedemannauthor=E.+M.+Magnenatauthor=T.+N.+C.+Wellsauthor=K.+J.+Clemetson&title=Platelet+activation+and+signal+transduction+by+convulxin%2C+a+C-type+lectin+from+Crotalus+durissus+terrificus+%28tropical+rattlesnake%29+venom+via+the+p62%2FGPVI+collagen+receptor&doi=10.1074%2Fjbc.272.21.13576"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.21.13576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.21.13576%26sid%3Dliteratum%253Aachs%26aulast%3DPolg%25C3%25A1r%26aufirst%3DJ.%26aulast%3DClemetson%26aufirst%3DJ.%2BM.%26aulast%3DKehrel%26aufirst%3DB.%2BE.%26aulast%3DWiedemann%26aufirst%3DM.%26aulast%3DMagnenat%26aufirst%3DE.%2BM.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26aulast%3DClemetson%26aufirst%3DK.%2BJ.%26atitle%3DPlatelet%2520activation%2520and%2520signal%2520transduction%2520by%2520convulxin%252C%2520a%2520C-type%2520lectin%2520from%2520Crotalus%2520durissus%2520terrificus%2520%2528tropical%2520rattlesnake%2529%2520venom%2520via%2520the%2520p62%252FGPVI%2520collagen%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D13576%26epage%3D13583%26doi%3D10.1074%2Fjbc.272.21.13576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Surin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span> </span><span class="NLM_article-title">Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1016/j.thromres.2007.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.thromres.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18045662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=786-803&author=W.+R.+Surinauthor=M.+K.+Barthwalauthor=M.+Dikshit&title=Platelet+collagen+receptors%2C+signaling+and+antagonism%3A+emerging+approaches+for+the+prevention+of+intravascular+thrombosis&doi=10.1016%2Fj.thromres.2007.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet collagen receptors, signaling, and antagonism: Emerging approaches for the prevention of intravascular thrombosis</span></div><div class="casAuthors">Surin, William Rasican; Barthwal, Manoj Kumar; Dikshit, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">786-803</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Collagen, one of the major proteins of sub-endothelial vasculature get exposed following endothelium denudement, is a potent stimulator of platelet adhesion and aggregation.  Adhesion of platelets following endothelial injury is the primary event usually assocd. with uncontrolled platelet activation culminating into intravascular thrombosis, thus needs to be intervened to prevent the pathol. related to various peripheral, myocardial, and cerebral ischemic episodes.  Recent advances in the understanding of collagen mediated platelet adhesion and aggregation have led to the identification of 2 prominent receptors, glycoprotein Ia/IIa (GPIa/IIa or integrin α2β1) and glycoprotein VI (GPVI) and assocd. intracellular signaling, which are undoubtedly the new emerging targets for the development of more effective antithrombotic drugs.  The optimism for collagen antagonism is based on results obtained so far by the use of monoclonal and polyclonal antibodies, peptide inhibitors, knockouts models and collagen-mimetics in various in vitro test systems and animal models.  These findings have revealed that collagen receptor inhibition is an attractive and secure strategy for the new drug development to prevent intravascular thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyost0DrcICLVg90H21EOLACvtfcHk0licleSKQmR-jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtb3O&md5=dbfd35e28f15f5f7b87a457e58fed830</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DSurin%26aufirst%3DW.%2BR.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26atitle%3DPlatelet%2520collagen%2520receptors%252C%2520signaling%2520and%2520antagonism%253A%2520emerging%2520approaches%2520for%2520the%2520prevention%2520of%2520intravascular%2520thrombosis%26jtitle%3DThromb.%2520Res.%26date%3D2008%26volume%3D122%26spage%3D786%26epage%3D803%26doi%3D10.1016%2Fj.thromres.2007.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hsu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. F.</span><span> </span><span class="NLM_article-title">A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1585</span><span class="refDoi"> DOI: 10.1111/j.1538-7836.2008.03071.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1111%2Fj.1538-7836.2008.03071.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18624975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1578-1585&author=C.+C.+Hsuauthor=W.+B.+Wuauthor=T.+F.+Huang&title=A+snake+venom+metalloproteinase%2C+kistomin%2C+cleaves+platelet+glycoprotein+VI+and+impairs+platelet+functions&doi=10.1111%2Fj.1538-7836.2008.03071.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions</span></div><div class="casAuthors">Hsu, C. C.; Wu, W. B.; Huang, T. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1578-1585</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Injuries to the vessel wall and subsequent exposure of the matrix of the subendothelial layer resulted in thrombus formation.  Platelet glycoprotein (GP) Ib and VI play a crucial role in matrix-induced activation and aggregation of platelets.  In the present study, we reported that the GPIb-cleaving snake venom metalloproteinase (SVMP), kistomin, inhibited collagen-induced platelet aggregation.  Moreover, kistomin inhibited platelet aggregation induced by convulxin (CVX, a GPVI agonist) and a GPVI-specific antibody in a concn. and time-dependent manner.  Kistomin treatment decreased platelet GPVI but not integrin α2β1 and αIIbβ3, accompanied with the formation of GPVI cleavage fragments, as detd. by flow cytometric and Western blot analyses.  In addn., intact platelet GPVI and recombinant GPVI were digested by kistomin to release 25- and 35-kDa fragments, suggesting that kistomin cleaved GPVI near the mucin-like region.  We designed four synthetic peptides ranging from Leu180 to Asn249 as the substrates for kistomin and found that kistomin cleaved these synthetic peptides at FSE205/A206TA and NKV218/F219TT, as analyzed by MALDI-TOF-MS.  In addn., GPVI-specific antibody-induced tyrosine kinase phosphorylation in platelets was reduced after kistomin pretreatment, and platelet adhesion to collagen but not to fibrinogen was attenuated by kistomin.  We provided here the first evidence that a P-I snake venom metalloproteinase, kistomin, inhibits the interaction between collagen and platelet GPVI through its proteolytic activity on GPVI, thus providing an alternative strategy for developing new anti-thrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsf1xf5kbYw7Vg90H21EOLACvtfcHk0licleSKQmR-jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqur3O&md5=46585511448428164ef65a1666dbb561</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2008.03071.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2008.03071.x%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DW.%2BB.%26aulast%3DHuang%26aufirst%3DT.%2BF.%26atitle%3DA%2520snake%2520venom%2520metalloproteinase%252C%2520kistomin%252C%2520cleaves%2520platelet%2520glycoprotein%2520VI%2520and%2520impairs%2520platelet%2520functions%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2008%26volume%3D6%26spage%3D1578%26epage%3D1585%26doi%3D10.1111%2Fj.1538-7836.2008.03071.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Takayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinozaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furusako, S.</span><span> </span><span class="NLM_article-title">A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1785</span><span class="NLM_x">–</span> <span class="NLM_lpage">1795</span><span class="refDoi"> DOI: 10.1172/JCI32513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1172%2FJCI32513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18382762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2ntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1785-1795&author=H.+Takayamaauthor=Y.+Hosakaauthor=K.+Nakayamaauthor=K.+Shirakawaauthor=K.+Naitohauthor=T.+Matsusueauthor=M.+Shinozakiauthor=M.+Hondaauthor=Y.+Yatagaiauthor=T.+Kawaharaauthor=J.+Hiroseauthor=T.+Yokoyamaauthor=M.+Kuriharaauthor=S.+Furusako&title=A+novel+antiplatelet+antibody+therapy+that+induces+cAMP-dependent+endocytosis+of+the+GPVI%2FFc+receptor+gamma-chain+complex&doi=10.1172%2FJCI32513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex</span></div><div class="casAuthors">Takayama, Hiroshi; Hosaka, Yoshitaka; Nakayama, Kazuyuki; Shirakawa, Kamon; Naitoh, Katsuki; Matsusue, Tomokazu; Shinozaki, Mikihiko; Honda, Motoyasu; Yatagai, Yukiko; Kawahara, Tetsushi; Hirose, Jiro; Yokoyama, Tooru; Kurihara, Michiru; Furusako, Shoji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1785-1795</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Platelet adhesion to vascular subendothelium, mediated in part by interactions between collagen and glycoprotein VI (GPVI) complexed with Fc receptor γ-chain, is crucial for thrombus formation.  Antiplatelet therapy benefits patients with various thrombotic and ischemic diseases, but the safety and efficacy of existing treatments are limited.  Recent data suggest GPVI as a promising target for a novel antiplatelet therapy, for example, GPVI-specific Abs that deplete GPVI from the surface of platelets.  Here, we characterized GPVI-specific auto-Abs (YA-Abs) from the first reported patient with ongoing platelet GPVI deficiency caused by the YA-Abs.  To obtain exptl. useful human GPVI-specific mAbs with characteristics similar to YA-Abs, we generated human GPVI-specific mouse mAbs and selected 2 representative mAbs, mF1201 and mF1232, whose binding to GPVI was inhibited by YA-Abs.  In vitro, mF1201, but not mF1232, induced human platelet activation and GPVI shedding, and mF1232 inhibited collagen-induced human platelet aggregation.  Administration of mF1201 and mF1232 to monkeys caused GPVI immunodepletion with and without both significant thrombocytopenia and GPVI shedding, resp.  When a human/mouse chimeric form of mF1232 (cF1232) was labeled with a fluorescent endocytosis probe and administered to monkeys, fluorescence increased in circulating platelets and surface GPVI was lost.  Loss of platelet surface GPVI mediated by cF1232 was successfully reproduced in vitro in the presence of a cAMP-elevating agent.  Thus, we have characterized cAMP-dependent endocytosis of GPVI mediated by a human GPVI-specific mAb as what we believe to be a novel antiplatelet therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf_nuBzYehpbVg90H21EOLACvtfcHk0ljTsHQCrchXbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2ntbw%253D&md5=afe1462e0115d9c6a2a23b76f15bc056</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI32513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI32513%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DNaitoh%26aufirst%3DK.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShinozaki%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DM.%26aulast%3DYatagai%26aufirst%3DY.%26aulast%3DKawahara%26aufirst%3DT.%26aulast%3DHirose%26aufirst%3DJ.%26aulast%3DYokoyama%26aufirst%3DT.%26aulast%3DKurihara%26aufirst%3DM.%26aulast%3DFurusako%26aufirst%3DS.%26atitle%3DA%2520novel%2520antiplatelet%2520antibody%2520therapy%2520that%2520induces%2520cAMP-dependent%2520endocytosis%2520of%2520the%2520GPVI%252FFc%2520receptor%2520gamma-chain%2520complex%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1785%26epage%3D1795%26doi%3D10.1172%2FJCI32513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ungerer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosport, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bultmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piechatzek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlieper, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Novel antiplatelet drug revacept (dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.110.980623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2FCIRCULATIONAHA.110.980623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21502572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVyntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1891-1899&author=M.+Ungererauthor=K.+Rosportauthor=A.+Bultmannauthor=R.+Piechatzekauthor=K.+Uhlandauthor=P.+Schlieperauthor=M.+Gawazauthor=G.+Munch&title=Novel+antiplatelet+drug+revacept+%28dimeric+Glycoprotein+VI-Fc%29+specifically+and+efficiently+inhibited+collagen-induced+platelet+aggregation+without+affecting+general+hemostasis+in+humans&doi=10.1161%2FCIRCULATIONAHA.110.980623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans</span></div><div class="casAuthors">Ungerer, Martin; Rosport, Kai; Bueltmann, Andreas; Piechatzek, Richard; Uhland, Kerstin; Schlieper, Peter; Gawaz, Meinrad; Muench, Goetz</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1891-1899</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Blocking of glycoprotein VI-dependent pathways by interfering in vascular collagen sites is commonly seen as an attractive target for an antiplatelet therapy of acute atherosclerotic diseases such as myocardial infarction or stroke.  Revacept (sol. dimeric glycoprotein VI-Fc fusion protein) has been shown to reduce platelet adhesion by blocking vascular collagen in plaques or erosion and to be safe in preclin. studies.  A dose-escalating clin. phase I study was performed to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of Revacept in humans.  In a first-in-humans study, 30 healthy men received a single i.v. administration of 10, 20, 40, 80, or 160 mg Revacept.  The serum concn.-time courses of each dosage of Revacept showed a narrow variation and a concn. and time dependence.  Revacept did not significantly affect the bleeding time.  Collagen-induced platelet aggregation was dose-dependently inhibited up to 48 h at lower doses and for 7 days after higher dose levels.  In contrast, ADP- or thrombin receptor activating peptide-dependent platelet aggregation remained unaltered.  There were no relevant drug-related adverse events or drug-related changes in lab. parameters (biochem., hematol., and coagulation parameters).  There were no drug-related changes in blood pressure, pulse rate, or ECG parameters (including 24-h Holter monitoring).  No anti-Revacept antibodies were detected.  This phase I study demonstrated that Revacept is a safe and well-tolerated new antiplatelet compd. with a clear dose-dependent pharmacokinetic profile with specific, dose-related inhibition of platelet aggregation despite completely unaltered general hemostasis.  Clin. TRIAL REGISTRATION-: URL: www.clinicaltrials.gov.  Unique identifier: NCT 01042964.  URL: eudract.ema.europa.eu.  Identifier: 2005-004656-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq2_xaQAwFvrVg90H21EOLACvtfcHk0ljTsHQCrchXbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVyntrk%253D&md5=bd70cbbb2592a81c0962fc5bba38962f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.110.980623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.110.980623%26sid%3Dliteratum%253Aachs%26aulast%3DUngerer%26aufirst%3DM.%26aulast%3DRosport%26aufirst%3DK.%26aulast%3DBultmann%26aufirst%3DA.%26aulast%3DPiechatzek%26aufirst%3DR.%26aulast%3DUhland%26aufirst%3DK.%26aulast%3DSchlieper%26aufirst%3DP.%26aulast%3DGawaz%26aufirst%3DM.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DNovel%2520antiplatelet%2520drug%2520revacept%2520%2528dimeric%2520Glycoprotein%2520VI-Fc%2529%2520specifically%2520and%2520efficiently%2520inhibited%2520collagen-induced%2520platelet%2520aggregation%2520without%2520affecting%2520general%2520hemostasis%2520in%2520humans%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1891%26epage%3D1899%26doi%3D10.1161%2FCIRCULATIONAHA.110.980623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valicherla, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheruvu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhunia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.3109/00498254.2015.1034224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.3109%2F00498254.2015.1034224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1016-1023&author=A.+Saxenaauthor=G.+R.+Valicherlaauthor=P.+Joshiauthor=R.+Saxenaauthor=S.+H.+Cheruvuauthor=S.+S.+Bhuniaauthor=G.+K.+Jainauthor=H.+H.+Siddiquiauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=Pharmacokinetics%2C+dose+proportionality+and+permeability+of+S002-333+and+its+enantiomers%2C+a+potent+antithrombotic+agent%2C+in+rabbits&doi=10.3109%2F00498254.2015.1034224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3109%2F00498254.2015.1034224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2015.1034224%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DValicherla%26aufirst%3DG.%2BR.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DCheruvu%26aufirst%3DS.%2BH.%26aulast%3DBhunia%26aufirst%3DS.%2BS.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DSiddiqui%26aufirst%3DH.%2BH.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DPharmacokinetics%252C%2520dose%2520proportionality%2520and%2520permeability%2520of%2520S002-333%2520and%2520its%2520enantiomers%252C%2520a%2520potent%2520antithrombotic%2520agent%252C%2520in%2520rabbits%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D1016%26epage%3D1023%26doi%3D10.3109%2F00498254.2015.1034224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bhateria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttrevu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerrabelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span> </span><span class="NLM_article-title">Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1031</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2016.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.jchromb.2016.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=27491065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1031&publication_year=2016&pages=154-162&author=M.+Bhateriaauthor=R.+Ramakrishnaauthor=S.+K.+Puttrevuauthor=S.+Yerrabelliauthor=A.+K.+Saxenaauthor=R.+S.+Bhatta&title=Pre-clinical+investigation+of+plasma+pharmacokinetics+and+biodistribution+of+a+novel+antithrombotic+agent+S002-333+in+mice+using+LC-MS%2FMS&doi=10.1016%2Fj.jchromb.2016.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS</span></div><div class="casAuthors">Bhateria, Manisha; Ramakrishna, Rachumallu; Puttrevu, Santosh Kumar; Yerrabelli, Sahithi; Saxena, Anil K.; Bhatta, Rabi Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1031</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">154-162</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide] is a novel and potent antithrombotic agent developed by CSIR-CDRI, India.  The present study was aimed to develop a sensitive LC-MS/MS method for the quantification of S002-333 in mice plasma and tissues.  The extn. of S002-333 from relatively small amt. of mouse biomatrices (50 μL) was accomplished using protein pptn. followed by liq.-liq. extn. and the sepn. of analytes was achieved on C18 reversed phase column using acetonitrile and triple distd. water (75:25, vol./vol.) as mobile phase at a flow rate of 0.6 mL/min.  The instrument was operated in the multiple reaction monitoring (MRM) mode using electrospray ionization (ESI) in the pos. scan mode.  For all the biomatrices, linear relationship was attained over the concn. range of 0.39-200 ng/mL with correlation coeffs. ≥0.992.  The lower limit of quantification for mouse plasma and tissue homogenates was 0.39 ng/mL.  The bioanal. method was reproducible and reliable for all the matrixes with inter-day and intra-day variability in precision being less than 15% and accuracy within ±15%.  The assay was successfully applied to pharmacokinetics and tissue distribution of S002-333 in mice.  The pharmacokinetic study revealed adequate gastrointestinal absorption of S002-333 into the systemic circulation of mice with abs. oral bioavailability of 45.8%.  Tissue distribution data showed rapid and wide distribution of S002-333 in the following order: small intestine > liver > kidney ≈ lungs > heart > spleen > brain.  The present findings may provide meaningful basis for further clin. development of this new chem. entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYAk61bf41BrVg90H21EOLACvtfcHk0lgsWJ5v0Ll-tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgsrnO&md5=36148a0cf4dbb5501a4d707870dccec2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2016.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2016.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DBhateria%26aufirst%3DM.%26aulast%3DRamakrishna%26aufirst%3DR.%26aulast%3DPuttrevu%26aufirst%3DS.%2BK.%26aulast%3DYerrabelli%26aufirst%3DS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26atitle%3DPre-clinical%2520investigation%2520of%2520plasma%2520pharmacokinetics%2520and%2520biodistribution%2520of%2520a%2520novel%2520antithrombotic%2520agent%2520S002-333%2520in%2520mice%2520using%2520LC-MS%252FMS%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2016%26volume%3D1031%26spage%3D154%26epage%3D162%26doi%3D10.1016%2Fj.jchromb.2016.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bhateria, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttrevu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span> </span><span class="NLM_article-title">Enantioselective inhibition of cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1016/j.cbi.2016.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.cbi.2016.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=27387538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2016&pages=257-265&author=M.+Bhateriaauthor=R.+Ramakrishnaauthor=S.+K.+Puttrevuauthor=A.+K.+Saxenaauthor=R.+S.+Bhatta&title=Enantioselective+inhibition+of+cytochrome+P450-mediated+drug+metabolism+by+a+novel+antithrombotic+agent%2C+S002-333%3A+Major+effect+on+CYP2B6&doi=10.1016%2Fj.cbi.2016.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6</span></div><div class="casAuthors">Bhateria, Manisha; Ramakrishna, Rachumallu; Puttrevu, Santosh Kumar; Saxena, Anil K.; Bhatta, Rabi Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-265</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A significant no. of new chem. entities (NCEs) fail in drug discovery due to inhibition of Cytochrome P 450 (CYP) enzymes.  Therefore, to avert costly drug failure at the clin. phase it becomes indispensable to evaluate the CYP inhibition profile of NCEs early in drug discovery.  In light of these concerns, we envisioned to investigate the inhibitory effects of S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide], a novel and potent antithrombotic agent, on nine major CYP enzymes (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4) of human liver microsomes (HLM).  S002-333 exists as racemic mixt. of S004-1032 (R-isomer) and S007-1558 (S-isomer), consequently, we further examd. the enantioselective differences of S002-333 in the inhibition of human CYP enzymes.  Of the CYP enzymes tested, CYP2B6-catalyzed bupropion 6-hydroxylation was inhibited by S002-333 (IC50 ∼ 9.25 ± 2.46 μM) in a stereoselective manner with (S)-isomer showing potent inhibition (IC50 ∼ 5.28 ± 1.25 μM) in contrast to (R)-isomer which showed negligible inhibition on CYP2B6 activity (IC50 > 50 μM).  S002-333 and its (S)-isomer inhibited CYP2B6 activity in a non-competitive fashion with estd. Ki values of 10.1 ± 3.4 μM and 5.09 ± 1.05 μM, resp.  No shift in the IC50 value was obsd. for S002-333 and its isomers when preincubated for 30 min in the presence of NADPH suggesting that neither S002-333 nor its enantiomers are time-dependent inhibitors.  Thus, the present findings signified that S002-333 is a potent stereoselective inhibitor of CYP2B6, whereas, inhibition for other CYPs was substantially negligible.  These in vitro findings would be useful in deciding the development of S002-333 as a single-enantiomer or as a racemic mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXLCvY6v1XLVg90H21EOLACvtfcHk0lgsWJ5v0Ll-tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GhtLbN&md5=15737bc1b51e01af72d3e508dae3b0a7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DBhateria%26aufirst%3DM.%26aulast%3DRamakrishna%26aufirst%3DR.%26aulast%3DPuttrevu%26aufirst%3DS.%2BK.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26atitle%3DEnantioselective%2520inhibition%2520of%2520cytochrome%2520P450-mediated%2520drug%2520metabolism%2520by%2520a%2520novel%2520antithrombotic%2520agent%252C%2520S002-333%253A%2520Major%2520effect%2520on%2520CYP2B6%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D256%26spage%3D257%26epage%3D265%26doi%3D10.1016%2Fj.cbi.2016.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valicherla, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1002/bdd.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fbdd.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=26477787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Kgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=185-199&author=A.+Saxenaauthor=G.+R.+Valicherlaauthor=G.+K.+Jainauthor=R.+S.+Bhattaauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=Metabolic+profiling+of+a+novel+antithrombotic+compound%2C+S002-333+and+enantiomers%3A+metabolic+stability%2C+species+comparison+and+in+vitro-in+vivo+extrapolation&doi=10.1002%2Fbdd.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation</span></div><div class="casAuthors">Saxena, Amrita; Valicherla, Guru R.; Jain, Girish K.; Bhatta, Rabi S.; Saxena, Anil K.; Gayen, Jiaur R.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">185-199</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objective : The aim of this research work was to characterize the metab. of S002-333, (2-(4'-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-pyrido (3,4-b) indole-3-carboxylic acid amide) and its enantiomers, S004-1032 (R-form) and S007-1558 (S-form) in pooled human liver microsomes (PHLM) and pooled liver microsomes (LM) of rat (RLM), rabbit (RABLM), dog (DLM) and monkey (MLM).  Another objective of this study was to identify suitable surrogate species to humans for further development of lead candidates.  Method : In vitro metabolic stability and metabolite identification of S002-333 and enantiomers were carried out in PHLM and LM of various species.  The prediction of surrogate species and in vitro in vivo extrapolation were performed based upon the calcd. in vitro intrinsic clearance (CLint).  Results/Conclusion : The in vitro CLint values for S002-333, S004-1032 and S007-1558 were 0.027 ± 0.005, 0.025 ± 0.004 and 0.036 ± 0.005 mL/min/mg, resp., in PHLM, indicating that S007-1558 was the most metabolically unstable of the three.  The LM of other species showed similar results.  A common surrogate species to humans for S002-333 and enantiomers was predicted as rabbit where the extrapolated hepatic clearance (CLH) did not show a significant difference to the in vivo CLH values.  However, none of the species closely mimic humans with respect to the proportion of major metabolites (M-1-M-4) formed in vitro.  Likewise, the CLH values were also predicted in humans for S002-333 and enantiomers using various math. models.  During anal., there was no chiral inversion evident among the individual isomers throughout in vitro and in vivo expts.  In conclusion, the in vitro results indicate a prominent role of phase I metab. in the degrdn. of S002-333 and enantiomers and predict rabbit as an alternative species to conduct further safety and efficacy studies.  Copyright © 2016 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUpd-Ck0cMbVg90H21EOLACvtfcHk0lictt7e67vnUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Kgtbs%253D&md5=9413e57e91ea3f7a816495007c117b9a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DValicherla%26aufirst%3DG.%2BR.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DMetabolic%2520profiling%2520of%2520a%2520novel%2520antithrombotic%2520compound%252C%2520S002-333%2520and%2520enantiomers%253A%2520metabolic%2520stability%252C%2520species%2520comparison%2520and%2520in%2520vitro-in%2520vivo%2520extrapolation%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2016%26volume%3D37%26spage%3D185%26epage%3D199%26doi%3D10.1002%2Fbdd.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhunia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayen, J. R.</span><span> </span><span class="NLM_article-title">In vitro metabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.3109/00498254.2013.831958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.3109%2F00498254.2013.831958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=295-308&author=A.+Saxenaauthor=G.+K.+Jainauthor=H.+H.+Siddiquiauthor=S.+S.+Bhuniaauthor=A.+K.+Saxenaauthor=J.+R.+Gayen&title=In+vitro+metabolism+of+a+novel+antithrombotic+compound%2C+S002-333%2C+and+its+enantiomers%3A+quantitative+cytochrome+P450+phenotyping%2C+metabolic+profiling+and+enzyme+kinetic+studies&doi=10.3109%2F00498254.2013.831958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.831958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.831958%26sid%3Dliteratum%253Aachs%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DG.%2BK.%26aulast%3DSiddiqui%26aufirst%3DH.%2BH.%26aulast%3DBhunia%26aufirst%3DS.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DGayen%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520a%2520novel%2520antithrombotic%2520compound%252C%2520S002-333%252C%2520and%2520its%2520enantiomers%253A%2520quantitative%2520cytochrome%2520P450%2520phenotyping%252C%2520metabolic%2520profiling%2520and%2520enzyme%2520kinetic%2520studies%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D295%26epage%3D308%26doi%3D10.3109%2F00498254.2013.831958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhonker, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, G. K.</span><span> </span><span class="NLM_article-title">Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</span> <span class="citation_source-journal">Biomed. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1002/bmc.1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1002%2Fbmc.1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20954216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1234-1239&author=R.+S.+Bhattaauthor=D.+Kumarauthor=Y.+S.+Chhonkerauthor=A.+K.+Saxenaauthor=G.+K.+Jain&title=Bioanalytical+method+development+and+validation+of+novel+antithrombotic+agent+S002-333+by+LC-MS%2FMS+and+its+application+to+pharmacokinetic+studies&doi=10.1002%2Fbmc.1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</span></div><div class="casAuthors">Bhatta, R. S.; Kumar, D.; Chhonker, Y. S.; Saxena, A. K.; Jain, G. K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Chromatography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1234-1239</span>CODEN:
                <span class="NLM_cas:coden">BICHE2</span>;
        ISSN:<span class="NLM_cas:issn">0269-3879</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A rapid, sensitive and simple liq. chromatog.-tandem mass spectrometry (LC-MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti-thrombotic agent S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-β-carboxylic acid amide] in rabbit plasma was developed and validated.  The extn. from plasma was carried out by simple protein pptn. extn. method.  The chromatog. sepn. was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 μm) with a guard column, using acetonitrile-water (75:25,vol./vol.) with flow rate of 0.6 mL/min as the mobile phase.  The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002-333 and m/z 393.4/171for the internal std. dexamethasone, using pos. ion mode.  The MS/MS response was linear over the concn. range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL.  The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concns. and showed no significant matrix effect.  The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6QkNafxqdLrVg90H21EOLACvtfcHk0lictt7e67vnUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqtrjI&md5=ec05deec72697d8a9363f6eae55e261e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fbmc.1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.1433%26sid%3Dliteratum%253Aachs%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26aulast%3DJain%26aufirst%3DG.%2BK.%26atitle%3DBioanalytical%2520method%2520development%2520and%2520validation%2520of%2520novel%2520antithrombotic%2520agent%2520S002-333%2520by%2520LC-MS%252FMS%2520and%2520its%2520application%2520to%2520pharmacokinetic%2520studies%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2010%26volume%3D24%26spage%3D1234%26epage%3D1239%26doi%3D10.1002%2Fbmc.1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Boilard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigrovic, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larabee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coblyn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarotti, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remold-O’Donnell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farndale, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. M.</span><span> </span><span class="NLM_article-title">Platelets amplify inflammation in arthritis via collagen-dependent microparticle production</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1126/science.1181928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1126%2Fscience.1181928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=20110505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=580-583&author=E.+Boilardauthor=P.+A.+Nigrovicauthor=K.+Larabeeauthor=G.+F.+Wattsauthor=J.+S.+Coblynauthor=M.+E.+Weinblattauthor=E.+M.+Massarottiauthor=E.+Remold-O%E2%80%99Donnellauthor=R.+W.+Farndaleauthor=J.+Wareauthor=D.+M.+Lee&title=Platelets+amplify+inflammation+in+arthritis+via+collagen-dependent+microparticle+production&doi=10.1126%2Fscience.1181928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production</span></div><div class="casAuthors">Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Remold-O'Donnell, Eileen; Farndale, Richard W.; Ware, Jerry; Lee, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5965</span>),
    <span class="NLM_cas:pages">580-583</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In addn. to their pivotal role in thrombosis and wound repair, platelets participate in inflammatory responses.  We investigated the role of platelets in the autoimmune disease rheumatoid arthritis.  We identified platelet microparticles-submicrometer vesicles elaborated by activated platelets-in joint fluid from patients with rheumatoid arthritis and other forms of inflammatory arthritis, but not in joint fluid from patients with osteoarthritis.  Platelet microparticles were proinflammatory, eliciting cytokine responses from synovial fibroblasts via interleukin-1.  Consistent with these findings, depletion of platelets attenuated murine inflammatory arthritis.  Using both pharmacol. and genetic approaches, we identified the collagen receptor glycoprotein VI as a key trigger for platelet microparticle generation in arthritis pathophysiol.  Thus, these findings demonstrate a previously unappreciated role for platelets and their activation-induced microparticles in inflammatory joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogezgHXfwd0LVg90H21EOLACvtfcHk0lictt7e67vnUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGmur8%253D&md5=0754291009f1bd3c999943f4262b6031</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscience.1181928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1181928%26sid%3Dliteratum%253Aachs%26aulast%3DBoilard%26aufirst%3DE.%26aulast%3DNigrovic%26aufirst%3DP.%2BA.%26aulast%3DLarabee%26aufirst%3DK.%26aulast%3DWatts%26aufirst%3DG.%2BF.%26aulast%3DCoblyn%26aufirst%3DJ.%2BS.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DMassarotti%26aufirst%3DE.%2BM.%26aulast%3DRemold-O%25E2%2580%2599Donnell%26aufirst%3DE.%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DD.%2BM.%26atitle%3DPlatelets%2520amplify%2520inflammation%2520in%2520arthritis%2520via%2520collagen-dependent%2520microparticle%2520production%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D580%26epage%3D583%26doi%3D10.1126%2Fscience.1181928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Dong, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, D. D.</span><span> </span><span class="NLM_article-title">Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2290</span><span class="NLM_x">–</span> <span class="NLM_lpage">2295</span><span class="refDoi"> DOI: 10.1161/01.CIR.101.19.2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1161%2F01.CIR.101.19.2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10811597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFSrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=2290-2295&author=Z.+M.+Dongauthor=A.+A.+Brownauthor=D.+D.+Wagner&title=Prominent+role+of+P-selectin+in+the+development+of+advanced+atherosclerosis+in+ApoE-deficient+mice&doi=10.1161%2F01.CIR.101.19.2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prominent role of P-selectin in the development of advanced atherosclerosis in apoE-deficient mice</span></div><div class="casAuthors">Dong, Zhao Ming; Brown, Allison A.; Wagner, Denisa D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2290-2295</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background-Adhesive interactions between leukocytes and endothelial cells are characteristic of the development of atherosclerotic lesions, but the receptors involved remain to be defined.  P-selectin is an adhesion receptor expressed on activated endothelial cells or platelets and was shown to be involved in fatty streak formation in LDL receptor-deficient mice on an atherogenic diet.  The main purpose of this study is to examine the role of P-selectin in the spontaneous development of advanced atherosclerosis in apoE-deficient mice.  Methods and Results-We intercrossed P-selectin-deficient mice with lacking apoE and compared lesion development in apoE-deficient mice with P-selectin (apoE-/-P+/+) and without P-selectin (apoE-/-P-/-) that were fed normal mouse chow.  At 4 mo of age, apoE-/-P-/- mice had 3.5-fold smaller aortic sinus lesions than apoE-/-P+/+ mice.  These were limited to fatty streaks in the apoE-/-P-/- mice, whereas 70% of apoE-/-P+/+ lesions contained smooth muscle cells.  Significantly more of the aortic sinus circumference was covered by lesions in the apoE-/-P+/+ animals.  The P-selectin genotype affected macrophage recruitment, because twice as many mononuclear cells were present in the P-selectin-pos. lesions.  At 15 mo, the lesions progressed to the fibrous plaque stage in both genotypes and spread throughout the aorta, but this process was delayed in apoE-/-P-/- mice.  In the aortic sinus, the lesions of the apoE-/-P-/- mice were 2.6-fold smaller and less calcified.  Conclusions-P-selectin appears to be a key adhesion receptor mediating leukocyte recruitment into lesions and promoting advanced atherosclerosis in apoE-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgs1Mt1ZLGVrVg90H21EOLACvtfcHk0lhAkoaS2YMtQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFSrtb4%253D&md5=ed9c5f0f59a11d1d608ad72d6ee0776c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.101.19.2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.101.19.2290%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DZ.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BA.%26aulast%3DWagner%26aufirst%3DD.%2BD.%26atitle%3DProminent%2520role%2520of%2520P-selectin%2520in%2520the%2520development%2520of%2520advanced%2520atherosclerosis%2520in%2520ApoE-deficient%2520mice%26jtitle%3DCirculation%26date%3D2000%26volume%3D101%26spage%3D2290%26epage%3D2295%26doi%3D10.1161%2F01.CIR.101.19.2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Collins, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, A. L.</span><span> </span><span class="NLM_article-title">P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span><span class="refDoi"> DOI: 10.1084/jem.191.1.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1084%2Fjem.191.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10620617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=189-194&author=R.+G.+Collinsauthor=R.+Veljiauthor=N.+V.+Guevaraauthor=M.+J.+Hicksauthor=L.+Chanauthor=A.+L.+Beaudet&title=P-Selectin+or+intercellular+adhesion+molecule+%28ICAM%29-1+deficiency+substantially+protects+against+atherosclerosis+in+apolipoprotein+E-deficient+mice&doi=10.1084%2Fjem.191.1.189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice</span></div><div class="casAuthors">Collins, Robert G.; Velji, Rizwan; Guevara, Natalia V.; Hicks, M. John; Chan, Lawrence; Beaudet, Arthur L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-194</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The expression of leukocyte and endothelial cell adhesion mols. (CAMs) is essential for the emigration of leukocytes during an inflammatory response.  The importance of the inflammatory response in the development of atherosclerosis is indicated by the increased expression of adhesion mols., proinflammatory cytokines, and growth factors in lesions and lesion-prone areas and by protection in mice deficient in various aspects of the inflammatory response.  The authors have quantitated the effect of deficiency for intercellular adhesion mol. (ICAM)-1, P-selectin, or E-selectin on atherosclerotic lesion formation at 20 wk of age in apolipoprotein (apo) E-/- (deficient) mice fed a normal chow diet.  All mice were apo E-/- and CAM+/+ or CAM-/- littermates, and no differences were found in body wt. or cholesterol levels among the various genotypes during the study.  ICAM-1-/- mice had less lesion area than their ICAM-1+/+ littermates: 4.08 mm2 for -/- males vs. 5.87 mm2 for +/+ males, and 3.95 mm2 for -/- females vs. 5.59 mm2 for +/+ females, combined.  An even greater redn. in lesion area was obsd. in P-selectin-/- mice: 3.06 mm2 for -/- males vs. 5.09 mm2 for +/+ males, and 2.85 mm2 for -/- females compared with 5.60 mm2 for +/+ females, combined.  The redn. in lesion area for the E-selectin null mice, although less than that seen for ICAM-1 or P-selectin, was still significant (4.54 mm2 for -/- males vs. 5.92 mm2 for +/+ males, and 4.38 mm2 for -/- females compared with 5.94 mm2 for +/+ females, combined).  These results, coupled with the closely controlled genetics of this study, indicate that redns. in the expression of P-selectin, ICAM-1, or E-selectin provide direct protection from atherosclerotic lesion formation in this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT0KNKK--6rVg90H21EOLACvtfcHk0lhAkoaS2YMtQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFyrug%253D%253D&md5=f52990e7a56e5b56e64323691746bcfd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1084%2Fjem.191.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.191.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DR.%2BG.%26aulast%3DVelji%26aufirst%3DR.%26aulast%3DGuevara%26aufirst%3DN.%2BV.%26aulast%3DHicks%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26atitle%3DP-Selectin%2520or%2520intercellular%2520adhesion%2520molecule%2520%2528ICAM%2529-1%2520deficiency%2520substantially%2520protects%2520against%2520atherosclerosis%2520in%2520apolipoprotein%2520E-deficient%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D189%26epage%3D194%26doi%3D10.1084%2Fjem.191.1.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Blann, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lip, G. Y.</span><span> </span><span class="NLM_article-title">The adhesion molecule P-selectin and cardiovascular disease</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span><span class="refDoi"> DOI: 10.1016/j.ehj.2003.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.ehj.2003.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=14659768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlOisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=2166-2179&author=A.+D.+Blannauthor=S.+K.+Nadarauthor=G.+Y.+Lip&title=The+adhesion+molecule+P-selectin+and+cardiovascular+disease&doi=10.1016%2Fj.ehj.2003.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The adhesion molecule P-selectin and cardiovascular disease</span></div><div class="casAuthors">Blann, Andrew D.; Nadar, Sunil K.; Lip, Gregory Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2166-2179</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The adhesion mol. P-selectin (CD62P) is of interest because of its role in modulating interactions between blood cells and the endothelium, and also because of the possible use of the sol. form as a plasma predictor of adverse cardiovascular events.  Although present on the external cell surface of both activated endothelium and activated platelets, it now seems clear that most, if not all, of the measured plasma P-selectin is of platelet origin.  P-selectin is partially responsible for the adhesion of certain leukocytes and platelets to the endothelium.  Animal models have also shown the important role of P-selectin in the process of atherogenesis.  For example, increased P-selectin expression has been demonstrated on active atherosclerotic plaques; in contrast, fibrotic inactive plaques lack P-selectin expression, and animals lacking P-selectin have a decreased tendency to form atherosclerotic plaques.  Increased levels of sol. P-selectin in the plasma have also been demonstrated in a variety of cardiovascular disorders, including coronary artery disease, hypertension and atrial fibrillation, with some relationship to prognosis.  The objective of this review is to provide an overview of the current literature on this mol. and thus present a concise view of its potential in dissecting the pathophysiol. of atherosclerosis.  In doing so we shall focus primarily on human biol. but will note a small no. of excellent lessons provided by non-human work.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhJ-SiUN4nbVg90H21EOLACvtfcHk0lhAkoaS2YMtQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlOisrs%253D&md5=62ef58ccfe557d311a11dd68876f5c50</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ehj.2003.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ehj.2003.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DBlann%26aufirst%3DA.%2BD.%26aulast%3DNadar%26aufirst%3DS.%2BK.%26aulast%3DLip%26aufirst%3DG.%2BY.%26atitle%3DThe%2520adhesion%2520molecule%2520P-selectin%2520and%2520cardiovascular%2520disease%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2003%26volume%3D24%26spage%3D2166%26epage%3D2179%26doi%3D10.1016%2Fj.ehj.2003.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhy9YDZ7rcp1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">DiMinno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, M. J.</span><span> </span><span class="NLM_article-title">Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=6834277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADyaL3sXitV2nu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=1983&pages=57-60&author=G.+DiMinnoauthor=M.+J.+Silver&title=Mouse+antithrombotic+assay%3A+a+simple+method+for+the+evaluation+of+antithrombotic+agents+in+vivo.+Potentiation+of+antithrombotic+activity+by+ethyl+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse antithrombotic assay:  a simple method for the evaluation of antithrombotic agents in vivo.  Potentiation of antithrombotic activity by ethyl alcohol</span></div><div class="casAuthors">DiMinno, Giovanni; Silver, Melvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-60</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">A simple method for screening antithrombotic agents is presented.  When mice were given an i.v. injection of 0.1 mL of a mixt. of collagen (dose, 15 μg/mouse) and epinephrine  [51-43-4] (dose, 1.8 μg/mouse), 94% died within 5 min or remained paralyzed for more than 15 min.  Examples of the use of the system for the study of antithrombotic agents are given.  Solns. of agents were administered to the animals i.p. about 1 h before the thrombotic challenge.  aspirin  [50-78-2] (20 Mg/kg), OKY-1581  [75987-18-7] (30 mg/kg) and EtOH  [64-17-5] (2 g/kg), administered as single agents in aq. medium, protected 40, 50 and 35% of the animals, resp.  heparin  [9005-49-6] (150 U/kg) was ineffective.  Combinations of EtOH with indomethacin  [53-86-1] or indobufen  [63610-08-2] provided complete protection, whereas EtOH plus aspirin protected 84% and EtOH plus OKY-1581 protected 70% of the animals.  dipyridamole  [58-32-2] Alone (3 mg/kg), dipyridamole (1.65 mg/kg) plus EtOH or dipyridamole (1.65 mg/kg) plus aspirin were ineffective.  The method appears well suited for screening potential antithrombotic agents which act primarily against platelet thromboembolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOz6Gt5i2kqbVg90H21EOLACvtfcHk0lhy9YDZ7rcp1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitV2nu74%253D&md5=3d024281f05c800bf8d03caf5101be48</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMinno%26aufirst%3DG.%26aulast%3DSilver%26aufirst%3DM.%2BJ.%26atitle%3DMouse%2520antithrombotic%2520assay%253A%2520a%2520simple%2520method%2520for%2520the%2520evaluation%2520of%2520antithrombotic%2520agents%2520in%2520vivo.%2520Potentiation%2520of%2520antithrombotic%2520activity%2520by%2520ethyl%2520alcohol%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1983%26volume%3D225%26spage%3D57%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Prakash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surin, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span> </span><span class="NLM_article-title">Anti-platelet effects of curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.thromres.2010.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.thromres.2010.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=21144557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2011&pages=111-118&author=P.+Prakashauthor=A.+Misraauthor=W.+R.+Surinauthor=M.+Jainauthor=R.+S.+Bhattaauthor=R.+Palauthor=K.+Rajauthor=M.+K.+Barthwalauthor=M.+Dikshit&title=Anti-platelet+effects+of+curcuma+oil+in+experimental+models+of+myocardial+ischemia-reperfusion+and+thrombosis&doi=10.1016%2Fj.thromres.2010.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis</span></div><div class="casAuthors">Prakash, Prem; Misra, Ankita; Surin, William R.; Jain, Manish; Bhatta, Rabi S.; Pal, Raghvendra; Raj, Kanwal; Barthwal, Manoj K.; Dikshit, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-118</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Extensive research on the mechanism of action and medicinal importance of curcumin obtained from turmeric (Curcuma longa) has unfolded its potential therapeutic value against many chronic ailments.  Curcuma oil (C.oil), the highly lipophilic component from Curcuma longa has been documented for its neuroprotective efficacy against rat cerebral ischemia-reperfusion injury; however its effect on myocardial reperfusion injury remains unexplored.  In the present study, effect of C.oil (500 mg/kg, po) was evaluated against myocardial ischemia-reperfusion induced injury in the rat model.  C.oil failed to confer protection against cardiac injury, however significant reversal of ADP induced platelet aggregation (p < 0.05) was evident in the same animals.  Moreover, collagen and thrombin induced platelet aggregation (p < 0.001) as well as tyrosine phosphorylation of various proteins in activated platelets was also suppressed.  C.oil also offered significant protection against collagen-epinephrine induced thromboembolism in mice as well as augmented total time to occlusion against FeCl3 induced arterial thrombosis in rats.  C.oil however had no effect on coagulation parameters (TT, PT and aPTT) and exerted a mild effect on the bleeding time.  Bioavailability of C.oil, as assessed by monitoring ar-turmerone, α,β-turmerone and curlone, was 13%, 11% and 7% resp., indicating high systemic exposure.  Moreover, longer mean residence time (MRT) of ar-turmerone (13.2 h), α,β-turmerone (11.6 h) and Curlone (14.0 h) and plasma elimination half lives in the range of 5.5 to 7.2 h correlated with single 500 mg/kg dose regimen of C.oil.  In the present study, C.oil thus seems to be an efficacious and safe anti-platelet agent which was protective against intravascular thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4rO8_w5_3bVg90H21EOLACvtfcHk0lhkeUlGxr08vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVartrY%253D&md5=ed1c8d4c6f3f58a9d060c5c08e55c2a1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2010.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2010.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DP.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DSurin%26aufirst%3DW.%2BR.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DPal%26aufirst%3DR.%26aulast%3DRaj%26aufirst%3DK.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26atitle%3DAnti-platelet%2520effects%2520of%2520curcuma%2520oil%2520in%2520experimental%2520models%2520of%2520myocardial%2520ischemia-reperfusion%2520and%2520thrombosis%26jtitle%3DThromb.%2520Res.%26date%3D2011%26volume%3D127%26spage%3D111%26epage%3D118%26doi%3D10.1016%2Fj.thromres.2010.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anil Kumar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandilya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, D. K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1016%2Fj.ejmech.2016.01.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=1-12&author=A.+Misraauthor=K.+S.+Anil+Kumarauthor=M.+Jainauthor=K.+Bajajauthor=S.+Shandilyaauthor=S.+Srivastavaauthor=P.+Shuklaauthor=M.+K.+Barthwalauthor=M.+Dikshitauthor=D.+K.+Dikshit&title=Synthesis+and+evaluation+of+dual+antiplatelet+activity+of+bispidine+derivatives+of+N-substituted+pyroglutamic+acids&doi=10.1016%2Fj.ejmech.2016.01.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DAnil%2BKumar%26aufirst%3DK.%2BS.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBajaj%26aufirst%3DK.%26aulast%3DShandilya%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DDikshit%26aufirst%3DM.%26aulast%3DDikshit%26aufirst%3DD.%2BK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520dual%2520antiplatelet%2520activity%2520of%2520bispidine%2520derivatives%2520of%2520N-substituted%2520pyroglutamic%2520acids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D110%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.01.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jandrot-Perrus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagrue, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span> </span><span class="NLM_article-title">Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">27035</span><span class="NLM_x">–</span> <span class="NLM_lpage">27041</span><span class="refDoi"> DOI: 10.1074/jbc.272.43.27035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.272.43.27035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=27035-27041&author=M.+Jandrot-Perrusauthor=A.+H.+Lagrueauthor=M.+Okumaauthor=C.+Bon&title=Adhesion+and+activation+of+human+platelets+induced+by+convulxin+involve+glycoprotein+VI+and+integrin+alpha2beta1&doi=10.1074%2Fjbc.272.43.27035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.43.27035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.43.27035%26sid%3Dliteratum%253Aachs%26aulast%3DJandrot-Perrus%26aufirst%3DM.%26aulast%3DLagrue%26aufirst%3DA.%2BH.%26aulast%3DOkuma%26aufirst%3DM.%26aulast%3DBon%26aufirst%3DC.%26atitle%3DAdhesion%2520and%2520activation%2520of%2520human%2520platelets%2520induced%2520by%2520convulxin%2520involve%2520glycoprotein%2520VI%2520and%2520integrin%2520alpha2beta1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D27035%26epage%3D27041%26doi%3D10.1074%2Fjbc.272.43.27035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Dikshit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srimal, R. C.</span><span> </span><span class="NLM_article-title">Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=8510015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADyaK3sXltlKluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=1369-1373&author=M.+Dikshitauthor=R.+Kumariauthor=R.+C.+Srimal&title=Pulmonary+thromboembolism-induced+alterations+in+nitric+oxide+release+from+rat+circulating+neutrophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils</span></div><div class="casAuthors">Dikshit, M.; Kumari, R.; Srimal, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1369-73</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The effect of circulating polymorphonuclear leukocytes (PMNL) isolated from normal and thrombotic rats was studied on platelet aggregation in platelet-rich plasma.  PMNL inhibited the platelet aggregation in a concn.- and time-dependent manner at 37°.  The platelet aggregation inhibitory response of PMNL was more pronounced in the presence of superoxide dismutase and was abolished by Hb and methylene blue.  These observations suggested that the inhibitory effect of PMNL on platelets was mediated by neutrophil-derived relaxing factor.  PMNL, obtained after thromboembolism, inhibited the platelet aggregation response more strongly due to an increased release of NO from them.  It is suggested that PMNL play an important role in the regulation of hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcwU-hO3rT7Vg90H21EOLACvtfcHk0lhkeUlGxr08vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlKluro%253D&md5=c75687d1f06a122209132811eb6751ea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDikshit%26aufirst%3DM.%26aulast%3DKumari%26aufirst%3DR.%26aulast%3DSrimal%26aufirst%3DR.%2BC.%26atitle%3DPulmonary%2520thromboembolism-induced%2520alterations%2520in%2520nitric%2520oxide%2520release%2520from%2520rat%2520circulating%2520neutrophils%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D1369%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bellavite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrioli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arigliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirumbolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santonastaso, C.</span><span> </span><span class="NLM_article-title">A colorimetric method for the measurement of platelet adhesion in microtiter plates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1006/abio.1994.1066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1006%2Fabio.1994.1066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1994&pages=444-450&author=P.+Bellaviteauthor=G.+Andrioliauthor=P.+Guzzoauthor=P.+Ariglianoauthor=S.+Chirumboloauthor=F.+Manzatoauthor=C.+Santonastaso&title=A+colorimetric+method+for+the+measurement+of+platelet+adhesion+in+microtiter+plates&doi=10.1006%2Fabio.1994.1066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1006%2Fabio.1994.1066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1994.1066%26sid%3Dliteratum%253Aachs%26aulast%3DBellavite%26aufirst%3DP.%26aulast%3DAndrioli%26aufirst%3DG.%26aulast%3DGuzzo%26aufirst%3DP.%26aulast%3DArigliano%26aufirst%3DP.%26aulast%3DChirumbolo%26aufirst%3DS.%26aulast%3DManzato%26aufirst%3DF.%26aulast%3DSantonastaso%26aufirst%3DC.%26atitle%3DA%2520colorimetric%2520method%2520for%2520the%2520measurement%2520of%2520platelet%2520adhesion%2520in%2520microtiter%2520plates%26jtitle%3DAnal.%2520Biochem.%26date%3D1994%26volume%3D216%26spage%3D444%26epage%3D450%26doi%3D10.1006%2Fabio.1994.1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yacoub, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoret, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Saleh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merhi, Y.</span><span> </span><span class="NLM_article-title">Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">30024</span><span class="NLM_x">–</span> <span class="NLM_lpage">30035</span><span class="refDoi"> DOI: 10.1074/jbc.M604504200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1074%2Fjbc.M604504200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=30024-30035&author=D.+Yacoubauthor=J.+F.+Theoretauthor=L.+Villeneuveauthor=H.+Abou-Salehauthor=W.+Mouradauthor=B.+G.+Allenauthor=Y.+Merhi&title=Essential+role+of+protein+kinase+C+delta+in+platelet+signaling%2C+alpha+IIb+beta+3+activation%2C+and+thromboxane+A2+release&doi=10.1074%2Fjbc.M604504200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M604504200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M604504200%26sid%3Dliteratum%253Aachs%26aulast%3DYacoub%26aufirst%3DD.%26aulast%3DTheoret%26aufirst%3DJ.%2BF.%26aulast%3DVilleneuve%26aufirst%3DL.%26aulast%3DAbou-Saleh%26aufirst%3DH.%26aulast%3DMourad%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DB.%2BG.%26aulast%3DMerhi%26aufirst%3DY.%26atitle%3DEssential%2520role%2520of%2520protein%2520kinase%2520C%2520delta%2520in%2520platelet%2520signaling%252C%2520alpha%2520IIb%2520beta%25203%2520activation%252C%2520and%2520thromboxane%2520A2%2520release%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D30024%26epage%3D30035%26doi%3D10.1074%2Fjbc.M604504200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambayashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, H.</span><span> </span><span class="NLM_article-title">Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2014</span><span class="refDoi"> DOI: 10.1182/blood-2007-06-097824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=10.1182%2Fblood-2007-06-097824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=18056842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVeisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2007-2014&author=S.+Yoshidaauthor=T.+Sudoauthor=M.+Niimiauthor=L.+Taoauthor=B.+Sunauthor=J.+Kambayashiauthor=H.+Watanabeauthor=E.+Luoauthor=H.+Matsuoka&title=Inhibition+of+collagen-induced+platelet+aggregation+by+anopheline+antiplatelet+protein%2C+a+saliva+protein+from+a+malaria+vector+mosquito&doi=10.1182%2Fblood-2007-06-097824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito</span></div><div class="casAuthors">Yoshida, Shigeto; Sudo, Toshiki; Niimi, Masashi; Tao, Lian; Sun, Bing; Kambayashi, Junichi; Watanabe, Hiroyuki; Luo, Enjie; Matsuoka, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2007-2014</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">During blood feeding, mosquitoes inject saliva contg. a mixt. of mols. that inactivate or inhibit various components of the hemostatic response to the bite injury as well as the inflammatory reactions produced by the bite, to facilitate the ingestion of blood.  However, the mol. functions of the individual saliva components remain largely unknown.  Here, the authors describe anopheline antiplatelet protein (AAPP) isolated from the saliva of Anopheles stephensi, a human malaria vector mosquito.  AAPP exhibited a strong and specific inhibitory activity toward collagen-induced platelet aggregation.  The inhibitory mechanism involves direct binding of AAPP to collagen, which blocks platelet adhesion to collagen and inhibits the subsequent increase in intracellular Ca2+ concn. ([Ca2+]i).  The binding of AAPP to collagen effectively blocked platelet adhesion via glycoprotein VI (GPVI) and integrin α2β1.  Cell adhesion assay showed that AAPP inhibited the binding of GPVI to collagen type I and III without direct effect on GPVI.  Moreover, i.v. administered recombinant AAPP strongly inhibited collagen-induced platelet aggregation ex vivo in rats.  In summary, AAPP is a malaria vector mosquito-derived specific antagonist of receptors that mediate the adhesion of platelets to collagen.  The authors' study may provide important insights for elucidating the effects of mosquito blood feeding against host hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcylwgxh9pOrVg90H21EOLACvtfcHk0ljHU0PiEcwSwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVeisLs%253D&md5=dc7bbe07d2d1d52b8dd946b835b50419</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-06-097824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-06-097824%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DM.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DKambayashi%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DE.%26aulast%3DMatsuoka%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520collagen-induced%2520platelet%2520aggregation%2520by%2520anopheline%2520antiplatelet%2520protein%252C%2520a%2520saliva%2520protein%2520from%2520a%2520malaria%2520vector%2520mosquito%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2007%26epage%3D2014%26doi%3D10.1182%2Fblood-2007-06-097824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>LigPrep, version <span class="NLM_edition">2.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>Protein Preparation Wizard. Schrödinger Suite 2009; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard.+Schr%C3%B6dinger+Suite+2009%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Preparation%2520Wizard.%2520Schr%25C3%25B6dinger%2520Suite%25202009%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>Schrödinger, version <span class="NLM_edition">9.0</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger%2C+version+9.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span>Glide, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GI7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GI7','PDB','2GI7'); return false;">PDB: 2GI7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01360">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53672"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01360">10.1021/acs.jmedchem.6b01360</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Effect of compound <b>6b</b> in ferric chloride induced arterial thrombosis model and docking scores of different conformations for <b>6c</b> and <b>6d</b> in Table S1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Structure coordinates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Structure coordinates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_004.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_001.pdf">jm6b01360_si_001.pdf (84.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_002.pdb">jm6b01360_si_002.pdb (223.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_003.pdb">jm6b01360_si_003.pdb (223.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01360/suppl_file/jm6b01360_si_004.csv">jm6b01360_si_004.csv (1.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01360&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-1%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01360%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01360" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997484df6f3d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
